,key_value,label,ontology_mapping
0,"{'cell line': 'Nalm6', 'construct': 'TEL-AML1', 'replicate': '2', 'source_name': 'Nalm6 pre-B-ALL cell line with inducible TEL-AML1 construct', 'time': '24 h'}",cell_line,"['CVCL:0092', 'EFO:0000322', 'EFO:0002245', 'EFO:0000220', 'CL:0000010']"
1,"{'BioSampleModel': 'Generic', 'cell line': 'U2OS cell line', 'source_name': 'U2OS cell line', 'treatment': 'miR-155 transfection'}",cell_line,"['EFO:0000637', 'DOID:3347', 'UBERON:0003100', 'UBERON:0002481', 'EFO:0000322', 'EFO:0000727', 'EFO:0002869', 'UBERON:0001474', 'CVCL:0042', 'DOID:4', 'EFO:0003156', 'EFO:0000408', 'EFO:0000298', 'EFO:0000726', 'CL:0000010']"
2,"{'cell line': 'HEK293', 'source_name': 'siPAP nuclear fraction replicate #1'}",cell_line,"['CVCL:0045', 'EFO:0000322', 'UBERON:0002113', 'EFO:0001182', 'CL:0000010']"
3,"{'BioSampleModel': 'Generic', 'cell type': 'Basal Cell Carcinoma, nodular', 'source_name': 'Nodular basal cell carcinoma'}",tissue,"['DOID:2513', 'DOID:4280', 'EFO:0006858', 'EFO:0004198', 'EFO:0000311', 'EFO:0000616', 'EFO:0004193', 'EFO:0000313', 'DOID:305', 'EFO:0000408', 'DOID:14566']"
4,"{'cell type': 'sorted CD4- ILC1', 'cohort': 'Control; healthy control subject', 'gender': 'male', 'source_name': 'sorted CD4- ILC1', 'tissue': 'Peripheral blood'}",primary_cells,"['UBERON:0003101', 'UBERON:0000178']"
5,"{'BioSampleModel': 'Generic', 'diagnosis': 'non-ischemic cardiomyopathy', 'lvad support': 'pre-LVAD', 'source_name': 'human left ventricle apex tissue', 'tissue': 'left ventricle apex tissue'}",tissue,"['UBERON:0002082', 'EFO:0001425', 'UBERON:0002084']"
6,"{'BIOMATERIAL_PROVIDER': 'Shin Lin, Stanford University', 'BIOMATERIAL_TYPE': 'Primary Tissue', 'BioSampleModel': 'Generic', 'COLLECTION_METHOD': 'Autopsy', 'DISEASE': 'None', 'DONOR_AGE': '34', 'DONOR_ETHNICITY': 'Caucasian', 'DONOR_HEALTH_STATUS': 'polysubstance abuse (NO diabetes, hypertension, coronary artery disease, cancer)', 'DONOR_ID': 'STL003', 'DONOR_SEX': 'Male', 'MOLECULE': 'genomic DNA', 'TISSUE_DEPOT': 'N/A', 'TISSUE_TYPE': 'Adrenal Gland', 'sample_term_id': 'UBERON_0002369'}",tissue,"['DOID:9351', 'UBERON:0003101', 'EFO:0000319', 'EFO:0001645', 'UBERON:0002530', 'EFO:0004264', 'EFO:0000616', 'EFO:0000311', 'EFO:0000537', 'EFO:0000378', 'EFO:0003156', 'DOID:3393', 'EFO:0000589', 'EFO:1000639', 'DOID:162', 'UBERON:0002369', 'DOID:10763', 'DOID:14566', 'EFO:0000400', 'EFO:0000408']"
7,"{'age': '110 day', 'blood type': 'A+', 'cell line': 'embryonic stem cell line WA09 (H9) NIH registry #0062.', 'growth condition': 'Organoid culture', 'karyotype': '46, XX', 'organism': 'Homo sapiens', 'sex': 'female'}",in_vitro_differentiated_cells,"['UBERON:0003100', 'EFO:0003045', 'EFO:0000322', 'CVCL:9773', 'CL:0000034', 'CL:0002322', 'CL:0000010']"
8,"{'BioSampleModel': 'Generic', 'cell line': 'MDA-MB-231', 'rep': '4', 'source_name': 'MDA-MB-231', 'time-point': '2'}",cell_line,"['CVCL:0062', 'UBERON:0000175', 'UBERON:0003100', 'EFO:0000228', 'EFO:0000322', 'DOID:299', 'DOID:4', 'EFO:0003156', 'UBERON:0007023', 'EFO:0000408', 'EFO:0001209', 'CL:0000010', 'EFO:0001272']"
9,"{'BioSampleModel': 'Generic', 'diagnosis': 'Normal (no amyloid)', 'disease group': 'control', 'source_name': 'control_cerebral cortex', 'tissue': 'temporal neocortex gray matter'}",tissue,"['UBERON:0016538', 'EFO:0003534', 'UBERON:0002020', 'UBERON:0000956']"
10,"{'2nd troponin': '12.18', 'asa': '--', 'batch': '1', 'bun': '9', 'ca': '9.4', 'cad': 'No', 'cl': '100', 'co2': '28', 'creatinine': '0.79', 'current smoking': 'Yes', 'dyslipidemia': 'Yes', 'gender': 'female', 'glucose': '145', 'gpiib/iiia': '--', 'heparin/lovenox': 'Yes', 'ht': 'Yes', 'hx smoking': 'Yes', 'k': '3.7', 'mi type': 'STEMI', 'na': '135', 'pk/day': '0.5', 'pk/year': '--', 'plavix': 'Yes', 'prasugrel': '--', 'rr': '--', 'source_name': 'Plalelets', 'statin': 'Yes', 'study id': 'S34', 'ticagrelor': '--'}",primary_cells,"['UBERON:0003100', 'EFO:0003768', 'EFO:0000589', 'DOID:3146', 'EFO:0004318', 'EFO:0000408']"
11,"{'BioSampleModel': 'Generic', 'cell type': 'tumor cells', 'library': 'polyA RNA', 'source_name': 'HelaS3 cells'}",cell_line,"['EFO:0000616', 'DOID:14566', 'EFO:0000408']"
12,"{'BioSampleModel': 'Generic', 'disease state': 'sALS', 'source_name': 'Whole lumbar spinal cord homogenate', 'tissue': 'whole lumbar spinal cord'}",tissue,"['EFO:0000618', 'EFO:0000253', 'EFO:0003782', 'UBERON:0002240', 'EFO:0000408', 'UBERON:0002792', 'DOID:332', 'EFO:0005772']"
13,"{'BioSampleModel': 'Generic', 'cell line': 'Hs 578T', 'source_name': 'cell line Hs 578T', 'supplier': 'ATCC', 'treatment': 'HAS1 inhibitor'}",cell_line,"['EFO:0003156', 'UBERON:0003100', 'EFO:0001192', 'EFO:0000322', 'EFO:0000727', 'EFO:0000313', 'DOID:4', 'UBERON:0007023', 'DOID:305', 'EFO:0000408', 'CVCL:0332', 'CL:0000010', 'EFO:0001272']"
14,"{'cell type': 'Cranial neural crest cells (CNCCs)', 'cnccs derived from': 'ADRC40 iPSC', 'culture conditions': '+BMP2+ChIRON', 'individual': '2', 'source_name': 'Cranial neural crest cells'}",in_vitro_differentiated_cells,"['UBERON:0003099', 'EFO:0004905', 'CL:0002248', 'CL:0002371', 'CL:0011012', 'CL:0000723', 'CL:0000034', 'CL:0002321', 'EFO:0000795']"
15,"{'BioSampleModel': 'Generic', 'analyte type': 'RNA', 'biospecimen repository': 'NHGRI_ER_PositiveBreastCancer', 'biospecimen repository sample id': 'BRE077608_B42', 'gap_accession': 'phs000857', 'gap_sample_id': '1440750', 'gap_subject_id': '1108711', 'is tumor': 'Yes', 'molecular data type': 'RNA_Seq (NGS)', 'sex': 'female', 'study design': 'Clinical Trial', 'study name': 'Primary ER-positive Breast Cancer Treated with Neoadjuvant Letrozole', 'submitted sample id': 'BRE077608_B42', 'submitted subject id': 'BRE077608', 'submitter handle': 'NHGRI_ER_PositiveBreastCancer'}",tissue,"['EFO:0000616', 'UBERON:0003100', 'DOID:14566', 'EFO:0000408']"
16,"{'age': '59', 'gender': 'female', 'source_name': 'lesional skin sample', 'tissue': 'lesional skin'}",tissue,"['UBERON:0000014', 'UBERON:0003100', 'EFO:0000962']"
17,"{'BioSampleModel': 'Generic', 'differentiation': 'Differentiation 1, 80% confluency', 'source_name': 'Human Adipose Derived Stem Cells', 'starting material': 'single cells', 'time point': 'Day 2'}",in_vitro_differentiated_cells,"['UBERON:0001013', 'CL:0000034']"
18,"{'BioSampleModel': 'Generic', 'cell line': 'HeLa', 'genotype/variation': 'SRSF1 knockdown', 'source_name': 'HeLa (cervical adenocarcinoma)'}",cell_line,"['EFO:0001185', 'UBERON:0003100', 'EFO:0006858', 'EFO:0000228', 'CVCL:0030', 'DOID:299', 'EFO:0001416', 'EFO:0000311', 'EFO:0000313', 'DOID:3702', 'DOID:4', 'EFO:0001061', 'EFO:0000408', 'EFO:0003150', 'UBERON:0000002', 'DOID:14566', 'EFO:0000616', 'CL:0000010', 'EFO:0000322']"
19,"{'BioSampleModel': 'Generic', 'ercc': '2% by volume of ERCC mix #2', 'replicate number': '3', 'sample composition': 'Several brain regions from 23 adult donors', 'source_name': 'Ambion Human Brain Reference RNA (HBRR)'}",tissue,"['UBERON:0000955', 'UBERON:0007023', 'EFO:0001272']"
20,"{'Sex': 'male', 'age': '33', 'brain region': 'BA9', 'identifier': '1905', 'source_name': 'Human brain'}",tissue,"['EFO:0003534', 'UBERON:0000955', 'UBERON:0003101', 'UBERON:0013540']"
21,"{'BioSampleModel': 'Generic', 'cell type': 'M2 macrophages (alternatively activated)', 'donor': '1', 'source_name': 'human monocyte derived macrophages'}",primary_cells,"['CL:0000738', 'CL:0000235', 'CL:0000988', 'CL:0000766', 'CL:0000890']"
22,"{'cell type': 'human primary dermal fibroblast', 'donor': 'donor A', 'passage': 'between 4 and 7', 'source_name': 'NHDF, TGFbeta'}",cell_line,"['CL:0000057', 'CL:0000010']"
23,"{'cell type': 'peripheral monocytes', 'source_name': 'obese women_before bariatric surgery', 'subject id': '#20', 'time point': 'T0; before bariatric surgery', 'type of surgical procedure': 'adjustable gastric banding'}",primary_cells,"['CL:0000738', 'CL:0000766', 'CL:0000842', 'EFO:0002571', 'EFO:0001073', 'CL:0000576', 'CL:0000988']"
24,"{'BioSampleModel': 'Generic', 'ar-v7 status': 'Negative', 'cell type': 'Metastatic castration resistant prostate cancer', 'source_name': 'Metastatic castration resistant prostate cancer', 'therapy': 'Castration'}",tissue,"['EFO:0000616', 'EFO:0000727', 'EFO:0000311', 'DOID:10283', 'EFO:0007355', 'EFO:0000512', 'DOID:162', 'DOID:14566', 'EFO:0000408']"
25,"{'BioSampleModel': 'Generic', 'cell line': 'Ewing sarcoma cell line SKMNC', 'source_name': 'SKNMC cells', 'time': '96 hrs', 'treatment': 'shFLI1'}",cell_line,"['EFO:0000174', 'EFO:0000616', 'EFO:0000727', 'EFO:0000311', 'DOID:3369', 'EFO:0003820', 'DOID:14566', 'EFO:0000322', 'CL:0000010', 'EFO:0000408']"
26,"{'BioSampleModel': 'Generic', 'cell line': 'H1', 'cell type': 'ES-derived cells', 'passage': '30-38', 'source_name': 'overexpression of RUNX1c in Embryonic stem cells; cells collected 3 days after transduction'}",in_vitro_differentiated_cells,"['CL:0002322', 'EFO:0000322', 'CL:0000034', 'CL:0000010']"
27,"{'cell line': 'HeLa', 'genotype': 'Unk-and-GFP-Tet-on', 'organism': 'Homo sapiens', 'phenotype': 'Doxycycline-induced GFP and Unk overexpression'}",cell_line,"['EFO:0001185', 'UBERON:0003100', 'EFO:0000228', 'CVCL:0030', 'DOID:299', 'DOID:4', 'EFO:0000408', 'EFO:0003150', 'UBERON:0000002', 'EFO:0000322', 'CL:0000010']"
28,"{'BioSampleModel': 'Generic', 'cell type': 'Cord blood CD34+ cells', 'growth time': '16 hour culture', 'modulating agent': 'UM171[19nM]', 'source_name': 'Cord blood CD34+_UM171'}",primary_cells,"['UBERON:0012168', 'UBERON:0000178']"
29,"{'BioSampleModel': 'Generic', 'disease status': 'normal', 'source_name': 'Colon tissue,normal', 'tissue': 'Colon tissue'}",tissue,['UBERON:0001155']
30,"{'diagnosis': 'Neurologically normal', 'source_name': 'brain', 'tissue': 'BA9 prefrontal cortex'}",tissue,"['EFO:0003534', 'UBERON:0035944', 'UBERON:0000071', 'UBERON:0000955', 'UBERON:0000451', 'UBERON:0013540']"
31,"{'BioSampleModel': 'Generic', 'cell line': 'C4-2B', 'chip antibody': 'none', 'chip antibody manufacturer': 'none', 'source_name': 'prostate cancer cells', 'treatment': 'DHT treated (16h)'}",cell_line,"['EFO:0000616', 'EFO:0000727', 'EFO:0000311', 'CVCL:4784', 'DOID:10283', 'EFO:0007355', 'EFO:0006365', 'EFO:0000512', 'DOID:162', 'DOID:14566', 'EFO:0000322', 'CL:0000010', 'EFO:0000408']"
32,"{'cell type': 'embryonic stem cell', 'source_name': 'Human embryonic stem cells', 'treatment': 'Gata6 overexpressing hESC line2 in KSR media'}",stem_cells,"['CL:0002322', 'EFO:0000727', 'CL:0000034', 'CL:0000010']"
33,"{'BioSampleModel': 'Generic', 'cell line': 'Saos-2', 'cell type': 'osteosarcoma', 'genetic modification': 'Tet-on TAp73alpha', 'source_name': 'TAp73alpha Saos-2 cell line'}",cell_line,"['EFO:0000637', 'DOID:3347', 'UBERON:0003100', 'EFO:0000691', 'EFO:0000408', 'EFO:0000311', 'EFO:0000616', 'UBERON:0002481', 'UBERON:0001474', 'DOID:4', 'CVCL:0548', 'EFO:0003820', 'EFO:0000510', 'EFO:0000298', 'DOID:14566', 'EFO:0000322', 'CL:0000010', 'EFO:0003156']"
34,"{'analyte type': 'RNA', 'biospecimen repository': 'NCI_PeripheralT_Cell_Lymphomas', 'biospecimen repository sample id': 'B20', 'body site': 'Skin, parotis region', 'gap_accession': 'phs000689', 'gap_consent_code': '1', 'gap_consent_short_name': 'DS-CA-PUB-MDS', 'gap_sample_id': '1224626', 'gap_subject_id': '949077', 'histological type': 'ALCL, ALK-', 'is tumor': 'Yes', 'molecular data type': 'Whole Exome (NGS)', 'study design': 'Case-Control', 'study disease': 'Lymphoma, T-Cell, Peripheral', 'study name': 'Genomic Analysis of Peripheral T-Cell Lymphomas', 'subject is affected': 'Yes', 'submitted sample id': 'B20', 'submitted subject id': 'B20', 'submitter handle': 'NCI_PeripheralT_Cell_Lymphomas'}",tissue,"['UBERON:0000014', 'EFO:0000962', 'EFO:0000616', 'DOID:14566', 'EFO:0000408']"
35,"{'age': '64', 'gender': 'male', 'source_name': 'Human aortic valve leaflet', 'tissue': 'Calcified tricuspid aortic valve'}",tissue,"['UBERON:0011742', 'UBERON:0003101', 'UBERON:0002137']"
36,"{'analyte type': 'RNA', 'biospecimen repository': 'UCSD_CLL', 'biospecimen repository sample id': 'SA52314', 'body site': 'Blood', 'gap_accession': 'phs000767', 'gap_consent_code': '1', 'gap_consent_short_name': 'DS-CLL', 'gap_sample_id': '1317815', 'gap_subject_id': '1027964', 'histological type': 'Chronic Lymphocytic Leukemia', 'is tumor': 'Yes', 'molecular data type': 'RNA_Seq (NGS)', 'sex': 'female', 'study design': 'Tumor vs. Matched-Normal', 'study disease': 'Chronic Lymphocytic Leukemia', 'study name': 'The UC San Diego Chronic Lymphocytic Leukemia (CLL) Study', 'subject is affected': 'Yes', 'submitted sample id': 'SA52314', 'submitted subject id': 'SU11596', 'submitter handle': 'UCSD_CLL'}",tissue,"['UBERON:0003100', 'EFO:0000616', 'EFO:0000311', 'EFO:0001642', 'UBERON:0000178', 'EFO:0005803', 'EFO:0000095', 'DOID:1040', 'EFO:0000408', 'EFO:0000565', 'EFO:0000540', 'DOID:14566']"
37,"{'cell_line': 'HCT15', 'tissue_type': 'epithelial'}",cell_line,"['EFO:0000365', 'UBERON:0003101', 'DOID:0050861', 'EFO:0002188', 'UBERON:0001155', 'EFO:0000322', 'DOID:4', 'EFO:0000408', 'CL:0000010', 'CL:0000066', 'CVCL:0292']"
38,"{'BioSampleModel': 'Generic', 'cell type': 'Cultured primary human lung fibroblast', 'source_name': 'Cultured human lung fibroblast'}",cell_line,"['CL:0000057', 'CL:0002553']"
39,"{'BioSampleModel': 'Generic', 'cell type': 'primary foot fibroblast', 'sample type': 'RNA sequencing', 'source_name': 'Foot (c45) fibroblasts'}",cell_line,"['EFO:0002693', 'UBERON:0002387', 'CL:0000057']"
40,"{'BioSampleModel': 'Generic', 'age': '71', 'gender': 'female', 'group': 'alzheimer patient', 'source_name': 'whole blood'}",tissue,"['UBERON:0003100', 'EFO:0000249', 'UBERON:0000178']"
41,"{'BioSampleModel': 'Generic', 'age': '76', 'bmi': '33.1', 'gender': 'Female', 'hba1c': '6.8', 'source_name': 'pancreatic islets', 'tissue': 'pancreatic islets', 'year of birth': '1934'}",primary_cells,"['UBERON:0035946', 'UBERON:0003100', 'UBERON:0000006']"
42,"{'BioSampleModel': 'Generic', 'agent': 'DMSO', 'cell line': '584-A2', 'cell type': 'Head and Neck Squamous Cell Carcinoma cells', 'source_name': '584-A2_DMSO'}",cell_line,"['CVCL:V278', 'EFO:0000616', 'EFO:0000311', 'EFO:0000408', 'EFO:0000181', 'DOID:14566', 'EFO:0000322', 'CL:0000010', 'DOID:5520']"
43,"{'BioSampleModel': 'Generic', 'disease state': 'Control', 'sex': 'M', 'source_name': 'Brain cortex', 'tissue': 'Human brain cortex (BA9)'}",tissue,"['UBERON:0000955', 'EFO:0003534', 'UBERON:0013540', 'UBERON:0000956', 'UBERON:0003101']"
44,"{'cell line': 'MCF7+BORIS (Clone2, single-cell clone of MCF7 cell, stably expressing BORIS)', 'source_name': 'Human breast cancer cell line'}",cell_line,"['DOID:4', 'UBERON:0000175', 'UBERON:0003100', 'EFO:0000228', 'EFO:0000322', 'CVCL:0031', 'DOID:299', 'UBERON:0001911', 'EFO:0000311', 'DOID:162', 'DOID:1612', 'EFO:0003156', 'EFO:0002885', 'UBERON:0007023', 'EFO:0000408', 'EFO:0001203', 'UBERON:0000310', 'DOID:14566', 'EFO:0000616', 'CL:0000010', 'EFO:0001272']"
45,"{'BioSampleModel': 'Generic', 'source_name': 'islets of Langerhans', 'tissue': 'islets of Langerhans', 'treatment': 'palmitate'}",primary_cells,"['EFO:0000727', 'UBERON:0000006']"
46,"{'BioSampleModel': 'Generic', 'source_name': 'skin', 'tissue type': 'Uninvolved skin'}",tissue,"['UBERON:0000014', 'EFO:0000962']"
47,"{'BioSampleModel': 'Generic', 'cell cycle phase': 'G1 (day6-0 h)', 'cell line': 'H9', 'cell type': 'hESC-derived endoderm cells', 'source_name': 'hESC-derived endoderm cells, G1'}",in_vitro_differentiated_cells,"['UBERON:0000925', 'EFO:0003045', 'EFO:0000322', 'CVCL:9773', 'CL:0000034', 'CL:0000223', 'CL:0002322', 'EFO:0000795', 'CL:0000010']"
48,"{'source_name': 'small airway epithelial cell line', 'tgf-beta treatment': 'None', 'tnf-alpha treatment': '1 hour'}",cell_line,"['EFO:0000322', 'EFO:0000727', 'CL:0002368', 'CL:0000066', 'CL:0000010']"
49,"{'BioSampleModel': 'Generic', 'biopsy location': 'left leg', 'exercise status': 'untrained', 'gender': 'male', 'original sample id': '2T1', 'source_name': 'skeletal muscle', 'time point': 'pre-training period 1', 'tissue': 'skeletal muscle'}",tissue,"['UBERON:0014895', 'UBERON:0003101', 'EFO:0000483', 'UBERON:0000978', 'UBERON:0014892', 'UBERON:0001134', 'UBERON:0001015', 'UBERON:0001630']"
50,"{'barcode': 'CATTGTTAGC', 'source_name': 'CD4+ T cells', 'status': 'healthy'}",primary_cells,"['CL:0000084', 'CL:0000738', 'CL:0000988', 'CL:0000624', 'CL:0000542']"
51,"{'BioSampleModel': 'Generic', 'cell line': 'HEK293', 'purification': 'oligo(dT) beads', 'source_name': 'HEK293 cell culture', 'transfection': 'MOV10 siRNA'}",cell_line,"['EFO:0001182', 'CVCL:0045', 'EFO:0000726', 'UBERON:0002113', 'EFO:0000322', 'CL:0000010']"
52,"{'BioSampleModel': 'Generic', 'cell type': 'CD34+ HSPC-derived proerythroblasts', 'shRNA': 'shSUZ12', 'source_name': 'Human primary fetal live proerythroblasts (ProEs), shSUZ12', 'tissue': 'fetal liver'}",in_vitro_differentiated_cells,"['CL:0000763', 'CL:0000764', 'UBERON:0007220', 'CL:0000547', 'UBERON:0000323', 'CL:0000988', 'UBERON:0002107']"
53,"{'BioSampleModel': 'Generic', 'cell line': 'WI38', 'cell type': 'primary fibroblasts', 'genotype/variation': 'infected with pBABE-puro-empty', 'source_name': 'Proliferatives_RNAseq', 'status': 'Proliferative'}",cell_line,"['CVCL:0579', 'UBERON:0003100', 'CL:0000057', 'EFO:0000322', 'EFO:0003156', 'EFO:0001260', 'UBERON:0002048', 'CL:0000010']"
54,"{'BioSampleModel': 'Generic', 'cell line': 'IMR90', 'cell type': 'proliferating', 'source_name': 'IMR90 human fiboblasts'}",cell_line,"['EFO:0001196', 'UBERON:0003100', 'CL:0000057', 'EFO:0000322', 'EFO:0003156', 'CVCL:0347', 'UBERON:0002048', 'CL:0000010']"
55,"{'BioSampleModel': 'Generic', 'cell type': 'MCF7', 'source_name': 'MCF7 cell line', 'treatment': '10nM E2 treatment for 24h'}",cell_line,"['EFO:0003156', 'UBERON:0000175', 'UBERON:0003100', 'EFO:0000228', 'CVCL:0031', 'EFO:0000322', 'EFO:0001203', 'EFO:0000727', 'UBERON:0000310', 'DOID:4', 'UBERON:0007023', 'EFO:0000408', 'UBERON:0001911', 'DOID:299', 'CL:0000010', 'EFO:0001272']"
56,"{'BioSampleModel': 'Generic', 'cell line': '11-18', 'source_name': '11-18 cells, treated with PBS-1086', 'tissue': 'Lung adenocarcinoma', 'treatment': 'treated with PBS-1086'}",cell_line,"['EFO:0000684', 'EFO:0006858', 'EFO:0000228', 'CVCL:A596', 'EFO:0000571', 'EFO:0000322', 'EFO:0000727', 'EFO:0000311', 'EFO:0000313', 'EFO:0003818', 'EFO:0001071', 'DOID:3910', 'EFO:0000408', 'DOID:299', 'EFO:0003060', 'DOID:14566', 'EFO:0000616', 'CL:0000010']"
57,"{'BioSampleModel': 'Human', 'age': 'not collected', 'biomaterial_provider': 'Prlic Lab, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA.', 'cell_line': 'not applicable', 'cell_subtype': 'not applicable', 'cell_type': 'Mucosal Associated Invariant T-cell', 'culture_collection': 'not applicable', 'dev_stage': 'not applicable', 'disease': 'not applicable', 'disease_stage': 'not applicable', 'ethnicity': 'not collected', 'health_state': 'healthy', 'isolate': 'single cell S65', 'karyotype': 'not collected', 'phenotype': 'not applicable', 'population': 'not applicable', 'race': 'not collected', 'sample_type': 'single-cell', 'sex': 'not collected', 'tissue': 'Immune System', 'treatment': 'Unstim'}",primary_cells,"['CL:0000738', 'EFO:0000727', 'UBERON:0002405', 'CL:0000084', 'CL:0000542', 'CL:0000988']"
58,"{'cell line': 'BJ', 'cell type': 'Fibroblast', 'rna type': 'Total RNA', 'source_name': 'Fibroblast cell'}",cell_line,"['EFO:0000322', 'CL:0000057', 'CL:0000010']"
59,"{'BioSampleModel': 'Generic', 'cell type': 'lymphoblastoid cell line', 'sex': 'Male', 'source_name': 'GM18507'}",cell_line,"['EFO:0005292', 'UBERON:0003101']"
60,"{'BioSampleModel': 'Generic', 'genotype/variation': 'reduced PTEN', 'source_name': 'MCF7L breast cancer cells'}",cell_line,"['EFO:0000616', 'EFO:0000311', 'DOID:1612', 'EFO:0000408', 'DOID:162', 'DOID:14566']"
61,"{'cell line': 'MCF-7M', 'parental cell line': 'MCF-7', 'sirna': 'LIN28 +A1 (LIN28A1)', 'source_name': 'MCF-7M cells', 'tissue': 'breast'}",cell_line,"['EFO:0003156', 'CVCL:6672', 'UBERON:0003100', 'EFO:0000228', 'CVCL:0031', 'DOID:299', 'UBERON:0001911', 'UBERON:0000175', 'UBERON:0000310', 'DOID:4', 'UBERON:0007023', 'EFO:0000408', 'EFO:0001203', 'EFO:0000322', 'CL:0000010', 'EFO:0001272']"
62,"{'BioSampleModel': 'Generic', 'cell line': 'MCF7', 'source_name': 'MCF7'}",cell_line,"['EFO:0003156', 'UBERON:0000175', 'UBERON:0003100', 'EFO:0000228', 'CVCL:0031', 'EFO:0000322', 'EFO:0001203', 'UBERON:0000310', 'DOID:4', 'UBERON:0007023', 'EFO:0000408', 'UBERON:0001911', 'DOID:299', 'CL:0000010', 'EFO:0001272']"
63,"{'BioSampleModel': 'Generic', 'cell type': 'human GBM-derived ""stem-like"" cells', 'genotype': 'BMI1 dox-inducible', 'source_name': 'human GBM1 GSCs+BMI1 knockdown+BMP7+Arvanil+doxycycline', 'treatment': 'BMI1 knockdown+BMP7+Arvanil+doxycycline'}",stem_cells,"['EFO:0000272', 'DOID:3068', 'EFO:0000727', 'EFO:0000311', 'EFO:0000408', 'EFO:0005543', 'DOID:14566', 'EFO:0000616', 'EFO:0000519']"
64,"{'BioSampleModel': 'Generic', 'antibody': 'no', 'experiment': 'RNA-Seq', 'restriction enzyme': 'no', 'source_name': 'fetal lung fibroblast', 'treatment': 'no treat'}",cell_line,"['CL:0000057', 'CL:0002553', 'UBERON:0007220', 'EFO:0000727', 'UBERON:0000323', 'EFO:0002694']"
65,"{'BioSampleModel': 'Generic', 'developmental stage': 'Embryonic stem cells', 'source_name': 'Embryonic stem cells'}",stem_cells,"['CL:0002322', 'CL:0000034']"
66,"{'BioSampleModel': 'Generic', 'cell line': 'MDA-MB231 cells', 'sirna': 'siE2', 'source_name': 'MDA-MB231 cells'}",cell_line,"['CVCL:0062', 'UBERON:0000175', 'UBERON:0003100', 'EFO:0000228', 'EFO:0000322', 'DOID:299', 'DOID:4', 'EFO:0003156', 'UBERON:0007023', 'EFO:0000408', 'EFO:0001209', 'CL:0000010', 'EFO:0001272']"
67,"{'BioSampleModel': 'Generic', 'cell line': 'MCF-7', 'source_name': 'Breast cancer cells', 'treatment': 'Non-specific control RNA'}",cell_line,"['DOID:4', 'UBERON:0000175', 'UBERON:0003100', 'EFO:0000228', 'EFO:0000322', 'EFO:0000311', 'DOID:299', 'UBERON:0001911', 'EFO:0000727', 'DOID:162', 'DOID:1612', 'EFO:0003156', 'UBERON:0007023', 'EFO:0000408', 'EFO:0001203', 'CVCL:0031', 'UBERON:0000310', 'DOID:14566', 'EFO:0000616', 'CL:0000010', 'EFO:0001272']"
68,"{'cell type': 'normal', 'patient': 'follicular thyroid carcinoma', 'source_name': 'formalin-fixed paraffin-embedded tissue'}",primary_cells,"['DOID:3963', 'DOID:3962', 'EFO:0006858', 'EFO:0000228', 'EFO:0003769', 'EFO:0003841', 'EFO:0000616', 'EFO:0000311', 'EFO:0000313', 'DOID:305', 'EFO:0000501', 'EFO:0002892', 'DOID:14566', 'EFO:0001379', 'EFO:0000408']"
69,"{'BioSampleModel': 'Generic', 'co-culture': 'OP9-GFP', 'source_name': 'CD34+, OP9-GFP, donor4'}",primary_cells,[]
70,"{'BioSampleModel': 'Generic', 'antibody': 'Ago2', 'antibody manufacturer': 'Abnova', 'cell line': '293S', 'source_name': '293S cells', 'treatment': 'no treatment (control)'}",cell_line,"['CVCL:A784', 'EFO:0000322', 'EFO:0000727', 'CL:0000010']"
71,"{'BioSampleModel': 'Generic', 'cell type': 'HeLa-229 cells', 'sample collection time': '72h post-transfection', 'source_name': 'HeLa-229_miR-503', 'transfected with': 'miR-503 (final conc. of 50nM)'}",cell_line,"['EFO:0000726', 'CVCL:1276', 'CL:0000010']"
72,"{'BioSampleModel': 'Generic', 'cell type': 'iPSC-derived midbrain dopamine (mDA) neurons', 'expression construct': 'Nuclear GFP', 'source_name': 'iPSC-derived midbrain dopamine (mDA) neurons'}",in_vitro_differentiated_cells,"['UBERON:0001891', 'CL:0002248', 'CL:0000034', 'CL:0002371', 'CL:0000723', 'CL:0000540', 'EFO:0004905']"
73,"{'cell line': 'KBM7', 'cell type': 'Chronic myelogenous leukemia cell line', 'passages': '2', 'source_name': 'KBM7_gene_trap_3kb_downstream'}",cell_line,"['CVCL:A426', 'DOID:1240', 'EFO:0005294', 'EFO:0000616', 'EFO:0000565', 'EFO:0000311', 'EFO:0000339', 'EFO:0001642', 'EFO:0005903', 'EFO:0000408', 'DOID:8552', 'EFO:0000540', 'DOID:14566', 'EFO:0000322', 'CL:0000010']"
74,"{'BioSampleModel': 'Generic', 'cdh1 genotype': 'CDH1-/-', 'cell line': 'MCF10A', 'cell type': 'mammary epithelial cells', 'source_name': 'MCF10A CDH1-/-'}",cell_line,"['EFO:0003156', 'UBERON:0003100', 'CL:0000066', 'EFO:0000322', 'UBERON:0000310', 'DOID:4', 'EFO:0001200', 'EFO:0000408', 'UBERON:0001911', 'CVCL:0598', 'CL:0002327', 'CL:0000010']"
75,"{'BioSampleModel': 'Generic', 'cell line': 'SGBS', 'cell type': 'pre-adipocyte', 'culture media': 'SGBS pre-adipocytes were grown in DMEM/F12 medium supplemented with 10% fetal calf serum (FCS), 1.7 mM panthotenat, 3.3 mM biotin and 1% penicillin/streptomycin', 'differentiation days': '0', 'passages': '42-46', 'source_name': 'human pre-adipocyte'}",cell_line,"['CVCL:GS28', 'EFO:0000322', 'UBERON:0001977', 'CL:0002334', 'CL:0000010']"
76,"{'BioSampleModel': 'Generic', 'cells': 'K562', 'shRNA expression': 'yes, targeting SRF', 'source_name': 'SL2934', 'treatment': 'Puromycin, doxycycline'}",cell_line,['EFO:0000727']
77,"{'BioSampleModel': 'Generic', 'cell type': 'CD4+ T cells', 'source_name': 'CD4+ T cells', 'treatment': 'JQ1 treated'}",primary_cells,"['CL:0000738', 'EFO:0000727', 'CL:0000084', 'CL:0000624', 'CL:0000542', 'CL:0000988']"
78,"{'BioSampleModel': 'Generic', 'source_name': 'Psoriasis_skin', 'tissue type': 'lesional psoriatic skin'}",tissue,"['EFO:0000701', 'DOID:8893', 'EFO:0000676', 'EFO:0000408', 'UBERON:0000014', 'EFO:0000962']"
79,"{'cell line': 'MCF7', 'cell state': 'AKT1 WT', 'cell type': 'breast adenocarcinoma', 'source_name': 'MCF7 breast adenocarcinoma cells, DMSO treated'}",cell_line,"['EFO:0006858', 'UBERON:0000310', 'DOID:3458', 'EFO:0001203', 'UBERON:0000175', 'UBERON:0003100', 'EFO:0000228', 'EFO:0000304', 'EFO:0000305', 'CVCL:0031', 'EFO:0000322', 'CL:0000010', 'EFO:0000616', 'DOID:4', 'EFO:0000408', 'EFO:0001272', 'EFO:0000311', 'EFO:0000313', 'EFO:0003156', 'UBERON:0007023', 'UBERON:0001911', 'DOID:14566', 'DOID:299']"
80,"{'BioSampleModel': 'Generic', 'cell source': 'ATCC  CRL-11268™', 'cell type': 'HEK293T', 'genotype': 'wild type', 'source_name': 'miApoB', 'tissue': 'Kidney'}",cell_line,"['CVCL:0063', 'EFO:0001184', 'UBERON:0007220', 'UBERON:0002113', 'CL:0000010', 'EFO:0001082', 'UBERON:0002120', 'UBERON:0000323']"
81,"{'BioSampleModel': 'Generic', 'clinical characteristics': 'Distal normal liver tissue of liver hemangioma', 'source_name': 'Human Normal Liver Tissue', 'tissue': 'liver', 'tumor stage': 'Normal liver'}",tissue,"['EFO:0000616', 'DOID:255', 'EFO:0000408', 'EFO:0002422', 'EFO:1000635', 'DOID:14566', 'UBERON:0002107']"
82,"{'BioSampleModel': 'Generic', 'cell line': 'BC-1', 'source_name': 'primary effusion lymphoma cell line BC-1'}",cell_line,"['CL:0000236', 'UBERON:0003101', 'EFO:0000408', 'EFO:0000616', 'EFO:0000311', 'CVCL:1079', 'EFO:1000491', 'DOID:4', 'EFO:0001642', 'EFO:0000540', 'EFO:0000574', 'DOID:0060058', 'DOID:14566', 'EFO:0000322', 'CL:0000010', 'EFO:0002044']"
83,"{'analyte type': 'RNA', 'biospecimen repository': 'NCI_SMO_BRAF_Mutations', 'biospecimen repository sample id': 'A73U04XZQ', 'body site': 'Maxilla', 'gap_accession': 'phs000739', 'gap_consent_code': '1', 'gap_consent_short_name': 'GRU-MDS', 'gap_sample_id': '1252686', 'gap_subject_id': '973957', 'histological type': 'Plexiform', 'is tumor': 'Yes', 'molecular data type': 'RNA_Seq (NGS)', 'sex': 'female', 'study design': 'Case Set', 'study disease': 'Ameloblastoma', 'study name': 'Identification of Recurrent SMO and BRAF Mutations in Ameloblastomas', 'subject is affected': 'Yes', 'submitted sample id': 'A73U04XZQ', 'submitted subject id': '1', 'submitter handle': 'NCI_SMO_BRAF_Mutations'}",tissue,"['EFO:0000616', 'UBERON:0003100', 'DOID:14566', 'EFO:0000408', 'UBERON:0002397']"
84,"{'BioSampleModel': 'Generic', 'cell line': 'HeLa', 'source_name': 'HeLa', 'treated with': 'puromycoin'}",cell_line,"['EFO:0001185', 'UBERON:0003100', 'EFO:0000228', 'CVCL:0030', 'DOID:299', 'DOID:4', 'EFO:0000408', 'EFO:0003150', 'UBERON:0000002', 'EFO:0000322', 'CL:0000010']"
85,"{'BioSampleModel': 'Generic', 'cell type': 'CD19+ B-cells', 'source_name': 'CLL primary B-cells', 'tissue': 'Tumor', 'tissues': 'Blood'}",primary_cells,"['EFO:0000095', 'CL:0000988', 'EFO:0000616', 'EFO:0000311', 'EFO:0001642', 'UBERON:0000178', 'CL:0000236', 'EFO:0005803', 'CL:0000738', 'DOID:1040', 'EFO:0000408', 'CL:0000542', 'EFO:0000565', 'EFO:0000540', 'DOID:14566', 'CL:0000945']"
86,"{'cell type': 'endothelial', 'culture medium': 'F99', 'imortalization': 'telemorase', 'source_name': 'corneal endothelial cell line'}",cell_line,"['EFO:0000322', 'CL:0000132', 'CL:0000010', 'UBERON:0004852']"
87,"{'cell type': 'Purified normal B cells', 'genotype': 'Normal', 'source_name': 'Purified normal B cells'}",primary_cells,"['CL:0000236', 'CL:0000738', 'CL:0000988', 'CL:0000945', 'CL:0000542']"
88,"{'BioSampleModel': 'Generic', 'cell line': 'A2058', 'source_name': 'A2058 human melanoma'}",cell_line,"['DOID:1909', 'EFO:0000962', 'UBERON:0003101', 'EFO:0000756', 'UBERON:0000029', 'CVCL:1059', 'EFO:0000616', 'EFO:0000311', 'DOID:4', 'EFO:0003156', 'UBERON:0007023', 'EFO:0000408', 'UBERON:0000014', 'DOID:14566', 'EFO:0000322', 'CL:0000010', 'EFO:0001272']"
89,"{'human cell line': 'HeLa-S3 (ATCC CCL-2.2)', 'organism': 'mixed sample (human cell line HeLa-S3 + Salmonella typhimurium SL1344)', 'source_name': 'cell culture infection model', 'strain': 'Salmonella typhimurium SL1344'}",cell_line,"['EFO:0002791', 'CVCL:0058', 'CL:0000010', 'EFO:0000322']"
90,"{'BioSampleModel': 'Generic', 'biomaterial_provider': 'http', 'cell type': 'EBV transformed peripheral blood B lymphocytes', 'individual': 'NA12893', 'source_name': 'lymphoblastoid cell lines (LCL)'}",cell_line,"['EFO:0005292', 'CL:0000738', 'UBERON:0000178', 'CL:0000236', 'CL:0000542', 'CL:0000988', 'CL:0000945']"
91,"{'BioSampleModel': 'Human', 'age': 'not applicable', 'biomaterial_provider': 'Landthaler Lab', 'cell_line': 'HEK293', 'experiment': 'APOBEC3 (B,C,F) knockdown 1', 'isolate': 'HEK293', 'sex': 'not determined', 'tissue': 'Embryonic Kidney', 'treatment': 'APOBEC3 (B,C,F) knockdown'}",cell_line,"['EFO:0001182', 'CVCL:0045', 'EFO:0000322', 'EFO:0000727', 'UBERON:0002113', 'EFO:0002694', 'CL:0000010']"
92,"{'BioSampleModel': 'Generic', 'cell type': 'ES-RPE', 'parental cell line': 'H9', 'source_name': 'ES-RPE'}",in_vitro_differentiated_cells,"['UBERON:0001782', 'EFO:0000322', 'CVCL:9773', 'EFO:0003045', 'CL:0000010']"
93,"{'BioSampleModel': 'Generic', 'cell line': 'RWPE1', 'cell type': 'benign prostate epithelial cells', 'overexpressing': 'truncated ERG', 'passages': '20', 'source_name': 'RWPE1-ERG prostate epithelial cell line'}",cell_line,"['UBERON:0003101', 'CL:0002231', 'EFO:0000322', 'EFO:0003156', 'UBERON:0007023', 'EFO:0002323', 'UBERON:0002367', 'CVCL:3791', 'CL:0000066', 'CL:0000010', 'EFO:0001272']"
94,"{'BioSampleModel': 'Generic', 'cell line': 'K562', 'cell type': 'Human erythromyeloblastoid leukemia cells', 'source_name': 'Human bone marrow, chronic myelogenous leukemia', 'treated with': '300ul of DMS to 15mls of cells'}",cell_line,"['EFO:0000339', 'UBERON:0003100', 'DOID:1240', 'EFO:0000616', 'EFO:0000565', 'EFO:0000311', 'UBERON:0002371', 'DOID:4', 'EFO:0001642', 'DOID:8552', 'EFO:0000540', 'EFO:0000408', 'EFO:0002067', 'DOID:14566', 'EFO:0000322', 'CL:0000010', 'CVCL:0004']"
95,"{'BioSampleModel': 'Generic', 'cell type': 'HUVEC', 'source_name': 'Endothelial', 'tissue': 'umbilical vein/vascular endothelium', 'treatment': 'siRNA control'}",cell_line,"['EFO:0000727', 'UBERON:0001986', 'UBERON:0002066', 'UBERON:0001638', 'UBERON:0004852', 'CL:0000115']"
96,"{'screening chemicals': 'glucosamine', 'source_name': 'H1 human embryonic stem cell derived neural progenitor cells, endothelial cells, mesenchymal stem cells, and microglia/macrophage precursors'}",in_vitro_differentiated_cells,"['CL:0000738', 'CL:0000878', 'CL:0000134', 'CL:0000766', 'CL:0000864', 'CL:0000129', 'CL:0000047', 'CL:0000235', 'CL:0000034', 'CL:0002322', 'CL:0000988', 'CL:0000115']"
97,"{'BioSampleModel': 'Generic', 'source_name': 'Lung tissue'}",tissue,"['UBERON:0002048', 'UBERON:0000170']"
98,"{'BioSampleModel': 'Generic', 'cell line': 'HeLa', 'source_name': 'HeLa cells', 'tissue': 'Cervical Cancer', 'transfection': 'lentivirus carrying control shRNA'}",cell_line,"['EFO:0001185', 'UBERON:0003100', 'EFO:0000228', 'CVCL:0030', 'DOID:299', 'EFO:0000311', 'EFO:0000726', 'DOID:4', 'DOID:4362', 'EFO:0000408', 'EFO:0003150', 'DOID:162', 'UBERON:0000002', 'DOID:14566', 'EFO:0000616', 'CL:0000010', 'EFO:0000322']"
99,"{'BioSampleModel': 'Human', 'age': '54', 'biomaterial_provider': 'ATCC', 'cell_line': 'RWPE-1', 'cell_type': 'epithelial', 'isolate': 'RWPE-1 immortalized nontumorigenic prostate epithelial cell line', 'race': 'Caucasian', 'sample_type': 'cell culture', 'sex': 'male', 'tissue': 'prostate', 'treatment': 'RWPE-1 cells stably transduced with both pBabe and pLNCX-GFP vectors. Sorted for GFP.'}",cell_line,"['UBERON:0003101', 'CL:0002231', 'EFO:0000322', 'EFO:0000727', 'EFO:0003156', 'UBERON:0007023', 'EFO:0002323', 'UBERON:0002367', 'CVCL:3791', 'CL:0000066', 'CL:0000010', 'EFO:0001272']"
100,"{'BioSampleModel': 'Generic', 'pathology': 'renal clear cell', 'source_name': 'kidney cancer tissue', 'tissue': 'kidney cancer', 'tumor stage': 'T2N0M0'}",tissue,"['EFO:0003865', 'DOID:263', 'EFO:0000616', 'DOID:162', 'EFO:0000311', 'DOID:4', 'EFO:0003086', 'EFO:0000408', 'EFO:0000349', 'DOID:14566']"
101,"{'source_name': 'human brain reference RNA (HBRR) with ERCC control RNAs', 'tissue type': 'brain'}",tissue,['UBERON:0000955']
102,"{'BioSampleModel': 'Generic', 'age': '16 years old', 'source_name': 'primary bone marrow derived mesenchymal progenitor cells', 'tissue': 'primary bone marrow derived mesenchymal progenitor cells'}",stem_cells,"['CL:0000134', 'UBERON:0002371']"
103,"{'cell type': 'iPSC-derived neurons', 'genotype': 'CHD8+/-', 'source_name': 'Neuron'}",in_vitro_differentiated_cells,"['CL:0002371', 'CL:0000034', 'CL:0002248', 'CL:0000540', 'CL:0000723', 'EFO:0004905']"
104,"{'BioSampleModel': 'Generic', 'cell line': 'breast cancer cell line MCF-7/TAMR-4', 'genotype': 'tamoxifen resistant', 'source_name': 'Breast cancer cell line'}",cell_line,"['EFO:0000616', 'EFO:0000311', 'DOID:1612', 'CVCL:1D42', 'EFO:0002885', 'EFO:0000408', 'DOID:162', 'DOID:14566', 'EFO:0000322', 'CL:0000010']"
105,"{'BioSampleModel': 'Generic', 'biological replicate': '2', 'source_name': 'HEK293T17 cell culture'}",cell_line,[]
106,"{'cell type': 'umbilical cord blood hematopoietic stem cells', 'source_name': 'umbilical cord blood hematopoietic stem cells'}",in_vitro_differentiated_cells,"['UBERON:0000178', 'UBERON:0012168', 'CL:0000034', 'CL:2000095', 'CL:0000037', 'CL:0000988']"
107,"{'analyte type': 'RNA', 'biospecimen repository': 'NCI_TARGET', 'biospecimen repository sample id': 'TARGET-10-PAKTAL-03A-01R', 'body site': 'Primary Blood Derived Cancer - Bone Marrow', 'gap_accession': 'phs000463', 'gap_consent_code': '1', 'gap_consent_short_name': 'PCR', 'gap_sample_id': '563696', 'gap_subject_id': '466567', 'histological type': 'ALL', 'is tumor': 'Yes', 'molecular data type': 'RNA_Seq (NGS)', 'sex': 'female', 'study design': 'Tumor vs. Matched-Normal', 'study name': 'TARGET', 'submitted sample id': 'TARGET-10-PAKTAL-03A-01R', 'submitted subject id': 'TARGET-10-PAKTAL', 'submitter handle': 'NCI_TARGET'}",tissue,"['UBERON:0003100', 'EFO:0000616', 'EFO:0000311', 'EFO:0000220', 'UBERON:0002371', 'UBERON:0000178', 'EFO:0000408', 'DOID:162', 'DOID:14566']"
108,"{'BioSampleModel': 'Generic', 'cell type': 'PBMC', 'days': '311', 'disease status': 'Recovery', 'source_name': 'blood cell'}",primary_cells,"['DOID:4', 'CL:0000081', 'CL:0000988', 'EFO:0000408']"
109,"{'cell type': 'beta', 'donor': 'ICRH025', 'source_name': 'pancreatic islets'}",primary_cells,['UBERON:0000006']
110,"{'biopsy site': ""Barrett's Oesophagus segment"", 'degree of dysplasia': 'Low Grade Dsyplasia', 'source_name': 'Endoscopic Biopsy'}",tissue,"['EFO:0000280', 'DOID:9206', 'EFO:0000408']"
111,"{'BioSampleModel': 'Generic', 'cell type': 'Glioblastoma', 'patient id': 'MGH31', 'source_name': 'Single cell mRNA-seq_MGH31', 'subtype': 'None'}",primary_cells,"['EFO:0000272', 'EFO:0000616', 'DOID:3068', 'EFO:0000311', 'EFO:0000408', 'EFO:0005543', 'DOID:14566', 'EFO:0000519']"
112,"{'BioSampleModel': 'Generic', 'cell line': 'MCF7', 'cell type': 'breast cancer', 'source_name': 'MCF7, siZNF217'}",cell_line,"['DOID:4', 'UBERON:0000175', 'UBERON:0003100', 'EFO:0000228', 'EFO:0000322', 'CVCL:0031', 'DOID:299', 'UBERON:0001911', 'EFO:0000311', 'DOID:162', 'DOID:1612', 'EFO:0003156', 'UBERON:0007023', 'EFO:0000408', 'EFO:0001203', 'UBERON:0000310', 'DOID:14566', 'EFO:0000616', 'CL:0000010', 'EFO:0001272']"
113,"{'biomaterial_provider': 'American Type Culture Collection', 'cell line': 'AsPC1', 'source_name': 'Pancreas'}",cell_line,"['DOID:4', 'UBERON:0003100', 'EFO:0000228', 'CVCL:0152', 'DOID:299', 'EFO:0002112', 'UBERON:0001264', 'EFO:0003156', 'EFO:0000408', 'UBERON:0007795', 'EFO:0000322', 'CL:0000010']"
114,"{'BioSampleModel': 'Generic', 'cell type': 'bone marrow CD34+ cells', 'disease status': 'myelodysplastic syndromes (MDS)', 'mds subtype': 'RCMD-RS', 'sf3b1 status': 'mutated', 'source_name': 'CD34+ cells, MDS, SF3B1 mutated'}",primary_cells,"['DOID:0050908', 'EFO:0000198', 'EFO:0000616', 'EFO:0000311', 'EFO:0001642', 'DOID:4', 'EFO:0005803', 'UBERON:0002371', 'DOID:0060469', 'EFO:0000540', 'DOID:14566', 'EFO:0000408']"
115,"{'BioSampleModel': 'Generic', 'cell line': 'HeLa', 'source_name': 'HeLa mRNA-seq'}",cell_line,"['EFO:0001185', 'UBERON:0003100', 'EFO:0000228', 'CVCL:0030', 'DOID:299', 'DOID:4', 'EFO:0000408', 'EFO:0003150', 'UBERON:0000002', 'EFO:0000322', 'CL:0000010']"
116,"{'cell line': 'ELF embryonic stem cell', 'pluripotency state': 'naïve', 'source_name': 'embryonic stem cell', 'treatment': 'none'}",stem_cells,"['EFO:0000322', 'UBERON:0035963', 'CL:0000034', 'CL:0002322', 'EFO:0001985', 'CL:0000010']"
117,"{'BioSampleModel': 'Generic', 'cell type': 'Prostate cancer cell line overexpressing ERa', 'passages': '4 to 5', 'source_name': 'VCaP ERa cell line'}",cell_line,"['EFO:0001639', 'EFO:0000616', 'EFO:0000311', 'DOID:10283', 'EFO:0007355', 'EFO:0000512', 'DOID:162', 'DOID:14566', 'EFO:0000322', 'CL:0000010', 'EFO:0000408']"
118,"{'BioSampleModel': 'Generic', 'cell type': 'primary human umbilical vein endothelial cells', 'infected with': 'a lentivirus containing human PR', 'passage': '4-6', 'source_name': 'primary HUVECs', 'treated with': 'none'}",cell_line,"['CL:0000115', 'CL:0000010']"
119,"{'cell type': 'HUVEC', 'culture condition': 'fluid shear stress 20 dyne/cm^2', 'source_name': 'HUVEC', 'treatment': 'EZH2 knock-down'}",cell_line,"['UBERON:0006314', 'EFO:0000696', 'EFO:0000727', 'CL:0000115']"
120,"{'cell_type': 'granulocytes', 'sex': 'male', 'tissue_type': 'blood'}",primary_cells,"['UBERON:0003101', 'CL:0000738', 'CL:0000766', 'UBERON:0000178', 'CL:0000094', 'CL:0000988']"
121,"{'BioSampleModel': 'Generic', 'cell type': 'cd44+ cells from BRCA2 mutation carrier', 'source_name': 'expression library from cd44+ cells from BRCA1 and BRCA2 mutation carriers', 'tissue': 'mammary gland'}",primary_cells,"['UBERON:0002530', 'UBERON:0001911']"
122,"{'BioSampleModel': 'Generic', 'cell type': 'lymphoblastoid cell line', 'chip antibody': 'N/A', 'source_name': 'LCL'}",cell_line,['EFO:0005292']
123,"{'cell line': 'HepG2', 'cell type': 'Hepatocellular Carcinoma', 'source_name': 'HepG2 cells'}",cell_line,"['EFO:0001187', 'DOID:684', 'UBERON:0003101', 'EFO:0006858', 'CVCL:0027', 'EFO:0003769', 'EFO:0001421', 'EFO:0000182', 'EFO:0000311', 'EFO:0000313', 'DOID:4', 'EFO:0003156', 'DOID:305', 'EFO:0000408', 'UBERON:0002107', 'DOID:14566', 'EFO:0000616', 'CL:0000010', 'EFO:0000322']"
124,"{'BioSampleModel': 'Generic', 'cell line': 'HEK293', 'cell line stably expressing': 'HIS/FLAG/HA-tagged CAPRIN1', 'culture medium': 'DMEM', 'par-clip antibody': 'FLAG', 'source_name': 'HEK293 cell culture'}",cell_line,"['EFO:0001182', 'CVCL:0045', 'EFO:0000322', 'UBERON:0002899', 'UBERON:0002113', 'CL:0000010']"
125,"{'BioSampleModel': 'Generic', 'age': '31 years', 'cell line': 'HeLa S3', 'genotype': 'hOXR1 knockdown', 'source_name': 'HeLa cell line', 'tissue': 'cervix', 'treatment': '0.5 mM H2O2'}",cell_line,"['EFO:0001185', 'UBERON:0003100', 'EFO:0000228', 'CVCL:0058', 'CVCL:0030', 'DOID:299', 'EFO:0000727', 'EFO:0002791', 'DOID:4', 'UBERON:0007023', 'EFO:0000408', 'EFO:0003150', 'UBERON:0000002', 'EFO:0000322', 'CL:0000010', 'EFO:0001272']"
126,"{'BioSampleModel': 'Generic', 'cell line': 'GM12878', 'labexpid': '12819', 'source_name': 'GM12878'}",cell_line,"['CVCL:7526', 'EFO:0000322', 'EFO:0002784', 'CL:0000010']"
127,"{'BioSampleModel': 'Generic', 'binding/selection': 'Fragmentented & 2x Poly(A) selected ds-cDNA', 'cell line': 'HCT116', 'sample type': 'human colon carcinoma cell line established from the primary colon carcinoma of an adult man', 'source_name': 'HCT116', 'technique': 'ds-cDNA-sequencing'}",cell_line,"['EFO:0004288', 'UBERON:0003101', 'EFO:0006858', 'EFO:0000408', 'UBERON:0001155', 'EFO:0000322', 'EFO:0000311', 'EFO:0000616', 'EFO:0004187', 'EFO:0005842', 'EFO:0000313', 'DOID:4', 'EFO:0007330', 'UBERON:0007023', 'DOID:305', 'EFO:0002824', 'DOID:1520', 'DOID:14566', 'CVCL:0291', 'CL:0000010', 'EFO:0001272']"
128,"{'cell line': 'HeLa-S3', 'organism': 'Homo sapiens', 'treatment': 'Amanitin (RNA pol II inhibitor)'}",cell_line,"['EFO:0002791', 'EFO:0000727', 'CVCL:0058', 'CL:0000010', 'EFO:0000322']"
129,"{'BioSampleModel': 'Generic', 'GEO Accession': 'GSM1098574', 'cell type': 'Human Dermal Microvascular Endothelial Cells (Lonza)'}",cell_line,"['UBERON:0002067', 'CL:0000115', 'CL:2000008']"
130,"{'BioSampleModel': 'Generic', 'cell type': 'mural granulosa cells', 'etiology of infertility': 'male factor', 'source_name': 'mural granulosa cells', 'stimulation protocol': 'GnRH antagonist, rFSH, hCG'}",primary_cells,"['CL:0000501', 'DOID:5223', 'EFO:0000512', 'EFO:0000408', 'EFO:0000545']"
131,"{'BioSampleModel': 'Generic', 'genotype': 'wild type', 'source_name': 'Atypical Chronic Myeloid Leukemia cells'}",primary_cells,"['EFO:0000616', 'EFO:0000311', 'EFO:0001642', 'EFO:0005803', 'EFO:0002427', 'DOID:0060597', 'EFO:0000540', 'DOID:14566', 'EFO:0000408']"
132,"{'cell type': 'CD4+CD45RO+ T cells', 'diagnosis': 'Healthy control', 'source_name': 'Peripheral Blood', 'tissue': 'Peripheral Blood', 'treatment': 'JQ1(-)'}",primary_cells,"['CL:0000738', 'EFO:0000727', 'UBERON:0000178', 'CL:0000084', 'CL:0000542', 'CL:0000988']"
133,"{'BioSampleModel': 'Generic', 'cell type': 'peripheral blood mononuclear cells (PBMCs)', 'source_name': 'T16_Day 10 post-vaccine_PBMCs', 'subject id': 'T16', 'time point': 'Day 10 post-vaccine'}",primary_cells,"['CL:0000738', 'CL:0000842', 'CL:2000001', 'UBERON:0000178', 'CL:0000081', 'CL:0000988']"
134,"{'BioSampleModel': 'Generic', 'cell type': 'Farage cell line', 'source_name': 'Farage cell line', 'treatment': 'treated with 2uM GSK343 for 7 days'}",cell_line,"['CL:0000236', 'UBERON:0003100', 'UBERON:0000029', 'EFO:0000322', 'EFO:0000727', 'DOID:4', 'EFO:0003156', 'UBERON:0007023', 'EFO:0000408', 'CVCL:3302', 'EFO:0006393', 'EFO:0000574', 'DOID:0060058', 'CL:0000010', 'EFO:0001272']"
135,"{'BioSampleModel': 'Generic', 'cell_line': 'C4-4', 'disease': 'ovarian cancer', 'label': 'C4-4'}",cell_line,"['EFO:0000311', 'EFO:0000616', 'EFO:0003893', 'DOID:2394', 'DOID:4', 'EFO:0000408', 'DOID:162', 'DOID:14566', 'EFO:0000322', 'CL:0000010']"
136,"{'analyte type': 'selected small non-coding RNA', 'biospecimen repository': 'NICHD_IntellectualDisabilities', 'biospecimen repository sample id': 'S1.tRNA.3', 'body site': 'Skin/Dermal fibroblast', 'gap_accession': 'phs000645', 'gap_consent_code': '1', 'gap_consent_short_name': 'GRU', 'gap_sample_id': '1061260', 'gap_subject_id': '810275', 'molecular data type': 'RNA_Seq (NGS)', 'study design': 'Case-Control', 'study name': 'Location and Function of Cytosine-5 Methylation in RNA', 'subject is affected': 'No', 'submitted sample id': 'S1.tRNA.3', 'submitted subject id': '1', 'submitter handle': 'NICHD_IntellectualDisabilities'}",primary_cells,"['UBERON:0000014', 'EFO:0000962', 'CL:0002551', 'CL:0000057']"
137,"{'bd patient': 'no', 'cell type': 'Hippocampal dentate gyrus (DG) granule neurons', 'lithium treated': 'no', 'source_name': 'iPSC-derived hippocampal dentate gyrus granule neurons'}",in_vitro_differentiated_cells,"['UBERON:0001885', 'EFO:0003534', 'CL:0000034', 'CL:0002248', 'CL:0002371', 'CL:0000723', 'CL:0000540', 'EFO:0004905']"
138,"{'genotype': 'Healthy', 'source_name': 'brain', 'tissue': 'Frontal Cortex'}",tissue,"['UBERON:0000955', 'EFO:0003534', 'UBERON:0001870']"
139,"{'cell line': 'OVCAR8-ADR-Cas9', 'infected with sgrna': 'Awp12', 'source_name': 'Human ovarian cancer cell line'}",cell_line,"['EFO:0000311', 'EFO:0000616', 'EFO:0003893', 'DOID:2394', 'EFO:0002394', 'EFO:0000408', 'EFO:0005444', 'DOID:162', 'DOID:14566', 'EFO:0000322', 'CL:0000010', 'CVCL:1629']"
140,"{'BioSampleModel': 'Generic', 'cell type': 'HEK293T human embryonic kidney cell line', 'genotype/variation': 'overexpression of miR-146a', 'miRNA source': 'extracellular vesicles', 'source_name': 'HEK293T cell line'}",cell_line,"['CVCL:0063', 'EFO:0001184', 'EFO:0001182', 'CVCL:0045', 'UBERON:0007220', 'UBERON:0002113', 'UBERON:0002120', 'EFO:0001082', 'EFO:0000322', 'CL:0000010', 'UBERON:0000323']"
141,"{'BioSampleModel': 'Generic', 'age': '80', 'disease state': 'metastasis', 'microsatellite status': 'MSI', 'sex': 'female', 'source_name': 'metastasis biopsy, lymph node', 'subject': 'P5', 'tissue': 'metastasis biopsy, lymph node'}",tissue,"['UBERON:0000029', 'UBERON:0003100']"
142,"{'agent': 'LPS', 'cell type': 'monocyte', 'source_name': 'peripheral blood'}",primary_cells,"['CL:0000738', 'CL:0000766', 'CL:0000842', 'UBERON:0000178', 'CL:0000576', 'CL:0000988']"
143,"{'cell line': 'U2-OS', 'cell type': 'osteosarcoma', 'replicate': '1', 'sirna treatment': 'Bmal1 siRNA', 'source_name': 'U2-OS Cells'}",cell_line,"['UBERON:0001474', 'EFO:0000637', 'DOID:3347', 'UBERON:0003100', 'EFO:0000691', 'UBERON:0002481', 'EFO:0000616', 'EFO:0000727', 'EFO:0002869', 'EFO:0000311', 'CVCL:0042', 'DOID:4', 'EFO:0003156', 'EFO:0003820', 'EFO:0000298', 'DOID:14566', 'EFO:0000322', 'CL:0000010', 'EFO:0000408']"
144,"{'BioSampleModel': 'Generic', 'cell type': 'Jurkat cells', 'sample group': 'Polysome Pactamycin', 'source_name': 'Jurkat cells'}",cell_line,"['CVCL:S103', 'CVCL:T987', 'EFO:0002796', 'CVCL:0065', 'CL:0000010']"
145,"{'cell type': 'induced pluripotent stem cells', 'patient diagnosis': 'Healthy', 'source_name': 'Neural progenitor cells', 'tissue': 'Dorsal Forebrain Equivalent'}",in_vitro_differentiated_cells,"['UBERON:0001890', 'CL:0000047', 'CL:0000034', 'CL:0002248', 'CL:0002371', 'CL:0000723', 'EFO:0004905']"
146,"{'BioSampleModel': 'Human', 'age': '31', 'biomaterial_provider': 'ATCC', 'breed': 'Homo sapiens', 'cell_line': '8.TEV Cell/TEV#2', 'isolate': 'not applicable', 'sex': 'female', 'tissue': 'Cervical Carcinoma'}",cell_line,"['EFO:0001061', 'EFO:0000322', 'UBERON:0003100', 'CL:0000010']"
147,"{'BioSampleModel': 'Human', 'age': '50', 'biomaterial_provider': 'PSOC', 'cell_line': 'MDA-MB-231', 'disease_stage': '-', 'isolate': 'singlecell5', 'sex': 'F', 'tissue': 'cell line', 'treatment': '5'}",cell_line,"['CVCL:0062', 'UBERON:0000175', 'UBERON:0003100', 'EFO:0000228', 'EFO:0000322', 'DOID:299', 'EFO:0000727', 'DOID:4', 'EFO:0003156', 'UBERON:0007023', 'EFO:0000408', 'EFO:0001209', 'CL:0000010', 'EFO:0001272']"
148,"{'BioSampleModel': 'Generic', 'antibody': 'hnRNPM', 'antibody manufacturer': 'Aviva Systems Biology', 'cell line': '293T', 'source_name': 'human 293T cells'}",cell_line,"['CVCL:0063', 'EFO:0001184', 'UBERON:0007220', 'UBERON:0002120', 'EFO:0001082', 'EFO:0000322', 'CL:0000010', 'UBERON:0000323']"
149,"{'bioproject_id': 'PRJDB4235', 'cell_line': 'CCSC#11', 'description': 'sequence replicate 2. CCSC#11, single cell-derived subclones from the colon cancer cell line CCSC#P by limiting dilution', 'sample_name': 'CCSC-11-2', 'sample_title': 'Transcriptome of CCSC#11-2'}",cell_line,"['EFO:0000311', 'EFO:0000322', 'EFO:0001639', 'EFO:0005842', 'DOID:219', 'EFO:0007330', 'EFO:0000408', 'DOID:162', 'DOID:14566', 'EFO:0000616', 'CL:0000010', 'EFO:0004288']"
150,"{'BioSampleModel': 'Generic', 'cell type': 'foreskin fibroblast iPSC', 'source_name': 'foreskin fibroblast iPSC'}",induced_pluripotent_stem_cells,"['UBERON:0001332', 'CL:0000057', 'EFO:0004905', 'CL:1001608', 'CL:0002248', 'CL:0000034', 'CL:0000723', 'CL:0002371']"
151,"{'gender': 'male', 'group': 'PN', 'patient': '9', 'source_name': 'skin'}",tissue,"['UBERON:0000014', 'UBERON:0003101', 'EFO:0000962']"
152,"{'BioSampleModel': 'Generic', 'reference rna': 'FirstChoice® Human Brain Reference Total RNA', 'source_name': 'ABRF-ILMN-L-B', 'tissue': 'Brain'}",tissue,['UBERON:0000955']
153,"{'BioSampleModel': 'Human', 'age': '25', 'biomaterial_provider': 'ATCC', 'isolate': 'Calu-3', 'sex': 'male', 'tissue': 'lung adenocacinoma'}",cell_line,"['UBERON:0003101', 'EFO:0000684', 'EFO:0006858', 'EFO:0000228', 'EFO:0000571', 'EFO:0000616', 'EFO:0000311', 'EFO:0000313', 'EFO:0003818', 'EFO:0001071', 'DOID:3910', 'EFO:0000408', 'EFO:0003060', 'DOID:14566', 'DOID:299']"
154,"{'Cell type': 'Human Umbilical Vein Endothelial Cells', 'Cell type abbr.': 'HUVEC', 'Donor age': 'newborn', 'Donor cause-of-death': '-', 'Donor gender': 'male', 'Donor race': 'Arabic', 'Internal label': 'WadaLab-IHEC30', 'Lot. no.': '03321', 'Manufacture Date': '01-JUN-2013', 'Provider': 'Lonza Walkersville, Inc (Walkersville, MD)', 'Sample type': 'Cell', 'Source name': 'Human Umbilical Vein Endothelial Cells (HUVEC) Lot.03321', 'Total cell count': '380000', 'Total cell count unit': 'cell per mili-litter', 'Valid until': 'Not applicable when stored below -150 degrees celsius', 'Viability': '93%'}",cell_line,"['UBERON:0003101', 'UBERON:0004537', 'CL:0000071', 'UBERON:0035944', 'UBERON:0001986', 'UBERON:0001981', 'UBERON:0000055', 'UBERON:0000071', 'EFO:0003156', 'UBERON:0002066', 'UBERON:0001638', 'UBERON:0004852', 'CL:0002618', 'EFO:0001372', 'CL:0000115']"
155,"{'BioSampleModel': 'Generic', 'age': '52 Years', 'diagnosis': 'Sporadic ALS (C9orf72 expansion)', 'disease course': '1 year at time of biopsy', 'disease onset': 'Distal UE', 'drug treatment': 'Transfection Control - Cells were treated with a control ASO which does not have any human genomic target.', 'genotype': 'C9orf72 Intron 1 Hexanucleotide Expansion', 'sex': 'Male', 'source_name': 'Primary fibroblast cell cultures', 'tissue': 'Fibroblast'}",cell_line,"['UBERON:0003101', 'EFO:0000618', 'CL:0000057', 'EFO:0000253', 'EFO:0003782', 'EFO:0000726', 'EFO:0000727', 'DOID:4', 'UBERON:0007023', 'EFO:0000408', 'DOID:332', 'EFO:0005772', 'EFO:0001272']"
156,"{'BioSampleModel': 'Generic', 'biomaterial_provider': 'ATCC', 'biorep': '011WC', 'cell lineage': 'ectoderm', 'cell sex': 'F', 'datatype': 'Cage', 'datatype description': ""CAGE 5' RNA Tags"", 'labexpid': 'J80', 'labversion': 'IDR', 'localization': 'cell', 'localization description': 'Whole cell', 'replicate': '1', 'replicate description': 'tier 1', 'rnaextract': 'longPolyA', 'rnaextract description': 'Poly(A)+ RNA longer than 200 nt', 'source_name': 'HeLa-S3'}",cell_line,"['UBERON:0000924', 'UBERON:0003100', 'EFO:0000795']"
157,"{'BioSampleModel': 'Human', 'age': 'not collected', 'biomaterial_provider': 'National Institute of Health, USA', 'cell_line': 'XP34BE', 'cell_type': 'fibroblasts', 'disease': 'Xeroderma pigmentosum group D', 'isolate': 'cell culture', 'sample_type': 'primary cell culture', 'sex': 'not collected', 'tissue': 'unknown', 'treatment': 'none'}",cell_line,"['EFO:1000017', 'CL:0000057', 'EFO:0000322', 'DOID:4', 'DOID:0050427', 'EFO:0000408', 'EFO:0000508', 'CVCL:M321', 'CL:0000010']"
158,"{'BioSampleModel': 'Human', 'age': 'not applicable', 'biomaterial_provider': 'Daniel Campbell; Zilkha Neurogenetic Institute, 1501 San Pablo St., Los Angeles, CA, 90097', 'cell_line': 'SK-N-SH', 'dev_stage': '72h_post_EmptyVector_transfection', 'isolate': 'SK-N-SH_72HR_EV_Replicate1', 'sample_type': 'cell culture', 'sex': 'not applicable', 'tissue': 'neuronal progenitor cell'}",cell_line,"['EFO:0000621', 'UBERON:0000955', 'UBERON:0003100', 'CL:0000047', 'EFO:0003072', 'DOID:769', 'UBERON:0002371', 'DOID:4', 'CL:0000034', 'EFO:0000408', 'EFO:0000726', 'CVCL:0531', 'EFO:0000322', 'CL:0000010']"
159,"{'human cell line': 'HeLa-S3 (ATCC CCL-2.2)', 'organism': 'mixed sample (human cell line HeLa-S3 + Salmonella typhimurium SL1344)', 'source_name': 'cell culture infection model', 'strain': 'Salmonella Typhimurium SL1344'}",cell_line,"['EFO:0002791', 'CVCL:0058', 'CL:0000010', 'EFO:0000322']"
160,"{'BioSampleModel': 'Generic', 'sample comment': 'This sample is the RNA that isolated from peripheral blood samples of  following condition  malaria patients.From', 'sample_name': 'DRS005800'}",tissue,"['UBERON:0000178', 'EFO:0005741', 'EFO:0000408', 'EFO:0001067', 'EFO:0001068', 'DOID:12365']"
161,"{'cell markers': 'CD34+CD7neg CD1aneg CD4negCD8neg', 'source_name': 'CD34+CD7neg CD1aneg CD4negCD8neg', 'tissue': 'Thymus'}",primary_cells,['UBERON:0002370']
162,"{'cell line': 'TK6', 'cell type': 'lymphoblast', 'chemical': 'DMSO', 'dose': '1', 'irradiation': 'UVC', 'source_name': 'TK6 cell line', 'time': '8'}",cell_line,"['UBERON:0003101', 'DOID:12971', 'EFO:0000322', 'DOID:4', 'CL:0000010', 'CVCL:0561', 'CL:0000988', 'UBERON:0002106', 'EFO:0000408']"
163,"{'BioSampleModel': 'Generic', 'disease state': 'normal breast', 'patient number': '2', 'source_name': 'normal breast', 'tissue': 'breast', 'tissue id': 'STT5430'}",tissue,['UBERON:0000310']
164,"{'cell type': 'Immortalized prostate cancer cell line', 'library preparation protocol': 'whole-exome capture', 'rin': '8.2', 'source_name': 'VcaP_DHT_exome capture', 'time point': '24 hrs post-treatment', 'treated with': 'DHT (dihydrotestosterone)'}",cell_line,"['EFO:0001639', 'EFO:0000616', 'EFO:0000727', 'EFO:0000311', 'DOID:10283', 'EFO:0007355', 'EFO:0000512', 'DOID:162', 'DOID:14566', 'EFO:0000408']"
165,"{'BioSampleModel': 'Generic', 'source_name': 'islet preparation_cytokine treatment', 'tissue': 'islets of Langerhans'}",primary_cells,"['EFO:0000727', 'UBERON:0000006']"
166,"{'cell type': 'CD34+', 'source_name': 'Human cord blood derived CD34+ cells', 'treatment': 'ERG3 S238D overexpressing'}",primary_cells,"['UBERON:0012168', 'EFO:0000727', 'UBERON:0000178']"
167,"{'BioSampleModel': 'Generic', 'clip antibody': 'anti-Ago2 polyclonal antibody', 'molecule subtype': 'Ago2-bound RNA', 'sex': 'male', 'source_name': 'BA4 (motor cortex; grey matter)', 'tissue': 'motor cortex (grey matter)'}",tissue,"['EFO:0003534', 'UBERON:0013535', 'UBERON:0001384', 'UBERON:0002020', 'UBERON:0003101']"
168,"{'BioSampleModel': 'Generic', 'cell line': 'Raji B', 'source_name': 'Raji B-cell line'}",cell_line,"['DOID:4', 'UBERON:0003101', 'CL:0000738', 'CL:0000542', 'CVCL:0511', 'CL:0000236', 'EFO:0002324', 'EFO:0000408', 'EFO:0003150', 'EFO:0000574', 'DOID:0060058', 'CL:0000988', 'CL:0000945', 'CL:0000010', 'EFO:0000322']"
169,"{'BioSampleModel': 'Generic', 'source_name': 'Eutopic endometrium of endometriosis patient', 'subject': '47', 'tissue': 'Eutopic endometrium of endometriosis patient'}",tissue,"['UBERON:0001295', 'DOID:289', 'EFO:0001065', 'EFO:0000408', 'EFO:0000512']"
170,"{'host mouse treatment': 'vemurafenib', 'phenotype': 'vemurafenib-resistant', 'source_name': 'A375 melanoma bearing mouse', 'tissue': 'A375 tumor'}",tissue,"['DOID:1909', 'EFO:0000616', 'EFO:0000727', 'EFO:0000311', 'EFO:0000756', 'EFO:0000408', 'DOID:14566']"
171,"{'BioSampleModel': 'Generic', 'condition': 'control', 'source_name': 'NULL', 'tissue': 'alpha cell'}",primary_cells,"['CL:0000171', 'CL:0000066']"
172,"{'BioSampleModel': 'Generic', 'source_name': 'Sample_3_0', 'time': 'pre-LVAD', 'tissue': 'whole blood'}",tissue,['UBERON:0000178']
173,"{'BioSampleModel': 'Generic', 'cell marker': 'CD24+', 'cell type': 'epithelial cell', 'disease state': 'cancer', 'source_name': 'biopsy and surgery', 'tissue': 'breast'}",primary_cells,"['EFO:0000616', 'EFO:0000311', 'UBERON:0000310', 'EFO:0000408', 'DOID:162', 'DOID:14566', 'CL:0000066']"
174,"{'BioSampleModel': 'Generic', 'cell line': 'HEK293T', 'library prep protocol': 'SMART-Seq2 (variant 1)', 'source_name': 'single cell, HEK293T, SMART-Seq2 (variant 1)'}",cell_line,"['CVCL:0063', 'EFO:0001184', 'UBERON:0007220', 'UBERON:0002120', 'EFO:0001082', 'EFO:0000322', 'CL:0000010', 'UBERON:0000323']"
175,"{'BioSampleModel': 'Generic', 'cell type': 'Adrenocortical carcinoma', 'gender': 'M', 'source_name': 'Adrenocortical carcinoma'}",tissue,"['UBERON:0003101', 'EFO:0005539', 'EFO:0003769', 'EFO:0000616', 'EFO:0000311', 'DOID:3948', 'EFO:1000796', 'EFO:0003093', 'EFO:0000408', 'DOID:14566', 'EFO:0001379']"
176,"{'etoh/dox treatment': 'Dox', 'facs sorting': 'Unsorted', 'infected construct': 'pInducer21 empty', 'replicates': '1', 'source_name': 'IMEC cell line'}",cell_line,"['EFO:0000322', 'EFO:0000727', 'CL:0000010']"
177,"{'cell line': 'RKO', 'cell type': 'colon carcinoma cell line', 'source_name': 'RKO_KCNK1 siRNA', 'tansfected with': 'KCNK1 siRNA'}",cell_line,"['EFO:0006858', 'UBERON:0001155', 'CVCL:0504', 'EFO:0000311', 'EFO:0000616', 'EFO:0001232', 'EFO:0005842', 'EFO:0000313', 'DOID:4', 'EFO:0007330', 'DOID:305', 'EFO:0000408', 'DOID:1520', 'DOID:14566', 'EFO:0000322', 'CL:0000010', 'EFO:0004288']"
178,"{'cell type': 'human colon cancer', 'chip antibody': 'None', 'culture media': '(-) Methionine', 'source_name': 'HCT116'}",cell_line,"['EFO:0005842', 'EFO:0000616', 'EFO:0000311', 'DOID:219', 'EFO:0007330', 'EFO:0000408', 'DOID:162', 'DOID:14566', 'CL:0000010', 'EFO:0004288']"
179,"{'BioSampleModel': 'Generic', 'flowcell': 'C0HHGACXX', 'index': 'AGCGCT', 'internal_id': '5', 'lane': '1', 'library': 'INX745', 'lower_protocol': 'Illumina Index', 'mapped reads': '13171803', 'nanodrop 260/230': '1', 'nanodrop 260/280': '2.06', 'pool': 'FALSE', 'rin': '8.4', 'sex': 'female', 'source_name': 'PAXgene blood', 'taxonomy_id': '9606', 'tissue': 'blood', 'total reads': '66706078', 'treatment': 'GD', 'upper_protocol': 'SLX-Transcriptome', 'well_location': 'A05'}",tissue,"['UBERON:0003100', 'EFO:0000727', 'UBERON:0000178']"
180,"{'BioSampleModel': 'Generic', 'cell type': 'BJ fibroblast cells', 'growth stage': 'proliferative', 'rna subtype': 'polyA RNA', 'source_name': 'BJ fibroblast cells'}",cell_line,"['CL:1001608', 'CL:0000057']"
181,"{'BioSampleModel': 'Generic', 'cell line': 'JJN3', 'source_name': 'Multiple myeloma', 'timepoint': '4hr', 'tissue source': 'bone marrow', 'treatment': 'NMP'}",cell_line,"['EFO:0006605', 'DOID:14566', 'EFO:0000616', 'EFO:0000727', 'DOID:9538', 'EFO:0000311', 'EFO:0001642', 'EFO:0005803', 'EFO:0002427', 'UBERON:0002371', 'CVCL:2078', 'EFO:0000540', 'EFO:0001378', 'EFO:0000322', 'CL:0000010', 'EFO:0000408']"
182,"{'BioSampleModel': 'Generic', 'source_name': 'liver', 'tissue': 'liver'}",tissue,['UBERON:0002107']
183,"{'cell line': 'HSB-2', 'genotype/variation': 'expressing LDB1 {delta}LID', 'source_name': 'HSB-2 expressing LDB1 {delta}LID'}",cell_line,"['EFO:0000322', 'CVCL:1859', 'CL:0000010']"
184,"{'BioSampleModel': 'Generic', 'GEO Accession': 'GSM1099816', 'origen of cultured cells': 'hESC H9 line - derived RPE', 'transepithelial electrical resistance': '49± 4 ohm*cm^2'}",in_vitro_differentiated_cells,"['CL:0002322', 'UBERON:0001782', 'CL:0000034', 'CL:0000010']"
185,"{'BioSampleModel': 'Generic', 'all lineage': 'B-cell precursor (BCP) ALL', 'bcp all subtype': 'High Hyperploidy (HeH)', 'disease state': 'acute lymphoblastic leukemia (ALL)', 'source_name': 'Bone marrow', 'tissue': 'Bone marrow'}",primary_cells,"['CL:0000817', 'CL:0000738', 'DOID:14566', 'EFO:0000616', 'EFO:0000311', 'EFO:0000220', 'EFO:0001642', 'CL:0000236', 'UBERON:0002371', 'CL:0000542', 'EFO:0000565', 'EFO:0000540', 'CL:0000988', 'CL:0000945', 'DOID:9952', 'EFO:0000408']"
186,"{'BioSampleModel': 'Generic', 'bromouridine labeling start': 'Immediately after washout', 'bromouridine labeling time': '10 minutes', 'cell type': 'K562', 'drb exposure time': '60 minutes', 'exogenous dna': 'NA', 'source_name': 'K562', 'treatment group': 'DRB exposure'}",cell_line,"['EFO:0000339', 'UBERON:0003100', 'EFO:0000727', 'EFO:0000487', 'UBERON:0002371', 'DOID:4', 'CVCL:0004', 'DOID:8552', 'EFO:0002067', 'CL:0000010', 'EFO:0000408']"
187,"{'BioSampleModel': 'Generic', 'cell type': 'Primary human epidermal melanocytes (neonatal)', 'source_name': 'BRAF'}",primary_cells,"['CL:0000148', 'EFO:0001372', 'CL:2000000']"
188,"{'cell type': 'Pre-activated CD8+ T cells', 'source_name': 'Pre-activated CD8+ T cells', 'tissue': 'Peripheral blood'}",primary_cells,"['CL:0000738', 'UBERON:0000178', 'CL:0000084', 'CL:0001049', 'CL:0000625', 'CL:0000542', 'CL:0000988']"
189,"{'cell storage': 'cryopreserved tumor', 'source_name': 'high grade serous ovarian cancer', 'tumor state': 'ascites', 'tumor subpopulation': 'Bulk tumor'}",primary_cells,"['EFO:0000311', 'EFO:0000616', 'DOID:162', 'EFO:0003893', 'DOID:2394', 'EFO:0000408', 'UBERON:0007795', 'DOID:14566']"
190,"{'BioSampleModel': 'Generic', 'age group': 'old', 'age in years': '64', 'source_name': 'peripheral blood mononuclear cells', 'tissue': 'peripheral blood mononuclear cells'}",primary_cells,"['CL:0000738', 'CL:0000842', 'CL:2000001', 'UBERON:0000178', 'CL:0000081', 'CL:0000988']"
191,"{'condition': 'Vehicle', 'source_name': 'Colorectal cancer patient-derived xenograft', 'tissue': 'Colorectal cancer PDX'}",tissue,"['EFO:0005842', 'EFO:0000616', 'DOID:9256', 'EFO:0000311', 'EFO:0007330', 'EFO:0000408', 'DOID:162', 'EFO:0003942', 'DOID:14566']"
192,"{'BioSampleModel': 'Generic', 'sample comment': 'Hela long total cell fraction, LNA(+)', 'sample_name': 'DRS001021'}",cell_line,['CL:0002045']
193,"{'BioSampleModel': 'Generic', 'ancestry': 'Caucasian', 'gender': 'male', 'sample group': 'coronary artery calcification case', 'source_name': 'coronary artery calcification case', 'tissue': 'peripheral blood'}",tissue,"['EFO:0003156', 'UBERON:0003101', 'UBERON:0000178']"
194,"{'analyte type': 'RNA', 'biospecimen repository': 'NCI_BreastTissues_SequenceAnalysis', 'biospecimen repository sample id': 'S21', 'body site': 'Breast', 'gap_accession': 'phs000676', 'gap_consent_code': '2', 'gap_consent_short_name': 'DS-CA-MDS', 'gap_sample_id': '1088146', 'gap_subject_id': '828436', 'histological type': 'Breast tumor', 'is tumor': 'Yes', 'molecular data type': 'RNA_Seq (NGS)', 'study design': 'Tumor vs. Matched-Normal', 'study disease': 'Breast Neoplasms', 'study name': 'Sequence-Based Analysis of Human Breast Tumors', 'subject is affected': 'Yes', 'submitted sample id': 'S21', 'submitted subject id': '5', 'submitter handle': 'NCI_BreastTissues_SequenceAnalysis'}",tissue,"['EFO:0000616', 'EFO:0003869', 'EFO:0000311', 'UBERON:0000310', 'EFO:0000408', 'DOID:1612', 'DOID:14566']"
195,"{'BioSampleModel': 'Generic', 'cell line': 'HCT116 p53-/-', 'source_name': 'HCT116 p53-/-', 'time': '4 h', 'treatment': 'irradiation'}",cell_line,"['EFO:0000322', 'EFO:0000727', 'CL:0000010', 'CVCL:S744']"
196,"{'BioSampleModel': 'Generic', 'cell type': 'Normal basal cells', 'pathology': 'Normal', 'patient': 'Patient 1', 'source_name': 'Normal basal cells'}",stem_cells,"['CL:0000646', 'CL:0000034']"
197,"{'Age': '59 year', 'BMI': '24.2kg_per_m2', 'ClinicalHistory': 'cause of death', 'ClinicalInformation': 'Premortem non-fasting glycemia', 'Organism': 'Homo sapiens', 'Sex': 'male'}",cell_line,"['UBERON:0003101', 'UBERON:0007023', 'UBERON:0035944', 'EFO:0001272', 'UBERON:0000071']"
198,"{'BioSampleModel': 'Human', 'age': '69', 'biomaterial_provider': 'Valcarcel Laboratory', 'bp_acc': 'PRJNA258400', 'cell_line': 'MCF10', 'cell_part': 'Cytoplasm', 'isolate': 'monoisolate', 'sample_type': 'tissue', 'sex': 'female', 'tax_id': '9606', 'tissue': 'Breast', 'title': 'MCF10 cell line Cytoplasm', 'treatment': 'None'}",cell_line,"['EFO:0000322', 'UBERON:0003100', 'CL:0000010', 'UBERON:0000310']"
199,"{'BioSampleModel': 'Generic', 'cell type': 'mesenchymal stem cells', 'passage': '<10', 'source_name': 'Bone marrow mesenchymal stem cells', 'tissue': 'bone marrow'}",stem_cells,"['CL:0000034', 'CL:0000134', 'CL:0000010', 'UBERON:0002371']"
200,"{'BioSampleModel': 'Generic', 'cell type': 'Human embryonic stem cell cultured in conventional condition', 'gender': 'Male', 'protocol': 'Unsorted', 'source_name': 'Human embryonic stem cell cultured in conventional condition'}",stem_cells,"['CL:0002322', 'UBERON:0003101', 'CL:0000034']"
201,"{'cell type': 'megakaryocytes', 'source_name': 'CD34+ cord blood cell-derived megakaryocytes', 'tissue derivation': 'cord blood'}",primary_cells,"['CL:0000763', 'CL:0000556', 'UBERON:0000178', 'UBERON:0012168', 'CL:0000081', 'CL:0000988']"
202,"{'BioSampleModel': 'Generic', 'cell line': 'HEK293', 'clip variant': 'PAR-CLIP', 'enzymatic digestion': 'complete T1 digestion', 'protein': 'Ago2', 'source_name': 'HEK293'}",cell_line,"['CVCL:0045', 'EFO:0000322', 'UBERON:0002113', 'EFO:0001182', 'CL:0000010']"
203,"{'BioSampleModel': 'Generic', 'source_name': 'Biochain', 'tissue': 'heart'}",tissue,['UBERON:0000948']
204,"{'BioSampleModel': 'Generic', 'source_name': 'non-neoplastic brain tissue', 'tissue type': 'non-neoplastic brain'}",tissue,['UBERON:0000955']
205,"{'cell line': 'CEM-SS', 'cell type': 'T cell', 'genotype': 'T7-A3G overexpression', 'organism': 'Homo sapiens', 'specimen with known storage state': 'fresh specimen'}",cell_line,"['CL:0000738', 'EFO:0000322', 'CL:0000084', 'CL:0000542', 'CVCL:J318', 'CL:0000988', 'CL:0000010']"
206,"{'BioSampleModel': 'HapMap', 'Coriell panel': 'MGP00013', 'Coriell plate': 'HAPMAPPT03', 'DNA-ID': 'NA19238', 'Family ID': 'Y117-02', 'HapMap sample ID': 'NA19238', 'Population Description': 'Yoruba in Ibadan, Nigeria', 'Super Population Code': 'AFR', 'Super Population Description': 'African', 'culture_collection': 'Coriell', 'family_id': 'Y117', 'population': 'YRI', 'relationship': 'Mother', 'sex': 'female'}",cell_line,"['UBERON:0003100', 'EFO:0004900', 'EFO:0004561']"
207,"{'BioSampleModel': 'Generic', 'cell type': 'circulating B cells', 'source_name': 'T12_Day 3 post-vaccine_circulating B cells', 'subject id': 'T12', 'time point': 'Day 3 post-vaccine'}",primary_cells,"['CL:0000236', 'CL:0000738', 'CL:0000988', 'CL:0000945', 'CL:0000542']"
208,"{'BioSampleModel': 'Generic', 'culture': 'Colonies in feeder-free condition', 'donor': 'GDB-316', 'gender': 'female', 'genotype': 'WBS', 'library-type': 'unstranded 100bp PE reads', 'source_name': 'Skin fibroblast-derived iPSC', 'spike-in': 'none'}",induced_pluripotent_stem_cells,"['UBERON:0003100', 'CL:0000057', 'EFO:0004905', 'CL:0002620', 'CL:0002248', 'CL:0002371', 'CL:0000723', 'UBERON:0000014', 'CL:0000034', 'EFO:0000962']"
209,"{'agent': 'chloramphenicol', 'cell line': 'P2', 'cell type': 'fibroblast', 'genotype': 'complex I deficient (patient ND5)', 'passages': '15-20', 'source_name': 'Fibroblasts'}",cell_line,"['EFO:0000322', 'CL:0000057', 'CL:0000010']"
210,"{'BioSampleModel': 'Generic', 'cardioglycoside treatment': 'Control', 'cell line': 'hormone resistant LNCaP-abl', 'source_name': 'prostate cancer'}",cell_line,"['EFO:0000616', 'EFO:0000311', 'CVCL:4793', 'DOID:10283', 'EFO:0007355', 'EFO:0000512', 'DOID:162', 'DOID:14566', 'EFO:0000322', 'CL:0000010', 'EFO:0000408']"
211,"{'BioSampleModel': 'Generic', 'cell line': 'ME-1', 'cell type': 'leukemic cell line', 'source_name': 'ME-1 (leukemic)', 'treatment': '3 days Dox (1 mM)'}",cell_line,"['EFO:0000322', 'EFO:0000727', 'EFO:0006645', 'CL:0000010']"
212,"{'BioSampleModel': 'Generic', 'cell line': 'MDA-468', 'cell type': 'Human breast cancer cells', 'source_name': 'MDA-468-input'}",cell_line,"['UBERON:0000175', 'UBERON:0003100', 'EFO:0000228', 'EFO:0000322', 'DOID:299', 'EFO:0000311', 'DOID:1612', 'DOID:4', 'EFO:0001216', 'EFO:0000408', 'EFO:0003150', 'DOID:162', 'DOID:14566', 'EFO:0000616', 'CL:0000010', 'CVCL:0419']"
213,"{'BioSampleModel': 'Generic', 'cell line': 'MCF-10A-H1047R', 'source_name': 'H1047R 6hr rep2', 'time': '6hr'}",cell_line,"['EFO:0000322', 'CVCL:E778', 'CL:0000010']"
214,"{'BioSampleModel': 'Generic', 'cell line': 'PC3', 'sample type': 'polyA RNA', 'source_name': 'PC3 human prostate cancer cells', 'treatment': 'vehicle'}",cell_line,"['EFO:0000727', 'UBERON:0002481', 'UBERON:0002141', 'EFO:0000512', 'CVCL:S982', 'UBERON:0003101', 'EFO:0000228', 'EFO:0000322', 'CVCL:0035', 'DOID:10283', 'EFO:0007355', 'CL:0000010', 'EFO:0000616', 'UBERON:0001474', 'DOID:4', 'EFO:0000408', 'EFO:0002074', 'DOID:162', 'EFO:0000298', 'EFO:0001272', 'EFO:0000311', 'EFO:0003156', 'UBERON:0007023', 'UBERON:0002367', 'DOID:14566', 'DOID:299']"
215,"{'BioSampleModel': 'Generic', 'cell line': 'MCF-7', 'cell type': 'breast cancer', 'source_name': 'Exponentially growing'}",cell_line,"['DOID:4', 'UBERON:0000175', 'UBERON:0003100', 'EFO:0000228', 'EFO:0000322', 'CVCL:0031', 'DOID:299', 'UBERON:0001911', 'EFO:0000311', 'DOID:162', 'DOID:1612', 'EFO:0003156', 'UBERON:0007023', 'EFO:0000408', 'EFO:0001203', 'UBERON:0000310', 'DOID:14566', 'EFO:0000616', 'CL:0000010', 'EFO:0001272']"
216,"{'BioSampleModel': 'Generic', 'disease state': 'psoriasis', 'source_name': 'Skin psoriasis biopsy', 'tissue': 'skin psoriatic involved'}",tissue,"['EFO:0000701', 'DOID:8893', 'EFO:0000676', 'EFO:0000408', 'UBERON:0000014', 'EFO:0000962']"
217,"{'cell type': 'Pancreatic islet cells', 'source_name': 'Human donor IIDP ID 1121', 'strain': 'none'}",primary_cells,['UBERON:0000006']
218,"{'disease state': 'UC', 'inventory sample name': 'HF-35630', 'remission at week 10': 'Remitter', 'source_name': 'Colonic biopsy', 'tissue': 'colonic biopsy', 'tissue diagnosis': 'No Dx', 'tnf ir': 'ND'}",tissue,['UBERON:0001155']
219,"{'BioSampleModel': 'Generic', 'disease': 'Acute Myeloid Leukemia', 'source_name': 'BM'}",tissue,"['DOID:9119', 'DOID:1240', 'EFO:0000616', 'EFO:0000311', 'EFO:0001642', 'EFO:0000222', 'DOID:4', 'EFO:0000408', 'EFO:0000565', 'EFO:0000540', 'DOID:14566']"
220,"{'cell stimulation': 'Unstimulated', 'phenotype': 'Coeliac Individual', 'source_name': 'CD4+ T cells'}",primary_cells,"['CL:0000084', 'CL:0000738', 'CL:0000988', 'CL:0000624', 'CL:0000542']"
221,"{'BioSampleModel': 'Generic', 'cell line': 'Caco-2', 'source_name': 'Colon cancer cell line', 'treatment': 'None'}",cell_line,"['EFO:0000365', 'UBERON:0003101', 'DOID:0050861', 'EFO:0001099', 'UBERON:0001155', 'EFO:0000311', 'EFO:0000616', 'EFO:0001639', 'EFO:0005842', 'EFO:0007330', 'DOID:4', 'EFO:0003156', 'CVCL:0025', 'EFO:0000408', 'DOID:219', 'DOID:162', 'DOID:14566', 'EFO:0000322', 'CL:0000010', 'EFO:0004288']"
222,"{'BioSampleModel': 'Generic', 'source_name': 'Primary Tumor', 'tumor type': 'HER2 Positive Breast Tumor'}",tissue,"['EFO:0000616', 'EFO:0003869', 'EFO:0000311', 'DOID:1612', 'EFO:0000408', 'DOID:14566']"
223,"{'BioSampleModel': 'Generic', 'cell line': 'T-47D', 'replicate': '1', 'source_name': 'Breast cancer cell line', 'treatment': '8 hour 0.02% DMSO'}",cell_line,"['UBERON:0000175', 'UBERON:0003100', 'DOID:14566', 'EFO:0000616', 'DOID:162', 'EFO:0000727', 'EFO:0000311', 'DOID:1612', 'DOID:4', 'EFO:0002885', 'UBERON:0007023', 'EFO:0000408', 'UBERON:0001911', 'EFO:0000430', 'EFO:0001272', 'CVCL:0553', 'EFO:0000322', 'CL:0000010', 'EFO:0001247']"
224,"{'BioSampleModel': 'Generic', 'disease state': 'Tetralogy of Fallot (TOF)', 'source_name': 'right ventricle from TOF human heart', 'tissue': 'heart, right ventricle'}",tissue,"['EFO:0003777', 'EFO:0000319', 'DOID:6419', 'EFO:0000408', 'UBERON:0002080', 'UBERON:0002082', 'UBERON:0000948', 'EFO:0005207']"
225,"{'cell line': 'T47D', 'experiment group': 'EXPERIMENT 5', 'genotype/variation': 'wild type', 'sample description': 'T47D cells semi-permeabilized with digitonin for 9 minutes', 'source_name': 'T47D_Control 9m', 'tissue source': 'epithelium'}",cell_line,"['UBERON:0000175', 'UBERON:0003100', 'EFO:0000322', 'DOID:4', 'UBERON:0007023', 'UBERON:0000483', 'EFO:0000408', 'UBERON:0001911', 'EFO:0000430', 'EFO:0002694', 'EFO:0001272', 'CVCL:0553', 'CL:0000066', 'CL:0000010', 'EFO:0001247']"
226,"{'BioSampleModel': 'Generic', 'RNAi_depletion': 'ZCCHC8 and CBP80 siRNA treatment', 'cell_line': 'HeLa cells', 'cell_type': 'Cervical cancer cells', 'isolate': 'Total RNA', 'label': '02_ZCCHC8_CBP80'}",cell_line,"['EFO:0001185', 'UBERON:0003100', 'EFO:0000228', 'CVCL:0030', 'DOID:299', 'EFO:0000727', 'EFO:0000311', 'DOID:4', 'DOID:4362', 'EFO:0000408', 'EFO:0003150', 'DOID:162', 'UBERON:0000002', 'DOID:14566', 'EFO:0000616', 'CL:0000010', 'EFO:0000322']"
227,"{'BioSampleModel': 'Generic', 'cell line': 'HEK293T-rex', 'cell line clone': '18', 'recql5 status': 'wild-type', 'source_name': 'HEK293T-rex cells, 18.WT.t40', 'treatment': 'Doxycycline 40 min'}",cell_line,"['CVCL:0063', 'EFO:0001184', 'EFO:0001082', 'UBERON:0007220', 'EFO:0000727', 'CVCL:B501', 'UBERON:0002120', 'CVCL:6D58', 'EFO:0000322', 'CL:0000010', 'UBERON:0000323']"
228,"{'BioSampleModel': 'Generic', 'barcode': 'ATACAG', 'cell type': 'Mesenchymal Stem Cells', 'day': 'd7', 'patient code name': 'Charlotte', 'source_name': 'MSC', 'treatment': 'Chondrogenesis'}",in_vitro_differentiated_cells,"['CL:0000134', 'EFO:0000727', 'DOID:0080043', 'EFO:0005571', 'CL:0000034', 'EFO:0000408', 'EFO:0005541', 'EFO:0004260']"
229,"{'developmental stage': 'adult', 'organism': 'Homo sapiens', 'organism part': 'skeletal muscle', 'sex': 'male'}",tissue,"['UBERON:0014895', 'UBERON:0003101', 'UBERON:0014892', 'UBERON:0001134', 'UBERON:0007023', 'UBERON:0001015', 'UBERON:0001630', 'EFO:0001272']"
230,"{'cell line': 'THP-1 (-PMA)', 'organism': 'mixed sample', 'source_name': 'cell culture infection model', 'strain': 'Salmonella Typhimurium SL1344'}",cell_line,"['DOID:8864', 'UBERON:0003101', 'EFO:0000322', 'EFO:0001355', 'EFO:0000221', 'UBERON:0000178', 'DOID:4', 'CVCL:0006', 'EFO:0000408', 'CL:0000576', 'EFO:0001253', 'CL:0000010']"
231,"{'cell type': 'HeLa cells', 'source_name': 'HeLa cells', 'treatment': 'vehicle'}",cell_line,"['EFO:0001185', 'UBERON:0003100', 'EFO:0000228', 'CVCL:0030', 'DOID:299', 'EFO:0000727', 'DOID:4', 'EFO:0000408', 'EFO:0003150', 'UBERON:0000002', 'CL:0000010']"
232,"{'source_name': 'TRUSS-guided prostatic biopsy of clinically advanced/metastatic prostate cancer tissue', 'time point': 'Post-Treatment', 'tissue': 'Prostate Tumour'}",tissue,"['EFO:0000616', 'EFO:0000727', 'EFO:0000196', 'EFO:0000408', 'UBERON:0002367', 'DOID:14566']"
233,"{'gender': 'Female', 'source_name': 'Female FSHD1 biopsy F8', 'tissue': 'FSHD1 Muscle biopsy'}",tissue,"['UBERON:0001630', 'UBERON:0003100', 'UBERON:0001015', 'UBERON:0005090']"
234,"{'cell type': 'peripheral blood mononuclear cells', 'diagnosis': 'healthy', 'gender': 'female', 'source_name': 'Healthy twin', 'tissue': 'blood'}",primary_cells,"['CL:0000738', 'CL:0000842', 'CL:2000001', 'UBERON:0000178', 'UBERON:0003100', 'CL:0000081', 'CL:0000988']"
235,"{'cell line': 'PC9', 'cell type': 'human lung Adenocarcinoma', 'source_name': 'shCtrl', 'transfected with': 'lentivirus harboring shRNA of control (Arab1)'}",cell_line,"['EFO:0000684', 'EFO:0002847', 'EFO:0000228', 'EFO:0000571', 'DOID:299', 'EFO:0000311', 'EFO:0000313', 'EFO:0003818', 'EFO:0000726', 'EFO:0001071', 'DOID:3910', 'EFO:0000408', 'EFO:0006858', 'EFO:0003060', 'CVCL:B260', 'DOID:14566', 'EFO:0000616', 'CL:0000010', 'EFO:0000322']"
236,"{'age at death': '97 years', 'source_name': '7_Frontal', 'subject id': '7', 'tissue': 'Post morten brain', 'tissue region': 'frontal cortex'}",tissue,"['UBERON:0000955', 'UBERON:0000209', 'EFO:0003534', 'UBERON:0001870', 'UBERON:0004866']"
237,"{'biospecimen repository': 'NINDS Parkinson Cerebrospinal Fluid Biomarker', 'biospecimen repository sample id': 'PD_INVJG584UT4', 'body site': 'CSF', 'gap_accession': 'phs000901', 'gap_consent_code': '1', 'gap_consent_short_name': 'GRU', 'gap_sample_id': '1480066', 'gap_subject_id': '1178189', 'molecular data type': 'RNA Seq (NGS)', 'sex': 'female', 'study design': 'Case-Control', 'study name': 'University of Washington CSF biomarker study for Parkinson disease', 'subject is affected': 'No', 'submitted sample id': 'PD_INVJG584UT4', 'submitted subject id': 'PD_INVJG584UT4', 'submitter handle': 'NINDS Parkinson Cerebrospinal Fluid Biomarker'}",tissue,"['UBERON:0003100', 'UBERON:0001359']"
238,"{'cell type': 'acute myeloid leukemia', 'source_name': 'acute myeloid leukemia', 'tissue': 'Heparinised blood'}",primary_cells,"['DOID:9119', 'DOID:1240', 'EFO:0000616', 'EFO:0000311', 'EFO:0001642', 'EFO:0000222', 'EFO:0000408', 'EFO:0000565', 'EFO:0000540', 'UBERON:0000178', 'DOID:14566']"
239,"{'biomaterial_provider': 'Coriell Cell Repositories http', 'cell line': 'GM19238', 'hapmap': 'YRI', 'source_name': 'lymphoblastoid cell line'}",cell_line,"['EFO:0005292', 'EFO:0002788', 'EFO:0000322', 'CVCL:9633', 'EFO:0004900', 'CL:0000010']"
240,"{'development stage': 'peri-natal', 'sorted cell type': 'CD34+CD45RA-', 'source_name': 'cord blood cells', 'tissue': 'umbilical cord blood'}",primary_cells,"['CL:0000081', 'UBERON:0012168', 'CL:0000988', 'UBERON:0000178']"
241,"{'antibody': 'No', 'cell line': 'A549', 'cell type': 'Lung cancer cells', 'source_name': 'Lung cancer', 'type': 'RNA-seq'}",cell_line,"['EFO:0003156', 'UBERON:0003101', 'EFO:0000684', 'CVCL:0023', 'EFO:0000616', 'EFO:0000311', 'EFO:0000313', 'EFO:0003818', 'DOID:4', 'DOID:305', 'UBERON:0002048', 'DOID:162', 'EFO:0001086', 'DOID:1324', 'DOID:14566', 'EFO:0000322', 'CL:0000010', 'EFO:0000408']"
242,"{'cell line': 'EGFP-10a+ MDA-MB-231', 'protocol': 'supplemented with 1', 'source_name': 'mammary tumor xenograft'}",tissue,"['CVCL:0062', 'UBERON:0000175', 'UBERON:0003100', 'EFO:0001209', 'EFO:0000228', 'EFO:0000322', 'DOID:299', 'EFO:0000311', 'DOID:1612', 'DOID:4', 'EFO:0003156', 'UBERON:0007023', 'EFO:0000408', 'EFO:0003942', 'DOID:14566', 'EFO:0000616', 'CL:0000010', 'EFO:0001272']"
243,"{'age': '52', 'molecule subtype': 'microRNA', 'region': 'prefrontal cortex', 'sex': 'female', 'source_name': 'early stage_prefrontal cortex', 'tissue': 'brain'}",tissue,"['UBERON:0000955', 'EFO:0003534', 'UBERON:0003100', 'UBERON:0000451']"
244,"{'cell line': 'HeLa', 'knockdown chemistry': 'Gapmer', 'knockdown target': 'linc-FIRRE', 'source_name': 'HeLa Cells'}",cell_line,"['EFO:0001185', 'UBERON:0003100', 'EFO:0000228', 'CVCL:0030', 'DOID:299', 'DOID:4', 'EFO:0000408', 'EFO:0003150', 'UBERON:0000002', 'EFO:0000322', 'CL:0000010']"
245,"{'biopsy location': 'left leg', 'exercise status': 'untrained', 'gender': 'female', 'original sample id': '11U1', 'source_name': 'skeletal muscle', 'tissue': 'skeletal muscle'}",tissue,"['UBERON:0014895', 'UBERON:0003100', 'EFO:0000483', 'UBERON:0000978', 'UBERON:0014892', 'UBERON:0001134', 'UBERON:0001015', 'UBERON:0001630']"
246,"{'cell line': 'CUTLL1', 'cell type': 'human T cell leukemia cells', 'infected with': 'retroviruses expressing short haiprin against JMJD3', 'source_name': 'CUTLL1 cells_short hairpin against JMJD3'}",cell_line,"['EFO:0005592', 'EFO:0000311', 'EFO:0000616', 'EFO:0000565', 'CVCL:4966', 'EFO:0001642', 'EFO:0005803', 'CL:0000010', 'DOID:715', 'EFO:0000540', 'DOID:14566', 'EFO:0000322', 'EFO:0004289', 'EFO:0000408']"
247,"{'BioSampleModel': 'Human', 'age': 'Anonymous', 'biomaterial_provider': 'Anonymous', 'isolate': 'Anonymous', 'sex': 'not determined', 'tissue': 'plasma'}",tissue,['UBERON:0001969']
248,"{'cell line': 'IMR90', 'cell type': 'human primary lung fibroblasts', 'genotype/variation': 'expressing shRNA directed against macroH2A1', 'source_name': 'IMR90_macroH2A1 KD'}",cell_line,"['EFO:0001196', 'UBERON:0003100', 'CL:0000057', 'CL:0002553', 'EFO:0000322', 'EFO:0003156', 'CVCL:0347', 'UBERON:0002048', 'CL:0000010']"
249,"{'disease': 'Control', 'donor': 'N090710-F52', 'ercc_mix': '1', 'source_name': 'airway smooth muscle cells', 'tissue': 'human airway smooth muscle cells', 'treatment': 'Baseline'}",cell_line,"['UBERON:0004225', 'EFO:0000727']"
250,"{'disease state': 'healthy', 'source_name': 'blood, post-LPS', 'subject': 'individual A', 'time point': '2 hr post-LPS', 'tissue': 'blood', 'treatment': 'LPS'}",tissue,"['EFO:0000727', 'UBERON:0000178']"
251,"{'differentiation stage': 'late basophilic erythroblasts', 'source_name': 'erythroblasts'}",in_vitro_differentiated_cells,"['CL:0000988', 'CL:0000763', 'CL:0000764', 'CL:0000765', 'CL:0000549']"
252,"{'assigned cell type': 'NA', 'cell count': '1', 'ercc_dilution': '1000000', 'ercc_mix': 'mix2', 'qc pass': 'FALSE', 'source_name': 'pancreatic islet'}",primary_cells,['UBERON:0000006']
253,"{'cell type': 'LCLs B-cells', 'source_name': 'Olaparib 72hr.'}",cell_line,"['CL:0000236', 'CL:0000738', 'CL:0000988', 'CL:0000945', 'CL:0000542']"
254,"{'cell type': 'peripheral blood monocytes', 'disease state': 'healthy', 'donor id': 'A', 'source_name': 'human blood donor peripheral blood monocyte, IFNa', 'treatment': 'interferon-alpha'}",primary_cells,"['CL:0000738', 'CL:0000766', 'CL:0000842', 'EFO:0000727', 'UBERON:0000178', 'CL:0000576', 'CL:0000988']"
255,"{'cell line': 'HEK293', 'crosslinking': 'none', 'modified nucleotide': 'none', 'sirna transfection': 'anti-GFP', 'source_name': 'HEK293'}",cell_line,"['EFO:0001182', 'CVCL:0045', 'EFO:0000322', 'UBERON:0002113', 'EFO:0000726', 'CL:0000010']"
256,"{'cell line': 'MDA-MB-231', 'source_name': 'human breast & mouse normal lung tissue', 'strain': 'NOD scid gamma'}",cell_line,"['CVCL:0062', 'UBERON:0000175', 'UBERON:0003100', 'EFO:0001209', 'EFO:0000228', 'EFO:0000408', 'UBERON:0000170', 'DOID:299', 'UBERON:0000310', 'DOID:4', 'EFO:0003156', 'UBERON:0007023', 'UBERON:0002048', 'EFO:0000322', 'CL:0000010', 'EFO:0001272']"
257,"{'analyte type': 'RNA', 'biospecimen repository': 'NCI_TARGET', 'biospecimen repository sample id': 'TARGET-40-PATAWV-01A-01R', 'body site': 'Primary Solid Tumor', 'gap_accession': 'phs000468', 'gap_consent_code': '1', 'gap_consent_short_name': 'PCR', 'gap_parent_phs': 'phs000218', 'gap_sample_id': '563746', 'gap_subject_id': '466518', 'histological type': 'OS', 'is tumor': 'Yes', 'study design': 'Tumor vs. Matched-Normal', 'study name': 'TARGET', 'submitted sample id': 'TARGET-40-PATAWV-01A-01R', 'submitted subject id': 'TARGET-40-PATAWV', 'submitter handle': 'NCI_TARGET'}",tissue,"['EFO:0000616', 'UBERON:0003101', 'DOID:14566', 'EFO:0000408']"
258,"{'antibody vender': 'BD-Pharmingen', 'cell marker': 'CD44+', 'cell type': 'epithelial cell', 'disease state': 'normal', 'source_name': 'reduction mammoplasty', 'tissue': 'breast'}",primary_cells,"['CL:0000066', 'UBERON:0000310']"
259,"{'cell line': 'LoVo', 'cell type': 'epithelial cell', 'disease': 'Uninfected', 'organism': 'Homo sapiens', 'sex': 'male', 'strain': ''}",cell_line,"['EFO:0000365', 'UBERON:0003101', 'DOID:0050861', 'EFO:0006639', 'CVCL:0399', 'EFO:0000322', 'UBERON:0001155', 'DOID:4', 'EFO:0000408', 'CL:0000066', 'CL:0000010']"
260,"{'age': '57', 'disease staging': 'Extensive atrophy', 'organism': 'Homo sapiens', 'sex': 'female'}",tissue,['UBERON:0003100']
261,"{'Sex': 'Male', 'cell line': 'HGDP01081', 'cell type': 'Lymphoblast cells', 'population': 'Mbuti Pygmy', 'source_name': 'Lymphoblast cell line'}",cell_line,"['CVCL:I194', 'UBERON:0003101', 'CL:0000988', 'EFO:0000322', 'CL:0000010']"
262,"{'age': 'adult (22-36yrs range)', 'cell subtype': 'Cauda', 'patient id': 'UC-06', 'patient status': 'undergoing inguinal radical orchiectomy for a clinical diagnosis of testicular cancer', 'sample type': 'Tissue', 'source_name': 'Cauda_tissue', 'tissue origin': 'Epididymis'}",tissue,"['EFO:0000616', 'DOID:2998', 'EFO:0000311', 'EFO:0007355', 'UBERON:0007023', 'EFO:0000408', 'EFO:0004281', 'DOID:162', 'DOID:14566', 'EFO:0001397', 'UBERON:0001301', 'EFO:0001272']"
263,"{'source_name': 'reprogramming intermediates of hiF-T cells', 'surface antigen enrichment': 'TRA-1-60+', 'treatment': 'DOX days 0-19'}",in_vitro_differentiated_cells,"['CL:0000084', 'CL:0000738', 'CL:0000988', 'EFO:0000727', 'CL:0000542']"
264,"{'cell line': 'Differentiated NT-ESC', 'cell type': 'Fibroblast', 'sequenced molecule': 'polyA RNA', 'source_name': 'Differentiated Nuclear Transfer Stem Cell'}",in_vitro_differentiated_cells,"['CL:0002322', 'EFO:0000322', 'CL:0000034', 'CL:0000057', 'CL:0000010']"
265,"{'cell line': 'HCT116', 'source_name': 'HCT116 Cell line', 'treatment': 'transfect siRNA without N'}",cell_line,"['EFO:0000726', 'UBERON:0003101', 'UBERON:0001155', 'EFO:0000322', 'EFO:0000727', 'EFO:0002824', 'EFO:0000313', 'DOID:4', 'UBERON:0007023', 'DOID:305', 'EFO:0000408', 'CVCL:0291', 'CL:0000010', 'EFO:0001272']"
266,"{'cell line': 'MRC-5', 'cell type': 'fibroblasts', 'population doublings': '42', 'source_name': 'total RNA extracted from MRC-5 fibroblasts', 'treatment': 'none'}",cell_line,"['EFO:0003156', 'UBERON:0003101', 'CL:0000057', 'EFO:0000322', 'DOID:4', 'EFO:0002835', 'UBERON:0002048', 'CVCL:0440', 'CL:0000010', 'EFO:0000408']"
267,"{'cell line': 'induced pluripotent stem cell line', 'gender': 'Female', 'passage': '11+5', 'source_name': 'induced pluripotent stem cell line'}",induced_pluripotent_stem_cells,"['CL:0002371', 'UBERON:0003100', 'EFO:0000322', 'CL:0002248', 'CL:0000034', 'CL:0000723', 'EFO:0004905', 'CL:0000010']"
268,"{'age': '47', 'race': 'Asian', 'source_name': 'pure HG-DCIS', 'tissue': 'breast ductal carcinoma in situ'}",tissue,"['EFO:0006858', 'EFO:0000305', 'DOID:0060074', 'EFO:0000616', 'EFO:0000311', 'EFO:0000313', 'EFO:0003152', 'DOID:3007', 'EFO:0000432', 'DOID:14566', 'EFO:0000408']"
269,"{'cell line': 'HeLa', 'source_name': 'HeLa', 'transfection': 'control'}",cell_line,"['EFO:0001185', 'UBERON:0003100', 'EFO:0000228', 'CVCL:0030', 'DOID:299', 'DOID:4', 'EFO:0000408', 'EFO:0003150', 'UBERON:0000002', 'EFO:0000322', 'CL:0000010']"
270,"{'genotype/variation': 'SLE', 'passages': 'passages 4-11', 'source_name': 'fibroblast', 'tissue': 'skin biopsies'}",cell_line,"['UBERON:0000014', 'EFO:0002690', 'EFO:0000962', 'CL:0000057', 'CL:0000010']"
271,"{'cell type': 'lymphoblastoid cell line', 'condition': 'knockdown', 'hapmap individual': 'GM19238', 'multiplexing index number': '10', 'multiplexing index sequence': 'TAGCTT', 'rin score': '9', 'source_name': 'lymphoblastoid cell line', 'splicing factor targeted': 'SRSF4'}",cell_line,['EFO:0005292']
272,"{'source_name': 'control_heart', 'subject status': 'control', 'tissue': 'heart'}",tissue,['UBERON:0000948']
273,"{'CellLine': 'Ishikawa', 'CellType': 'endometrial epithelial cell', 'Organism': 'Homo sapiens'}",cell_line,"['CVCL:2529', 'EFO:0005718', 'CL:0000066', 'CL:0000010', 'EFO:0000322']"
274,"{'cell line': 'Hela', 'source_name': 'Hela cells (cervical cancer cells)', 'transfection': 'control esiRNA'}",cell_line,"['EFO:0001185', 'UBERON:0003100', 'EFO:0000228', 'CVCL:0030', 'DOID:299', 'EFO:0000311', 'EFO:0000726', 'DOID:4', 'DOID:4362', 'EFO:0000408', 'EFO:0003150', 'DOID:162', 'UBERON:0000002', 'DOID:14566', 'EFO:0000616', 'CL:0000010', 'EFO:0000322']"
275,"{'age': '0 DIV', 'cell line': 'HUES-7', 'source_name': 'neural crest like cells'}",in_vitro_differentiated_cells,"['CVCL:B205', 'UBERON:0002342', 'EFO:0000322', 'EFO:0000795', 'CL:0000010']"
276,"{'cancer or normal': 'normal', 'cell type': 'transitional', 'source_name': 'bladder, normal'}",tissue,"['UBERON:0018707', 'UBERON:0001255']"
277,"{'biomaterial_provider': 'http', 'cell line': 'GM18858', 'cell type': 'Lymphoblastoid Cell Line', 'enrichment type': 'ribosome protected fragments', 'gender': 'Female', 'molecule subtype': 'cytoplasmic RNA', 'source_name': 'lymphoblastoid cell lines derived fromHapMap Yoruba individual'}",cell_line,"['EFO:0005292', 'UBERON:0003100', 'EFO:0000322', 'CVCL:P473', 'EFO:0004900', 'CL:0000010']"
278,"{'cell line': 'Jurkat T cell', 'ectopic expression': 'wild type MALT1', 'p/i stimulation': 'unstimulated', 'source_name': 'GC003243'}",cell_line,"['CL:0000738', 'EFO:0002796', 'CVCL:0065', 'CVCL:S103', 'CL:0000084', 'CVCL:T987', 'CL:0000542', 'CL:0000988', 'EFO:0000322', 'CL:0000010']"
279,"{'analyte type': 'RNA', 'biospecimen repository': 'NHGRI_BreastCancer_Xenotransplants', 'biospecimen repository sample id': 'WHIM13_xenograft.rna', 'gap_accession': 'phs000611', 'gap_consent_code': '1', 'gap_consent_short_name': 'DS-CA', 'gap_sample_id': '1059056', 'gap_subject_id': '809777', 'is tumor': 'Yes', 'molecular data type': 'RNA Seq (NGS)', 'study design': 'Xenograft', 'study disease': 'Breast Neoplasms', 'study name': 'Whole Genome Comparisons of Breast Cancers and their Xenotransplants', 'subject is affected': 'Yes', 'submitted sample id': 'WHIM13_xenograft.rna', 'submitted subject id': '720171', 'submitter handle': 'NHGRI_BreastCancer_Xenotransplants'}",tissue,"['EFO:0000616', 'DOID:14566', 'EFO:0000408']"
280,"{'age': '56', 'gender': 'M', 'patient': 'Disease_K1', 'patient id': 'P1', 'source_name': 'Disease_K1, Nonlesion, Antagonist', 'tissue': 'Nonlesion', 'tissue/treatment id': '8', 'treatment': 'Antagonist'}",tissue,"['DOID:4', 'UBERON:0003101', 'EFO:0000727', 'EFO:0000408']"
281,"{'cell type': 'primary CD34+ stem/progenitor cells', 'source_name': 'CD34-pos cell in erythroid differentiation', 'time point': 'day10'}",in_vitro_differentiated_cells,[]
282,"{'developmental stage': 'adult', 'individual': 'V157', 'organism': 'Homo sapiens', 'organism part': 'lymph node', 'specimen with known storage state': 'frozen specimen'}",tissue,"['UBERON:0000029', 'UBERON:0007023', 'EFO:0001272']"
283,"{'BioSampleModel': 'Human', 'age': 'na', 'biomaterial_provider': 'ATCC', 'cell_line': 'SW480', 'isolate': 'SW480', 'sex': 'male', 'tissue': 'colon'}",cell_line,"['EFO:0000365', 'UBERON:0003101', 'DOID:0050861', 'UBERON:0001155', 'EFO:0000322', 'DOID:4', 'EFO:0003156', 'EFO:0000408', 'CVCL:0546', 'EFO:0002083', 'CL:0000010']"
284,"{'source_name': 'Pre-Treated Psoriasis', 'subject status': 'psoriasis patient', 'time point': 'before adalimumab treatment', 'tissue type': 'lesional skin from psoriasis patient'}",tissue,"['EFO:0000727', 'EFO:0000701', 'DOID:8893', 'EFO:0000676', 'EFO:0000408', 'UBERON:0000014', 'EFO:0000962']"
285,"{'cell line': 'IMR90', 'source_name': 'Fibroblasts'}",cell_line,"['EFO:0001196', 'UBERON:0003100', 'CL:0000057', 'EFO:0000322', 'EFO:0003156', 'CVCL:0347', 'UBERON:0002048', 'CL:0000010']"
286,"{'cell phenotype': 'Lin-CD34+CD38+CD123-CD45RA-', 'phenotype': 'MDS', 'source_name': 'MDS 71', 'tissue': 'Bone marrow MEP'}",primary_cells,"['CL:0000050', 'EFO:0000198', 'EFO:0000408', 'UBERON:0002371', 'DOID:0060469']"
287,"{'celltype': 'lymphocytes', 'source_name': 'lymphocytes from PBMC'}",primary_cells,"['CL:0000738', 'CL:0000988', 'CL:0000542']"
288,"{'biomaterial_provider': 'Coriell; http', 'cell line': 'GM12892', 'sample type': 'polyA RNA', 'source_name': 'polyA RNA Rnase V1 at 37Â°C'}",cell_line,"['EFO:0000322', 'CVCL:9631', 'CL:0000010', 'EFO:0002786']"
289,"{'cell line': 'MDA-MB-231', 'cell type': 'Breast Adenocarcinoma', 'organism': 'Homo sapiens', 'specimen with known storage state': 'fresh specimen'}",cell_line,"['CVCL:0062', 'UBERON:0000175', 'UBERON:0003100', 'EFO:0006858', 'EFO:0000228', 'EFO:0000304', 'EFO:0000305', 'EFO:0000322', 'DOID:299', 'EFO:0000311', 'EFO:0003156', 'EFO:0000313', 'EFO:0001209', 'DOID:4', 'DOID:3458', 'UBERON:0007023', 'EFO:0000408', 'DOID:14566', 'EFO:0000616', 'CL:0000010', 'EFO:0001272']"
290,"{'analyte type': 'DNA', 'biospecimen repository': 'NCI_CervicalCancer', 'biospecimen repository sample id': 'SGCX-NOR-013_T', 'body site': 'Cervix Uteri', 'gap_accession': 'phs000600', 'gap_consent_code': '1', 'gap_consent_short_name': 'DS-CA-MDS', 'gap_sample_id': '926936', 'gap_subject_id': '716921', 'histological type': 'Neuroendocrine carcinoma', 'is tumor': 'Yes', 'molecular data type': 'Whole Exome (NGS)', 'sex': 'female', 'study design': 'Case-Control', 'study disease': 'Uterine Cervical Neoplasms', 'study name': 'Genomic Sequencing of Cervical Cancers', 'subject is affected': 'Yes', 'submitted sample id': 'SGCX-NOR-013_T', 'submitted subject id': 'SGCX-NOR-013', 'submitter handle': 'NCI_CervicalCancer'}",tissue,"['UBERON:0000995', 'DOID:1800', 'UBERON:0003100', 'EFO:0006858', 'EFO:0000616', 'EFO:0000311', 'EFO:0000313', 'DOID:305', 'EFO:0000408', 'UBERON:0000002', 'DOID:14566']"
291,"{'cell line': 'MCF-7', 'cell type': 'breast cancer cell line', 'source_name': 'MCF-7 wild type', 'treated with': 'vehicle (0.1% EtOH) as control for 24hrs'}",cell_line,"['DOID:4', 'UBERON:0000175', 'UBERON:0003100', 'EFO:0000228', 'EFO:0000322', 'CVCL:0031', 'DOID:299', 'UBERON:0001911', 'EFO:0000311', 'DOID:162', 'DOID:1612', 'EFO:0003156', 'EFO:0002885', 'UBERON:0007023', 'EFO:0000408', 'EFO:0001203', 'UBERON:0000310', 'DOID:14566', 'EFO:0000616', 'CL:0000010', 'EFO:0001272']"
292,"{'diagnosis': 'healthy', 'source_name': 'Peripheral whole blood from healthy individual', 'tissue': 'Peripheral whole blood'}",tissue,['UBERON:0000178']
293,"{'sample group': '37C control', 'source_name': 'neuronal aggregates (day 50) derived from induced pluripotent stem cells', 'tissue': '3-dimensional neuronal aggregates that resemble a first trimester telencephalon'}",in_vitro_differentiated_cells,"['UBERON:0001893', 'CL:0000034', 'CL:0002248', 'CL:0002371', 'CL:0000723', 'EFO:0004905']"
294,"{'cell line': '293S', 'source_name': '293S cells', 'treatment': 'no treatment (control)'}",cell_line,"['CVCL:A784', 'EFO:0000322', 'EFO:0000727', 'CL:0000010']"
295,"{'cell line background': 'H9', 'cell type': 'human mesenchymal stem cell (hMSCs)', 'genotype/variation': 'KO; SIRT6-/-', 'source_name': 'late_passage_ko'}",in_vitro_differentiated_cells,"['CL:0000134', 'EFO:0000322', 'CVCL:9773', 'CL:0000034', 'CL:0000010', 'EFO:0003045']"
296,"{'ethnicity': 'Caucasian', 'gender': 'male', 'source_name': 'Whole blood', 'tissue': 'Whole blood'}",tissue,"['EFO:0003156', 'UBERON:0003101', 'UBERON:0000178']"
297,"{'cell line/type': 'HEK293 cells', 'dicer knockdown': 'No', 'source_name': ""3'READs cyto"", 'subcellular fraction': 'cytoplasmic'}",cell_line,"['CVCL:0045', 'EFO:0000322', 'UBERON:0002113', 'EFO:0001182', 'CL:0000010']"
298,"{'cell line': 'Sendai-Virus Derived', 'cell type': 'Human Pluripotent Stem Cell', 'source_name': 'induced Pluripotent Stem Cell'}",induced_pluripotent_stem_cells,"['CL:0002371', 'EFO:0000322', 'CL:0002248', 'CL:0000034', 'CL:0000723', 'EFO:0004905', 'CL:0000010']"
299,"{'BioSampleModel': 'Human', 'age': '24', 'biomaterial_provider': 'Michael Whitfield, Geisel School of Medicine at Dartmouth', 'isolate': 'n/a', 'sex': 'F', 'tissue': 'skin'}",tissue,"['UBERON:0000014', 'UBERON:0003100', 'EFO:0000962']"
300,"{'cell line': 'HeLa', 'cell type': 'human cervical cancer cell line', 'source_name': 'HeLa'}",cell_line,"['EFO:0001185', 'UBERON:0003100', 'EFO:0000228', 'CVCL:0030', 'EFO:0001639', 'DOID:299', 'EFO:0000311', 'DOID:4', 'DOID:4362', 'EFO:0000408', 'EFO:0003150', 'DOID:162', 'UBERON:0000002', 'DOID:14566', 'EFO:0000616', 'CL:0000010', 'EFO:0000322']"
301,"{'source_name': 'Adipose', 'tissue': 'Adipose'}",tissue,['UBERON:0001013']
302,"{'cell line': '293', 'genotype': 'wildtype', 'source_name': 'Flp-Inâ„¢ T-RExâ„¢ 293 Cell Line'}",cell_line,"['EFO:0000322', 'CL:0000010']"
303,"{'sample comment': 'This sample is total RNA  in the UPF1-depleted Hela cells. The RNA purified by polyA-selection (polyA+) were processed for sequencing analysis.', 'sample_name': 'DRS001618'}",cell_line,['UBERON:0004529']
304,"{'experimental condition': 'Polio-Infected / M25 HeLa cells / 8 hpa', 'exptl time': '8 hr post-adsorption (hpa)', 'source_name': 'Polio-Infected / M25 HeLa cells / 8 hpa', 'strain': 'M25 HeLa / dominant-negative mutant RNase L'}",cell_line,[]
305,"{'cell line': 'HeLa', 'source_name': 'HeLa/TO-SmN doxycycline treated'}",cell_line,"['EFO:0001185', 'UBERON:0003100', 'EFO:0000228', 'CVCL:0030', 'DOID:299', 'DOID:4', 'EFO:0000408', 'EFO:0003150', 'UBERON:0000002', 'EFO:0000322', 'CL:0000010']"
306,"{'cell type': 'Induced pluripotent stem cells from human fibroblasts from patients with FA disease', 'genotype correction status': 'not corrected', 'source_name': 'FA-iPSC#5'}",induced_pluripotent_stem_cells,"['CL:0002371', 'CL:0000057', 'DOID:4', 'CL:0002248', 'CL:0000034', 'EFO:0000408', 'CL:0000723', 'EFO:0004905']"
307,"{'antibody used for sorting': 'CD31 (BD Biosciences 555445), CD43 (BD Biosciences 555475), CD41a (BD Biosciences 555467), CD73(BD Biosciences 550257), CD144(BD Biosciences 560411), CD235a (BD Biosciences 555570)', 'cell type': 'Angiogenic hematopoietic progeniotrs', 'source_name': 'H1 differentiated on OP9'}",in_vitro_differentiated_cells,[]
308,"{'assay': 'RNA-seq', 'cell type': 'primary human B cells', 'donor': 'Donor', 'source_name': 'B cells', 'time': '1 d'}",primary_cells,"['CL:0000236', 'CL:0000738', 'CL:0000988', 'CL:0000945', 'CL:0000542']"
309,"{'source_name': 'RNA sequencing ccRCC', 'tag': 'ActiveMotif #61101', 'tissue subtype': 'renal cell carcinoma (RCC)', 'tissue type': 'kidney'}",tissue,"['EFO:0006858', 'EFO:0000228', 'EFO:0000681', 'DOID:4450', 'EFO:0000616', 'EFO:0000311', 'EFO:0000313', 'EFO:0003086', 'EFO:0002890', 'EFO:0000408', 'UBERON:0002113', 'DOID:14566', 'EFO:0002693']"
310,"{'source_name': 'Brain', 'tissue': 'germ cell tumor'}",tissue,"['EFO:0000616', 'EFO:0000311', 'UBERON:0000955', 'EFO:0000514', 'EFO:0000408', 'DOID:2994', 'DOID:14566']"
311,"{'cell type': 'n-tert keratinocytes', 'passage': '15-30', 'protocol': 'differentiated with calcium chloride for 5 days with recombinant human IL-4', 'source_name': 'Skin'}",in_vitro_differentiated_cells,"['CL:0000010', 'CL:0000312', 'UBERON:0000014', 'EFO:0000962', 'CL:0000066', 'CL:0000362']"
312,"{'developmental stage': 'adult', 'individual': '21', 'organism': 'Homo sapiens', 'organism part': 'animal ovary', 'sex': 'female', 'single cell well quality': 'OK'}",primary_cells,"['UBERON:0003100', 'EFO:0000973', 'UBERON:0000992', 'EFO:0001272', 'UBERON:0007023']"
313,"{'source_name': 'Skin', 'tissue': 'skin', 'treatment': 'Control'}",tissue,"['UBERON:0000014', 'EFO:0000962']"
314,"{'BioSampleModel': 'Human', 'age': 'not applicable', 'biomaterial_provider': 'Kenneth P Nephew', 'cell_line': 'A2780', 'cell_subtype': 'A2780 C1R5 resistant-C4re', 'isolate': 'immortalized cell line', 'sex': 'female', 'tissue': 'ovary'}",cell_line,"['UBERON:0003100', 'EFO:0000322', 'UBERON:0000992', 'EFO:0006362', 'CVCL:0134', 'EFO:0000973', 'CL:0000010']"
315,"{'Sample no': '21', 'collection date': '2013', 'sex': 'M', 'tissue': 'liver'}",tissue,"['UBERON:0003101', 'UBERON:0002107']"
316,"{'cell line': 'Kasumi-1', 'genotype': 'siMM', 'source_name': 'RNA_seq replicate 3 from Kasumi1 cells', 'treatment': 'transfection with scrambled siRNA'}",cell_line,"['UBERON:0003101', 'DOID:9119', 'EFO:0003164', 'EFO:0006607', 'EFO:0000727', 'EFO:0000726', 'UBERON:0000178', 'DOID:4', 'EFO:0000408', 'EFO:0000222', 'CL:0000835', 'CVCL:0589', 'CL:0000010', 'EFO:0000322']"
317,"{'cell line': 'HeLa', 'rip antibody': 'none', 'source_name': 'HeLa_Ctrl', 'tissue': 'ovary'}",cell_line,"['EFO:0001185', 'UBERON:0000992', 'EFO:0000228', 'CVCL:0030', 'DOID:299', 'DOID:4', 'UBERON:0003100', 'EFO:0000408', 'EFO:0003150', 'UBERON:0000002', 'EFO:0000973', 'EFO:0000322', 'CL:0000010']"
318,"{'source_name': 'human bronchial epithelial cells', 'time': '72 hour control sample'}",cell_line,"['CL:0000066', 'CL:0002328', 'EFO:0000307', 'UBERON:0002031']"
319,"{'human cell line': 'HeLa-S3 (ATCC CCL-2.2)', 'organism': 'mixed sample (human cell line HeLa-S3 + Salmonella typhimurium SL1344)', 'source_name': 'cell culture infection model', 'strain': 'Salmonella typhimurium SL1344'}",cell_line,"['EFO:0002791', 'CVCL:0058', 'CL:0000010', 'EFO:0000322']"
320,"{'cell line': 'LNCaP', 'cell type': 'Cancer Cell Line', 'origin': 'Cell Line', 'source_name': 'LNCaP', 'tissue': 'Prostate'}",cell_line,"['CVCL:0395', 'DOID:14566', 'EFO:0000616', 'UBERON:0002367', 'EFO:0000311', 'EFO:0002071', 'EFO:0000408', 'DOID:162', 'EFO:0001639', 'EFO:0000322', 'CL:0000010']"
321,"{'analyte type': 'mRNA', 'biospecimen repository': 'NCI_FL_HCC', 'biospecimen repository sample id': 'Sample_133', 'body site': 'Liver', 'gap_accession': 'phs000709', 'gap_consent_code': '1', 'gap_consent_short_name': 'DS-CA-IRB-MDS', 'gap_sample_id': '1252683', 'gap_subject_id': '973955', 'histological type': 'Fibrolamellar Hepatocellular Carcinoma', 'is tumor': 'No', 'molecular data type': 'RNA Seq (NGS)', 'study design': 'Tumor vs. Matched-Normal', 'study name': 'The Genome and Transcriptome of Fibrolamellar Hepatocellular Carcinoma', 'submitted sample id': 'Sample_133', 'submitted subject id': 'Subject_111', 'submitter handle': 'NCI_FL_HCC'}",tissue,"['EFO:0006858', 'EFO:0003769', 'EFO:0001421', 'EFO:0000616', 'EFO:0000311', 'EFO:0000313', 'DOID:684', 'DOID:305', 'EFO:0000408', 'DOID:14566', 'EFO:0000182', 'UBERON:0002107']"
322,"{'cell line': '293T', 'read length': '70', 'source_name': 'human 293T cells', 'treatment': 'hnRNPA2B1 siRNAs'}",cell_line,"['CVCL:0063', 'EFO:0001184', 'UBERON:0007220', 'EFO:0000727', 'UBERON:0002120', 'EFO:0001082', 'EFO:0000322', 'CL:0000010', 'UBERON:0000323']"
323,"{'cell type': 'IPS cells', 'development stage': 'adult', 'disease state': 'normal', 'source_name': 'IPS cells'}",induced_pluripotent_stem_cells,"['CL:0002371', 'CL:0002248', 'UBERON:0007023', 'CL:0000034', 'CL:0000723', 'EFO:0004905', 'EFO:0001272']"
324,{'label': 'CB3'},primary_cells,[]
325,"{'sample type': 'Wnt inhibitor (C3) treated', 'source_name': 'prostate cancer cells'}",cell_line,"['EFO:0000616', 'EFO:0000311', 'DOID:10283', 'EFO:0007355', 'EFO:0000512', 'DOID:162', 'DOID:14566', 'EFO:0000408']"
326,"{'cell line': 'HeLa', 'sample type': 'RNA-seq', 'source': 'HeLa Tet-inducible INTS11 shRNA cell clone', 'source_name': 'HeLa', 'treatment': 'total RNA was sequenced in a Hela cell clone upon EGF stimulation and depletion of INTS11'}",cell_line,"['EFO:0001185', 'UBERON:0003100', 'EFO:0000228', 'CVCL:0030', 'DOID:299', 'EFO:0000727', 'DOID:4', 'EFO:0000408', 'EFO:0003150', 'UBERON:0000002', 'EFO:0000322', 'CL:0000010']"
327,"{'cell line': 'HEK293', 'cell type': 'Embryonic kidney cells', 'iclip antibody': 'anti-myc antibody', 'source_name': 'miCLIP_NSUN2_HEK293', 'transfected with': 'myc-tagged NSUN2 C271A construct'}",cell_line,"['EFO:0001182', 'CVCL:0045', 'EFO:0000322', 'CL:1000497', 'UBERON:0002113', 'EFO:0000726', 'CL:0000010']"
328,"{'cell type': 'MDAH041 LFS fibroblasts', 'passages': '17-19', 'sample group': 'aging cells', 'source_name': 'MDAH041_LP', 'tissue origin': 'Skin', 'treated with': 'None'}",cell_line,"['UBERON:0000014', 'CVCL:E212', 'EFO:0000962', 'CL:0000057', 'CL:0000010']"
329,"{'source_name': 'MEF-depleted hiF-T cells at day 10 of reprogramming', 'well number': '48'}",in_vitro_differentiated_cells,"['CL:0000084', 'CL:0000738', 'CL:0000988', 'CL:0000542']"
330,"{'source_name': 'HeLa', 'time': '12hr', 'transfection': 'mock'}",cell_line,['EFO:0000726']
331,"{'er/pr/her2 status': '+ / + / -', 'molecule subtype': 'rRNA depleted RNA', 'source_name': 'FFPE breast tumor', 'tissue id': 'BRB123', 'tumor grade': '2', 'tumor size': '1.7cm'}",tissue,"['EFO:0000616', 'EFO:0003869', 'EFO:0000311', 'DOID:1612', 'EFO:0000408', 'DOID:14566']"
332,"{'BioSampleModel': 'Human', 'age': 'missing', 'biomaterial_provider': 'Coriell Institute for Medical Research', 'cell_line': 'GM18995', 'cell_type': 'Epstein-Barr virus transformed B-Lymphocyte', 'ethnicity': 'Asian', 'inversion_genotype': 'Std/Inv', 'isolate': 'NA18995', 'phenotype': 'JPT', 'population': 'Japanese in Tokyo, Japan (JPT)', 'sample_type': 'cell culture', 'sex': 'male', 'tissue': 'Lymphoblastoid cell line (LCL)'}",cell_line,"['EFO:0005292', 'UBERON:0003101', 'CL:0000738', 'EFO:0004017', 'EFO:0000322', 'CVCL:P079', 'CL:0000236', 'EFO:0003152', 'CL:0000542', 'EFO:0003164', 'CL:0000988', 'CL:0000945', 'CL:0000010']"
333,"{'cell line': 'HeLa', 'source_name': 'HeLa cells'}",cell_line,"['EFO:0001185', 'UBERON:0003100', 'EFO:0000228', 'CVCL:0030', 'DOID:299', 'DOID:4', 'EFO:0000408', 'EFO:0003150', 'UBERON:0000002', 'EFO:0000322', 'CL:0000010']"
334,"{'disease': 'clear cell renal carcinoma', 'genotype': 'SETD2 mutant', 'individual': 'G7', 'organism': 'Homo sapiens', 'organism part': 'kidney', 'specimen with known storage state': 'frozen specimen'}",tissue,"['DOID:4', 'UBERON:0002113', 'EFO:0000408', 'EFO:0000349']"
335,"{'analyte type': 'RNA', 'biospecimen repository': 'NCI_TARGET', 'biospecimen repository sample id': 'TARGET-21-PARNAW-41A-01R', 'body site': 'Blood Derived Cancer - Bone Marrow, Post-treatment', 'gap_accession': 'phs000515', 'gap_consent_code': '1', 'gap_consent_short_name': 'PCR', 'gap_parent_phs': 'phs000218', 'gap_sample_id': '851494', 'gap_subject_id': '671273', 'histological type': 'AML', 'is tumor': 'Yes', 'sex': 'female', 'study design': 'Tumor vs. Matched-Normal', 'study name': 'TARGET', 'submitted sample id': 'TARGET-21-PARNAW-41A-01R', 'submitted subject id': 'TARGET-21-PARNAW', 'submitter handle': 'NCI_TARGET'}",primary_cells,"['UBERON:0003100', 'EFO:0000616', 'EFO:0000727', 'EFO:0000311', 'UBERON:0002371', 'UBERON:0000178', 'EFO:0000408', 'DOID:162', 'EFO:0000222', 'DOID:14566']"
336,"{'replicates': '2', 'sirna': 'siCtrl', 'source_name': 'IMEC cell line'}",cell_line,"['EFO:0000322', 'CL:0000010']"
337,"{'cell line': 'CUTTL1', 'source_name': 'CUTTL1', 'time': '48h', 'treatment': 'DMSO'}",cell_line,"['EFO:0000322', 'EFO:0000727', 'CL:0000010']"
338,"{'age': '61 years', 'genotype/variation': 'PRKACA p.Leu206Arg mutation', 'sex': 'female', 'source_name': 'cortisol-producing adrenal tumor', 'tissue': 'adrenal tumor'}",tissue,"['UBERON:0003100', 'EFO:0000616', 'UBERON:0007023', 'EFO:0000408', 'UBERON:0002369', 'DOID:14566', 'EFO:0001272']"
339,"{'cell line': 'Huh7 cells', 'data type': 'RNA-seq fastq', 'source_name': 'Huh7 cells', 'transfection': 'Puc19(mock)'}",cell_line,"['CVCL:0336', 'EFO:0000726', 'EFO:0005384', 'CL:0000010', 'EFO:0000322']"
340,"{'cell line': 'THP1', 'cell type': 'human acute monocytic leukemia (AML) cell line', 'genotype/variation': 'PAF1 knockdown', 'source_name': 'THP1_PAF1KD_RNA-seq'}",cell_line,"['DOID:8864', 'UBERON:0003101', 'EFO:0000311', 'EFO:0000616', 'EFO:0001355', 'EFO:0000221', 'EFO:0001642', 'EFO:0000222', 'DOID:4', 'EFO:0001253', 'CVCL:0006', 'EFO:0000408', 'CL:0000576', 'EFO:0000540', 'EFO:0000565', 'UBERON:0000178', 'DOID:14566', 'CVCL:0462', 'CL:0000010', 'EFO:0000322']"
341,"{'cell line': 'HEK293T', 'source_name': 'HEK293T', 'treatment': 'ISRIB (200 nM) for 1 hour'}",cell_line,"['CVCL:0063', 'EFO:0001184', 'UBERON:0007220', 'EFO:0000727', 'UBERON:0002120', 'EFO:0001082', 'EFO:0000322', 'CL:0000010', 'UBERON:0000323']"
342,"{'cell line': 'HEK293', 'fragmentation': 'alkaline hydrolysis', 'sirna': 'Ambion S21772', 'source_name': 'HEK293'}",cell_line,"['CVCL:0045', 'EFO:0000322', 'UBERON:0002113', 'EFO:0001182', 'CL:0000010']"
343,"{'cell type': 'Breast adenocarcinoma epithelial cells', 'source_name': 'MCF-7', 'transfection': 'si-lncRNA67-2'}",cell_line,"['EFO:0006858', 'EFO:0000228', 'EFO:0000304', 'EFO:0000305', 'EFO:0000616', 'EFO:0000311', 'EFO:0000313', 'CL:0000066', 'EFO:0000726', 'DOID:3458', 'EFO:0000408', 'DOID:14566', 'DOID:299']"
344,"{'biomaterial provider': 'Chang Gung Memorial Hospital, Taiwan, ROC', 'phenotype': 'glioblastoma multiforme', 'source_name': 'W158_RNAseq_N', 'tissue': 'Tumor brain tissue'}",tissue,"['EFO:0000311', 'EFO:0000616', 'DOID:3068', 'EFO:0000408', 'EFO:0005543', 'DOID:14566', 'EFO:0003833', 'EFO:0000272', 'EFO:0000519']"
345,"{'ArrayExpress-CellType': 'RNA from whole blood', 'ArrayExpress-Compound': 'N/A', 'ArrayExpress-DevelopmentalStage': 'N/A', 'ArrayExpress-DiseaseState': 'N/A', 'ArrayExpress-Dose': 'N/A', 'ArrayExpress-Genotype': 'N/A', 'ArrayExpress-GrowthCondition': 'N/A', 'ArrayExpress-Immunoprecipitate': 'N/A', 'ArrayExpress-OrganismPart': 'N/A', 'ArrayExpress-Phenotype': 'Normal', 'ArrayExpress-Sex': 'unknown', 'ArrayExpress-Species': 'Homo sapiens', 'ArrayExpress-TimePoint': 'N/A', 'Sample Description': 'RNA from whole blood derived from humans infected with Salmonella Typhi', 'Strain': ''}",tissue,['UBERON:0000178']
346,"{'cell line': 'BJ-Fib', 'cell type': 'Fibroblasts', 'source_name': 'BJ fibroblast cell line'}",cell_line,"['EFO:0000322', 'CL:1001608', 'CL:0000010', 'CL:0000057']"
347,"{'aki': 'No', 'cardiovascular failure': 'No', 'coagulation failure': 'No', 'culture positive': 'No', 'group': 'No Sepsis T0', 'liver failure': 'No', 'organ failure count': '0', 'respiratory failure': 'No', 'sirs signs': '1', 'source_name': 'whole blood_No Sepsis T0', 'tissue': 'whole blood'}",tissue,"['UBERON:0000178', 'UBERON:0000062']"
348,"{'cell line': 'A549', 'source_name': 'A549 cell line_without_glucose', 'tissue': 'lung carcinoma'}",cell_line,"['EFO:0003156', 'UBERON:0003101', 'EFO:0000684', 'EFO:0006858', 'EFO:0000616', 'EFO:0000311', 'EFO:0000313', 'EFO:0003818', 'DOID:4', 'EFO:0001071', 'DOID:305', 'UBERON:0002048', 'DOID:3905', 'EFO:0001086', 'CVCL:0023', 'DOID:14566', 'EFO:0000322', 'CL:0000010', 'EFO:0000408']"
349,"{'cell line': 'CD4+ human T-cell line SupT1', 'infection': 'HIV', 'source_name': 'polyA RNA from mock-infected SUPT1 at 24 hours post-infection, replicate 1', 'time': '24 hours post-infection'}",cell_line,"['EFO:0005741', 'UBERON:0003101', 'CL:0000738', 'EFO:0000408', 'EFO:0000322', 'EFO:0003156', 'DOID:4', 'CL:0000084', 'CVCL:1714', 'EFO:0000763', 'DOID:0080147', 'EFO:0004289', 'CL:0000542', 'EFO:0000764', 'DOID:526', 'CL:0000988', 'CL:0000010', 'CL:0000624']"
350,"{'cell line': 'HPM3', 'cell source': 'pleural cavity', 'cell type': 'primary mesothelial cells', 'source_name': 'Primary mesothelial cell line HPM3, crocidolite asbestos exposure, 8hrs', 'treatment': '5 Î¼g/cm2 of crocidolite asbestos exposure for 8 hrs'}",cell_line,"['EFO:0000487', 'CL:0000077', 'EFO:0000322', 'EFO:0000727', 'UBERON:0002402', 'CL:0000066', 'CL:0000010']"
351,"{'cell line': 'embryonic kidney 293 cells', 'reporter': 'canonical Wnt signaling reporter', 'source_name': 'cell line'}",cell_line,"['EFO:0000322', 'CL:0000010']"
352,"{'cell line': 'Akata', 'cell type': 'An Epstein-Barr virus (EBV)-producer line', 'molecule subtype': 'Ribo-Zero treated RNA', 'source_name': 'Akata_Ribodepleted 30m', 'time after induction': '30 minues'}",cell_line,"['EFO:0000322', 'CVCL:0148', 'CL:0000010']"
353,"{'sample comment': 'Flag-tagged cDNAs of the wild-type and mutant U2AF35 were generated by in vitro mutagenesis, constructed into a tetracycline-inducible lentivirus-based expression vector, and used for gene transfer to cultured cell lines, with EGFP marking.', 'sample_name': 'DRS001233'}",cell_line,"['EFO:0000322', 'EFO:0004187', 'UBERON:2002284', 'CL:0000010']"
354,"{'cell type': 'HeLa-229 cells', 'infection': 'mock', 'source_name': 'HeLa-229_mock'}",cell_line,"['CVCL:1276', 'CL:0000010']"
355,"{'cell type': 'acute myeloid leukemia', 'source_name': 'acute myeloid leukemia', 'tissue': 'Heparinised blood'}",primary_cells,"['DOID:9119', 'DOID:1240', 'EFO:0000616', 'EFO:0000311', 'EFO:0001642', 'EFO:0000222', 'EFO:0000408', 'EFO:0000565', 'EFO:0000540', 'UBERON:0000178', 'DOID:14566']"
356,"{'antibodies': 'anti-CHKA (Sigma) cat no. HPA024153', 'cell line': 'C4-2', 'sample group': 'SiCHKA', 'source_name': 'prostate cancer epithelium'}",cell_line,"['CVCL:4782', 'EFO:0000616', 'EFO:0000311', 'DOID:10283', 'EFO:0007355', 'UBERON:0000483', 'EFO:0000512', 'DOID:162', 'DOID:14566', 'EFO:0000322', 'CL:0000010', 'EFO:0000408']"
357,"{'source_name': 'hiF-T cells', 'treatment': 'control'}",in_vitro_differentiated_cells,"['CL:0000084', 'CL:0000738', 'CL:0000988', 'CL:0000542']"
358,"{'cell type': 'Human iPSC-derived neural progenitor cells', 'differentiation time': 'Embryoid body, day 17', 'genotype': 'DISC1 exon 8 mut/mut', 'parental cell line': 'YZ1 hiPSC', 'source_name': 'Neural progenitor cells'}",in_vitro_differentiated_cells,"['CL:0000047', 'UBERON:0014374', 'EFO:0000322', 'EFO:0004905', 'CL:0002248', 'CL:0002371', 'CL:0000723', 'CL:0000034', 'EFO:0000795', 'CL:0000010']"
359,"{'source_name': 'Extraskeletal myxoid chondrosarcoma', 'tissue': 'extraskeletal myxoid chondrosarcoma', 'tissue archive method': 'FFPE'}",tissue,"['EFO:0000333', 'DOID:14566', 'EFO:0000616', 'EFO:0000311', 'EFO:0000408', 'DOID:6496']"
360,"{'cell type': 'U2OS', 'source_name': 'U2OS, Myc activation (5 hr)', 'treatment': 'Myc activation (5 hr)'}",cell_line,"['EFO:0000637', 'DOID:3347', 'UBERON:0003100', 'UBERON:0002481', 'EFO:0000727', 'EFO:0002869', 'UBERON:0001474', 'CVCL:0042', 'DOID:4', 'EFO:0003156', 'EFO:0000408', 'EFO:0000298', 'CL:0000010']"
361,"{'agent': 'DPN', 'patient': '2', 'source_name': 'Parathyroid adenoma', 'time': '24h', 'tissue': 'Parathyroid tumor'}",tissue,"['EFO:0000232', 'DOID:657', 'UBERON:0001132', 'DOID:7608', 'EFO:0000408', 'EFO:0002422', 'EFO:0000616', 'EFO:1001087', 'DOID:14566', 'EFO:0001379']"
362,"{'cell line': 'PC3', 'cell type': 'prostate cancer cells', 'source_name': 'PC3-Epi', 'treatment': 'Control (Epithelial)'}",cell_line,"['EFO:0000727', 'UBERON:0002481', 'UBERON:0002141', 'EFO:0000512', 'CVCL:S982', 'UBERON:0003101', 'EFO:0000228', 'EFO:0000322', 'CVCL:0035', 'DOID:10283', 'EFO:0007355', 'CL:0000010', 'EFO:0000616', 'UBERON:0001474', 'DOID:162', 'DOID:4', 'EFO:0000408', 'EFO:0002074', 'DOID:299', 'EFO:0000298', 'EFO:0001272', 'EFO:0000311', 'EFO:0003156', 'UBERON:0007023', 'UBERON:0002367', 'DOID:14566', 'CL:0000066']"
363,"{'cell line': 'IMR90', 'genotype/variation': 'wild type', 'source_name': 'IMR90 cells treated with 5azadC', 'treated with': '20 Î¼M 5azadC for 72 hrs'}",cell_line,"['EFO:0001196', 'UBERON:0003100', 'CL:0000057', 'EFO:0000322', 'EFO:0003156', 'CVCL:0347', 'UBERON:0002048', 'CL:0000010']"
364,"{'disease state': 'oral cancer', 'source_name': 'Oral cancer tissue', 'survival': 'Favorable 5-year survival', 'tissue': 'oral mucosa'}",tissue,"['UBERON:0000344', 'EFO:0003868', 'EFO:0003871', 'UBERON:0003729']"
365,"{'cell type': 'NPC', 'source_name': 'NPC'}",in_vitro_differentiated_cells,[]
366,"{'antibody': 'anti-m6A', 'cell line': 'A549', 'knockdown': 'siMETTL14', 'source_name': 'human_Exp2siMETTL14'}",cell_line,"['EFO:0003156', 'UBERON:0003101', 'EFO:0000322', 'EFO:0000313', 'DOID:4', 'DOID:305', 'UBERON:0002048', 'EFO:0001086', 'CVCL:0023', 'CL:0000010', 'EFO:0000408']"
367,"{'BioSampleModel': 'Human', 'age': '54', 'biomaterial_provider': 'Hutt-Fletcher lab, LSU', 'cell_line': 'AGS', 'cell_subtype': 'stable integration of pcDNA3-BART', 'disease': 'gastric adenocarcinoma', 'ethnicity': 'caucasian', 'isolate': 'cell line created from gastic carcinoma biopsy', 'karyotype': 'hyperdiploid', 'sex': 'female', 'tissue': 'stomach'}",cell_line,"['EFO:0003156', 'DOID:3717', 'UBERON:0003100', 'EFO:0006858', 'EFO:0000228', 'EFO:0002109', 'EFO:0000178', 'EFO:0000322', 'DOID:299', 'EFO:0000311', 'EFO:0000313', 'DOID:4', 'CVCL:0139', 'UBERON:0000945', 'DOID:305', 'EFO:0000408', 'EFO:0000503', 'EFO:0000616', 'DOID:14566', 'DOID:5517', 'CL:0000010']"
368,"{'analyte type': 'RNA', 'biospecimen repository': 'NCI_TARGET', 'biospecimen repository sample id': 'TARGET-52-PATENH-01A-01R', 'body site': 'Primary Solid Tumor', 'gap_accession': 'phs000470', 'gap_consent_code': '1', 'gap_consent_short_name': 'PCR', 'gap_parent_phs': 'phs000218', 'gap_sample_id': '861224', 'gap_subject_id': '571509', 'histological type': 'Kidney Tumors', 'is tumor': 'Yes', 'molecular data type': 'miRNA (NGS)', 'sex': 'female', 'study design': 'Tumor vs. Matched-Normal', 'study name': 'TARGET', 'submitted sample id': 'TARGET-52-PATENH-01A-01R', 'submitted subject id': 'TARGET-52-PATENH', 'submitter handle': 'NCI_TARGET'}",tissue,"['UBERON:0002113', 'EFO:0000616', 'UBERON:0003100', 'DOID:14566', 'EFO:0000408']"
369,"{'source_name': 'Breast tumor', 'tissue': 'ER+ Breast Tumor'}",tissue,"['EFO:0000616', 'EFO:0003869', 'EFO:0000311', 'DOID:1612', 'EFO:0000408', 'DOID:14566']"
370,"{'age': '0 year', 'cell type': 'Purified induced neurons (iN)', 'organism': 'Homo sapiens'}",in_vitro_differentiated_cells,['CL:0000540']
371,"{'cell line': 'LAPC-4', 'disease state': 'cancer', 'ets fusion status': 'ETV1+', 'patient id': 'NA', 'sample pool name': 'LAPC-4', 'sample type': 'Cell Line', 'source_name': 'prostate gland', 'tissue harvest site': 'None'}",cell_line,"['UBERON:0002530', 'DOID:14566', 'CVCL:4744', 'DOID:162', 'EFO:0000311', 'EFO:0000408', 'UBERON:0002367', 'EFO:0005392', 'EFO:0000616', 'CL:0000010', 'EFO:0000322']"
372,"{'cell line': 'LNCaP', 'source_name': 'LNCaP cell'}",cell_line,"['EFO:0000322', 'EFO:0002071', 'CVCL:0395', 'CL:0000010']"
373,"{'insert size': '144', 'source_name': 'leimyosarcoma', 'subtypes': 'I', 'tissue': 'Soft Tissue', 'tissue archive method': 'FFPE', 'tissue type': 'leimyosarcoma'}",tissue,"['EFO:0002970', 'EFO:0007384', 'DOID:1967', 'EFO:0000616', 'EFO:0000311', 'EFO:0000408', 'EFO:0000564', 'DOID:14566']"
374,"{'cell type': 'Pterygia cells', 'passages': '3-5', 'patient': '2', 'source_name': 'Pterygium', 'treatment': 'Control'}",cell_line,"['EFO:0003966', 'EFO:0000678', 'EFO:0000618', 'EFO:0000408', 'DOID:0002116', 'EFO:0001058', 'CL:0000010']"
375,"{'cell type': 'airway basal cells', 'smoking status': 'smoker', 'source_name': 'airway basal cells, smoker'}",primary_cells,"['EFO:0003768', 'CL:0000646', 'CL:0000034', 'EFO:0004318', 'CL:0002633']"
376,"{'cell type': '4-cell blastomere', 'ethnicity': 'Han Chinese', 'source_name': '4-cell blastomere', 'supplementary file': 'Human_expression_mat.txt'}",primary_cells,"['CL:0000353', 'EFO:0003161']"
377,"{'sample status': 'Autism', 'source_name': 'postmortem brain tissue', 'tissue': 'brain region BA41 (temporal cortex)'}",tissue,"['UBERON:0000955', 'UBERON:0006095', 'EFO:0003758', 'EFO:0003534', 'EFO:0003756', 'EFO:0000677', 'DOID:12849', 'UBERON:0016538', 'EFO:0005548', 'EFO:0000408']"
378,"{'cell type': 'H7', 'mutation': 'no', 'passage': '53', 'source_name': 'human embryonic stem cell', 'treatment': 'no'}",stem_cells,"['CVCL:9772', 'CL:0000034', 'CL:0002322', 'CVCL:HA52', 'CL:0000010', 'EFO:0005904']"
379,"{'diagnosis': 'Papillary Thyroid Carcinoma', 'sequenced molecule': 'mRNA', 'source_name': 'Normal Thyroid tissue', 'tissue': 'Normal Thyroid'}",tissue,"['DOID:3963', 'EFO:0006858', 'EFO:0003769', 'EFO:0003841', 'EFO:0000616', 'EFO:0000311', 'EFO:0000313', 'DOID:3969', 'EFO:0000641', 'DOID:305', 'EFO:0000408', 'EFO:0002892', 'UBERON:0002046', 'DOID:14566', 'EFO:0001379']"
380,"{'cell line': 'Jurkat', 'sample type': 'total RNA', 'source_name': 'Jurkat T cells', 'treatment': '3 hours'}",cell_line,"['CL:0000738', 'EFO:0002796', 'CVCL:0065', 'CVCL:S103', 'EFO:0000727', 'CL:0000084', 'CVCL:T987', 'CL:0000542', 'CL:0000988', 'EFO:0000322', 'CL:0000010']"
381,"{'cell line': 'NB1', 'plasmid': 'KIF1Bbeta(600-1400)', 'shRNA': 'DHX9', 'source_name': 'NB1 cell line'}",cell_line,"['CVCL:1440', 'EFO:0000322', 'CL:0000010']"
382,"{'cell line': 'HepG2', 'compound': 'DMSO', 'source_name': 'hepatocellular carcinoma cell line', 'time': '12h'}",cell_line,"['EFO:0001187', 'DOID:684', 'UBERON:0003101', 'EFO:0006858', 'CVCL:0027', 'EFO:0003769', 'EFO:0001421', 'EFO:0000322', 'EFO:0000182', 'EFO:0000311', 'EFO:0000313', 'DOID:4', 'EFO:0003156', 'DOID:305', 'EFO:0000408', 'DOID:14566', 'EFO:0000616', 'CL:0000010', 'UBERON:0002107']"
383,"{'cancer subtype': 'A172-GBM, A431-epidermoid carcinoma, D538MG-anaplastic astrocytoma', 'cell line': 'A172, A431, D538MG', 'source_name': 'Combined cancer cell lines (A172, A431, D538MG)'}",cell_line,"['EFO:0000707', 'EFO:0006858', 'DOID:3068', 'DOID:3069', 'EFO:0002101', 'EFO:0001639', 'EFO:0000519', 'CVCL:0131', 'UBERON:0003101', 'UBERON:0003100', 'EFO:0000322', 'CVCL:0037', 'UBERON:0000955', 'CVCL:1163', 'EFO:0006268', 'CL:0000010', 'EFO:0002499', 'EFO:0000616', 'DOID:3078', 'DOID:4', 'EFO:0000408', 'DOID:162', 'EFO:0005543', 'EFO:0000272', 'DOID:1749', 'EFO:0000311', 'EFO:0000313', 'DOID:14566']"
384,{'cell line': 'HeLa'},cell_line,"['EFO:0001185', 'UBERON:0003100', 'EFO:0000228', 'CVCL:0030', 'DOID:299', 'DOID:4', 'EFO:0000408', 'EFO:0003150', 'UBERON:0000002', 'EFO:0000322', 'CL:0000010']"
385,"{'1000 Genomes dataset': 'Pilot2', 'cell line': 'NA12891', 'cell type': 'lymphoblastoid', 'individual': 'NA12891', 'organism': 'Homo sapiens', 'population': 'HapMap CEU', 'population name': 'CEPH', 'sex': 'male'}",cell_line,"['EFO:0005292', 'UBERON:0003101', 'EFO:0004901', 'CL:0000010', 'EFO:0000322']"
386,"{'cell line': 'HEK293', 'molecule subtype': 'Cytoplasmic Poly(A) RNA', 'protein expressed': 'N/A', 'source_name': 'HEK293_Control_RNASeq_BiolReplica'}",cell_line,"['CVCL:0045', 'EFO:0000322', 'UBERON:0002113', 'EFO:0001182', 'CL:0000010']"
387,"{'human cell line': 'HeLa-S3 (ATCC CCL-2.2)', 'organism': 'mixed sample (human cell line HeLa-S3 + Salmonella typhimurium SL1344)', 'source_name': 'cell culture infection model', 'strain': 'Salmonella typhimurium SL1344'}",cell_line,"['EFO:0002791', 'CVCL:0058', 'CL:0000010', 'EFO:0000322']"
388,"{'BioSampleModel': 'Model organism or animal', 'age': 'not applicable', 'biomaterial_provider': 'Korea Cell Line Bank', 'breed': 'not applicable', 'cell_line': 'HeLa', 'sex': 'female', 'strain': 'not applicable', 'tissue': 'not applicable', 'treatment': 'HeLaB'}",cell_line,"['EFO:0001185', 'UBERON:0003100', 'EFO:0000228', 'CVCL:0030', 'EFO:0000322', 'EFO:0000727', 'DOID:4', 'EFO:0000408', 'EFO:0003150', 'UBERON:0000002', 'DOID:299', 'CL:0000010']"
389,"{'disease/status': 'Trisomy 21 (T21)', 'source_name': 'unrelated individual_T21_primary fibroblasts', 'tissue': 'Primary fibroblasts'}",cell_line,"['DOID:4', 'EFO:0001064', 'CL:0000057', 'EFO:0000408']"
390,"{'antibody': 'RNA-seq', 'cell line': '19193', 'replicate': '1', 'source_name': 'Lymphoblastoid Cell Lines'}",cell_line,"['EFO:0005292', 'EFO:0000322', 'CL:0000010']"
391,"{'cell line': 'MCF 10A', 'growth condition': '3D in matrigel for 34h', 'organism': 'Homo sapiens'}",cell_line,"['EFO:0003156', 'UBERON:0003100', 'EFO:0000322', 'UBERON:0000310', 'DOID:4', 'EFO:0001200', 'EFO:0000408', 'UBERON:0001911', 'CVCL:0598', 'CL:0000010']"
392,"{'age': 'young', 'gender': 'female', 'source_name': 'Young Woman', 'tissue': 'bone'}",tissue,"['EFO:0000298', 'UBERON:0003100', 'UBERON:0002481', 'UBERON:0001474']"
393,"{'BioSampleModel': 'Human', 'age': '24', 'biomaterial_provider': 'NCI', 'cell_line': 'SF268', 'disease': 'glioblastoma', 'isolate': 'total RNA', 'sex': 'female', 'tissue': 'Brain', 'treatment': 'siYAP6 rep2'}",cell_line,"['UBERON:0000955', 'UBERON:0003100', 'EFO:0000408', 'EFO:0000272', 'EFO:0000616', 'EFO:0000727', 'DOID:3068', 'EFO:0000311', 'DOID:4', 'EFO:0005451', 'EFO:0000519', 'EFO:0005543', 'DOID:14566', 'CVCL:1689', 'CL:0000010', 'EFO:0000322']"
394,"{'cell line': 'hMADS-3', 'cell type': 'human adipose-derived stem cells', 'source_name': 'human adipose-derived stem cells'}",in_vitro_differentiated_cells,"['UBERON:0001013', 'EFO:0000322', 'CL:0000034', 'CL:0000010']"
395,"{'cell type': 'iPSC', 'group': 'HD_iPSC', 'region': 'HD', 'source_name': 'HD_iPSC_2'}",induced_pluripotent_stem_cells,"['EFO:0004905', 'CL:0002371', 'CL:0000723', 'CL:0000034', 'CL:0002248']"
396,"{'cell type': 'ESC', 'data set': 'nonisogenic', 'source_name': 'ESC'}",stem_cells,"['CL:0002322', 'CL:0000034']"
397,"{'analyte type': 'RNA', 'biospecimen repository': 'MAST_Kinase_Notch_Gene_Breast_Cancer', 'biospecimen repository sample id': 'MCTP_S9', 'body site': 'Breast', 'gap_accession': 'phs000513', 'gap_consent_code': '1', 'gap_consent_short_name': 'CRGM', 'gap_sample_id': '772459', 'gap_subject_id': '629627', 'is tumor': 'Yes', 'molecular data type': 'RNA Seq (NGS)', 'study design': 'Case-Control', 'study disease': 'Breast Neoplasms', 'study name': 'MAST Kinase and Notch Gene Families in Breast Cancer', 'subject is affected': 'Yes', 'submitted sample id': 'MCTP_S9', 'submitted subject id': '9', 'submitter handle': 'MAST_Kinase_Notch_Gene_Breast_Cancer'}",tissue,"['EFO:0000616', 'DOID:14566', 'EFO:0000408', 'UBERON:0000310']"
398,"{'RNAi treatment': 'non-hairpin 18-mer', 'cell line': 'HEK293 Flp-In', 'shRNA info': 'negative control shRNA (Addgene #10879)', 'source_name': 'HEK293 Flp-In_non-hairpin 18-mer', 'stable exogenous dna': 'Promega pGL4.29'}",cell_line,"['EFO:0001182', 'CVCL:0045', 'EFO:0000322', 'EFO:0000727', 'UBERON:0002113', 'CL:0000010']"
399,"{'cell type': 'melanoma', 'mapki sensitivity': 'resistant', 'mapki treatment': 'BRAFi', 'source_name': 'Melanoma cell line'}",cell_line,"['DOID:1909', 'EFO:0000616', 'EFO:0000727', 'EFO:0000311', 'EFO:0000756', 'EFO:0000408', 'DOID:14566', 'EFO:0000322', 'CL:0000010']"
400,"{'age': '44', 'bmi': '22', 'cycle day': 'LH+7', 'first trimester losses': '0', 'live births': '0', 'source_name': 'Human Endometrial Pipelle Biopsy', 'tissue': 'Endometrial pipelle biopsy'}",tissue,['UBERON:0035946']
401,"{'cell line': 'EPC2-hTERT', 'growth conditions': 'submerged (day 8)', 'source_name': 'hTERT-immortalized human esophageal epithelial cell line_submerged', 'treatment': 'untreated'}",cell_line,"['UBERON:0001976', 'CL:0000066', 'CL:0000010', 'EFO:0000322']"
402,"{'average insert size': '249', 'cell line': 'K562', 'cell type': 'immortalised chronic myelogenous leukemia (CML)', 'sample type': 'K-562 truseq 250ng', 'source_name': 'K-562 cell line'}",cell_line,"['EFO:0000339', 'UBERON:0003100', 'UBERON:0002371', 'EFO:0000616', 'EFO:0000565', 'EFO:0000311', 'EFO:0001642', 'DOID:4', 'CVCL:E508', 'CVCL:0004', 'DOID:8552', 'EFO:0000540', 'EFO:0002067', 'DOID:14566', 'EFO:0000322', 'CL:0000010', 'EFO:0000408']"
403,"{'human cell line': 'HeLa-S3 (ATCC CCL-2.2)', 'organism': 'mixed sample (human cell line HeLa-S3 + Salmonella typhimurium SL1344)', 'source_name': 'cell culture infection model', 'strain': 'Salmonella typhimurium SL1344'}",cell_line,"['EFO:0002791', 'CVCL:0058', 'CL:0000010', 'EFO:0000322']"
404,"{'cell type': 'monolayer cardiomyocytes', 'days in culture': 'day 30 of differentiation', 'genotype/variation': 'ALDH2*2', 'source_name': 'hiPSC-CM, mutant ischemia', 'treatment': 'ischemia'}",in_vitro_differentiated_cells,"['EFO:0004264', 'EFO:0000319', 'CL:0000746', 'EFO:0000727', 'CL:0002494', 'CL:0002248', 'CL:0000034', 'EFO:0000408', 'CL:0000723', 'CL:0002371', 'CL:0000187', 'EFO:0004905', 'DOID:326']"
405,"{'cell line': 'HeLa', 'source_name': 'Human cervical cancer', 'time': '0 min', 'treatment': '3 h DRB 0 min 4sU'}",cell_line,"['EFO:0001185', 'UBERON:0003100', 'EFO:0000228', 'CVCL:0030', 'DOID:299', 'EFO:0000727', 'EFO:0000311', 'DOID:4', 'DOID:4362', 'EFO:0000408', 'EFO:0003150', 'DOID:162', 'UBERON:0000002', 'DOID:14566', 'EFO:0000616', 'CL:0000010', 'EFO:0000322']"
406,"{'patient id': '1', 'source_name': 'Tumor cells', 'tissue source': 'laser micro-dissected archival FFPE tissue specimens', 'tissue type': 'non-invasive adenocarcinoma in situ (ais)'}",primary_cells,"['EFO:0000616', 'DOID:14566', 'EFO:0000408', 'DOID:4943']"
407,"{'cell line': 'MDA-MB-231', 'cell type': 'breast adenocarcinoma', 'organism': 'Homo sapiens', 'specimen with known storage state': 'fresh specimen'}",cell_line,"['CVCL:0062', 'UBERON:0000175', 'UBERON:0003100', 'EFO:0006858', 'EFO:0000228', 'EFO:0000304', 'EFO:0000305', 'EFO:0000322', 'DOID:299', 'EFO:0000311', 'EFO:0003156', 'EFO:0000313', 'EFO:0001209', 'DOID:4', 'DOID:3458', 'UBERON:0007023', 'EFO:0000408', 'DOID:14566', 'EFO:0000616', 'CL:0000010', 'EFO:0001272']"
408,"{'diagnosis': 'Neonatal-Onset Multisystem Inflammatory Disease (NOMID)', 'disease/health status': 'active', 'source_name': 'NOMID patients with active disease prior to anakinra treatment', 'tissue': 'Peripheral blood', 'treatment status': 'Prior to anakinra treatment'}",tissue,"['DOID:4', 'EFO:0000727', 'EFO:0000408', 'EFO:0001372', 'UBERON:0000178']"
409,"{'cell line': 'P493-6', 'cell type': 'B cells', 'control': 'FALSE', 'doxycycline treatment': 'TRUE', 'kj-pyr-9 treatment': 'TRUE', 'source_name': 'B cell line'}",cell_line,"['CL:0000738', 'CVCL:6783', 'EFO:0000322', 'EFO:0000727', 'CL:0000236', 'CL:0000542', 'CL:0000988', 'CL:0000945', 'CL:0000010']"
410,"{'cell line': '293T', 'source_name': '293T, control'}",cell_line,"['CVCL:0063', 'EFO:0001184', 'UBERON:0007220', 'UBERON:0002120', 'EFO:0001082', 'EFO:0000322', 'CL:0000010', 'UBERON:0000323']"
411,"{'barcode': 'ATGCAGCAG', 'cell line': 'HeLa-S3', 'genotype/variation': 'Egfp knock out (control)', 'source_name': 'HeLa-S3'}",cell_line,"['EFO:0002791', 'CVCL:0058', 'CL:0000010', 'EFO:0000322']"
412,"{'BioSampleModel': 'Human', 'age': 'Not identified', 'biomaterial_provider': 'ATCC', 'cell_line': 'CaCo2', 'isolate': 'Colon carcinoma cells', 'sex': 'female', 'tissue': 'colon carcinoma'}",cell_line,"['EFO:0006858', 'EFO:0005842', 'EFO:0001099', 'DOID:0050861', 'EFO:0000365', 'UBERON:0003101', 'UBERON:0003100', 'EFO:0000322', 'EFO:0007330', 'CL:0000010', 'EFO:0004288', 'EFO:0000616', 'DOID:4', 'EFO:0000408', 'UBERON:0001155', 'EFO:0000311', 'EFO:0000313', 'EFO:0003156', 'CVCL:0025', 'DOID:305', 'DOID:1520', 'DOID:14566']"
413,"{'agent': 'Media', 'cell type': 'Primary CD14+/CD16+ monocytes', 'donor': 'A2737', 'source_name': 'Primary human CD14+/CD16+ monocytes', 'timepoint': '6hr', 'treatment': 'unstimulated'}",primary_cells,"['CL:0000738', 'CL:0000766', 'CL:0000842', 'CL:0002397', 'EFO:0000727', 'CL:0000576', 'CL:0000988', 'CL:0000010']"
414,"{'cell type': 'SGBS adipocyte D10', 'source_name': 'Adipocyte'}",in_vitro_differentiated_cells,"['CVCL:H945', 'CVCL:GS28', 'CL:0000010', 'CL:0000136']"
415,"{'cell line': 'MCF10a', 'condition': 'EGF Stimulation + DMSO', 'genotype': 'WT', 'source_name': 'MCF10a Breast Epithelium Cell line', 'timepoint': '300 min'}",cell_line,"['DOID:4', 'UBERON:0003100', 'EFO:0000322', 'CL:0000066', 'EFO:0003156', 'EFO:0001200', 'EFO:0000408', 'UBERON:0001911', 'CVCL:0598', 'UBERON:0000310', 'CL:0002327', 'CL:0000010']"
416,"{'source_name': 'PCFCL case 1', 'tissue': 'skin tumor (lymphoma)', 'tumor type': 'primary cutaneous follicle center lymphoma'}",tissue,"['EFO:1000095', 'DOID:0050608', 'EFO:0000408', 'DOID:14566', 'EFO:0000616', 'EFO:0000311', 'EFO:0001642', 'EFO:0000540', 'UBERON:0003199', 'UBERON:0036150', 'EFO:0000574', 'DOID:0060058', 'EFO:0000962', 'EFO:0003820', 'EFO:0000174']"
417,"{'cell line': 'MCF7', 'source_name': 'MCF7', 'treatment': '1hr treatment with 100nM E2'}",cell_line,"['EFO:0003156', 'UBERON:0000175', 'UBERON:0003100', 'EFO:0000228', 'CVCL:0031', 'EFO:0000322', 'EFO:0001203', 'EFO:0000727', 'UBERON:0000310', 'DOID:4', 'UBERON:0007023', 'EFO:0000408', 'UBERON:0001911', 'DOID:299', 'CL:0000010', 'EFO:0001272']"
418,"{'analyte type': 'DNA,RNA', 'biospecimen repository': 'Genentech_NSCLC', 'biospecimen repository sample id': 'GS000000528', 'body site': 'Pleural effusion', 'gap_accession': 'phs000299', 'gap_consent_code': '1', 'gap_consent_short_name': 'HMB-MDS', 'gap_sample_id': '851845', 'gap_subject_id': '671381', 'histological type': 'Carcinoma Large Cell', 'is tumor': 'Yes', 'molecular data type': 'Whole Genome (NGS)', 'sex': 'male', 'study design': 'Tumor vs. Matched-Normal', 'study disease': 'Lung Neoplasms', 'study name': 'Genentech Lung Cancer Sequencing', 'subject is affected': 'Yes', 'submitted sample id': 'GS000000528', 'submitted subject id': '16', 'submitter handle': 'Genentech_NSCLC'}",tissue,"['UBERON:0000175', 'EFO:0003050', 'EFO:0000616', 'UBERON:0003101', 'EFO:0000408', 'DOID:14566']"
419,"{'BioSampleModel': 'Human', 'Treatment replicate': '1', 'age': '58', 'biomaterial_provider': 'ATCC', 'cell_line': 'A549', 'cell_type': 'Lung epithelial', 'isolate': 'ATCC', 'sex': 'male', 'timepoint': '12 hours after infection', 'tissue': 'lung carcinoma', 'treatment': 'infected with human adenovirus type 6'}",cell_line,"['EFO:0006858', 'EFO:0000727', 'EFO:0001071', 'UBERON:0003101', 'EFO:0000684', 'UBERON:0000170', 'EFO:0000322', 'UBERON:0002048', 'DOID:3905', 'CVCL:0023', 'CL:0000010', 'EFO:0000616', 'DOID:4', 'EFO:0000408', 'EFO:0001086', 'EFO:0000311', 'EFO:0000313', 'EFO:0003818', 'EFO:0003156', 'DOID:305', 'DOID:14566', 'CL:0000066']"
420,"{'cell_type': 'HCET', 'shRNA': 'doxycycline-inducible shRNA against PNN', 'source_name': 'Doxycycline-treated sample 4, technical replicate', 'treatment': 'Doxycycline treated'}",cell_line,"['EFO:0000727', 'CL:0000010', 'CVCL:1272']"
421,"{'cell line': 'HEK293T', 'source_name': 'inhouse_low_1pg_rep4'}",cell_line,"['CVCL:0063', 'EFO:0001184', 'UBERON:0007220', 'UBERON:0002120', 'EFO:0001082', 'EFO:0000322', 'CL:0000010', 'UBERON:0000323']"
422,"{'Sex': 'M', 'source_name': 'VC', 'strain/background': 'C57BL/6', 'tissue': 'primary visual cortex'}",tissue,"['EFO:0003534', 'UBERON:0000411', 'UBERON:0003101', 'UBERON:0002436']"
423,"{'average age': '41.7', 'cell type': 'large airway epithelial cells', 'lung cancer': '3 No', 'packyears': '21.5', 'sex': '1 Male, 2 Female', 'smoking status': '3 Current', 'source_name': 'Large airway epithelial cells'}",primary_cells,"['UBERON:0003101', 'UBERON:0003100', 'EFO:0003768', 'EFO:0000616', 'DOID:162', 'EFO:0000311', 'EFO:0003818', 'EFO:0000684', 'EFO:0000408', 'DOID:1324', 'EFO:0004318', 'DOID:14566', 'CL:0000066', 'CL:0002368']"
424,"{'cell type': 'Peripheral blood mononuclear cells', 'source_name': 'PBMCs from CF patient 3', 'treatment': 'Flagelline at 0.25 ug/ml for 4 hours'}",primary_cells,"['CL:0000738', 'CL:0000842', 'EFO:0000727', 'CL:2000001', 'UBERON:0000178', 'CL:0000081', 'CL:0000988']"
425,"{'cell line': 'IRM90', 'cell type': 'senescent cells expressing ZFP36L1mut', 'days after 4oht induction': '7', 'passage': 'p15', 'source_name': 'IRM90 ER'}",cell_line,"['EFO:0000322', 'CL:0000010']"
426,"{'biomaterial_provider': 'Coriell', 'datatype': 'RnaSeq', 'datatype description': 'Sequencing analysis of RNA expression', 'insertlength': '200', 'insertlength description': 'insert length of 200nt', 'labexpid': '11038', 'labversion': '02971', 'mapalgorithm': 'TH1014', 'mapalgorithm description': 'TopHat v1.0.14', 'readtype': '2x75', 'readtype description': 'Paired 75 nt reads', 'replicate': '1', 'source_name': 'GM12891', 'treatment': 'None', 'treatment description': 'No special treatment or protocol applies'}",cell_line,['EFO:0000727']
427,"{'source_name': 'Skin', 'tissue': 'skin', 'treatment': 'Control'}",tissue,"['UBERON:0000014', 'EFO:0000962']"
428,"{'cell line': 'BCBL-1', 'source_name': 'B-cell line'}",cell_line,"['CL:0000738', 'EFO:0000322', 'CVCL:0165', 'CL:0000236', 'EFO:0002048', 'CL:0000542', 'CL:0000988', 'CL:0000945', 'CL:0000010']"
429,"{'cell line': 'MCF7', 'source_name': 'MCF-7 cells', 'time': '48h', 'treatment': '1 percent Oxygen'}",cell_line,"['EFO:0003156', 'UBERON:0000175', 'UBERON:0003100', 'EFO:0000228', 'CVCL:0031', 'DOID:299', 'EFO:0001203', 'EFO:0000727', 'UBERON:0000310', 'DOID:4', 'UBERON:0007023', 'EFO:0000408', 'UBERON:0001911', 'EFO:0000322', 'CL:0000010', 'EFO:0001272']"
430,"{'cell line': 'WIBR3 with fused GFP+LGR5', 'organoid stage': 'organoid', 'source_name': 'differentiated human embryonic stem cells'}",in_vitro_differentiated_cells,"['CL:0002322', 'CVCL:9767', 'EFO:0000322', 'CL:0000034', 'CL:0000010']"
431,"{'cell line': 'HCT116', 'cell type': 'colon cancer', 'length of treatment': '24 hours', 'passages': '33', 'source_name': 'HNF4a8 Line', 'treatment': '0.1 Âµg/mL Doxycycline'}",cell_line,"['UBERON:0003101', 'EFO:0000408', 'UBERON:0001155', 'EFO:0000322', 'EFO:0000311', 'EFO:0000616', 'EFO:0000727', 'EFO:0005842', 'DOID:219', 'EFO:0000313', 'DOID:4', 'EFO:0007330', 'UBERON:0007023', 'DOID:305', 'EFO:0002824', 'DOID:162', 'EFO:0004288', 'DOID:14566', 'CVCL:0291', 'CL:0000010', 'EFO:0001272']"
432,"{'cell line': 'BJ cells', 'condition': 'Quiescence induced by serum depletion', 'source_name': 'Immortalized primary fibroblasts'}",cell_line,"['EFO:0000322', 'UBERON:0001977', 'CL:0000057', 'CL:0000010']"
433,"{'cell type': 'Pre-activated CD8+ T cells', 'source_name': 'Pre-activated CD8+ T cells', 'tissue': 'Peripheral blood'}",primary_cells,"['CL:0000738', 'UBERON:0000178', 'CL:0000084', 'CL:0001049', 'CL:0000625', 'CL:0000542', 'CL:0000988']"
434,"{'cell line': 'WI-38', 'crosslinking': 'not applied', 'ip protein': 'not applied', 'passages': 'PDL55', 'rna type': 'WI-38 Total RNA', 'source_name': 'WI-38'}",cell_line,"['CVCL:0579', 'UBERON:0003100', 'CL:0000057', 'EFO:0000322', 'EFO:0003156', 'EFO:0001260', 'UBERON:0002048', 'CL:0000010']"
435,"{'cell line': 'H1264', 'source_name': 'Total RNA from H1264 xenograft'}",tissue,"['EFO:0000322', 'EFO:0003942', 'CVCL:3970', 'CL:0000010']"
436,"{'ajcc stage': 'Stage IV', 'source_name': 'primary colorectal cancer', 'tissue': 'primary colorectal cancer'}",tissue,"['EFO:0000311', 'EFO:0000616', 'DOID:9256', 'EFO:0005842', 'EFO:0007330', 'EFO:0000408', 'DOID:162', 'DOID:14566']"
437,"{'ad type': 'ADEH+', 'cell type': 'PBMCs', 'source_name': 'peripheral blood mononuclear cells', 'treatment': 'HSV-1'}",primary_cells,"['CL:0000738', 'CL:0000842', 'EFO:0000727', 'CL:2000001', 'UBERON:0000178', 'CL:0000081', 'CL:0000988']"
438,"{'cell line': 'vorinostat-resistant HCT116', 'source_name': 'colorectal carcinoma cell line', 'treatment': 'siCDK10'}",cell_line,"['UBERON:0003101', 'EFO:0006858', 'EFO:0000408', 'UBERON:0001155', 'EFO:0000322', 'EFO:0000616', 'EFO:0000727', 'EFO:0000311', 'EFO:0000313', 'DOID:4', 'UBERON:0007023', 'DOID:305', 'EFO:0002824', 'DOID:14566', 'CVCL:0291', 'CL:0000010', 'EFO:0001272']"
439,"{'cell line': 'HeLa', 'source_name': 'HeLa', 'treatment': '20nM RRP6 siRNA - Dharmacon'}",cell_line,"['EFO:0001185', 'UBERON:0003100', 'EFO:0000228', 'CVCL:0030', 'DOID:299', 'EFO:0000727', 'DOID:4', 'EFO:0000408', 'EFO:0003150', 'UBERON:0000002', 'EFO:0000322', 'CL:0000010']"
440,"{'collectiondate': '2013-02-26', 'rin': '4.29', 'source_name': 'PBMC', 'tissue': 'Peripheral blood mononuclear cells (PBMCs)'}",primary_cells,"['CL:0000738', 'CL:0000842', 'CL:2000001', 'UBERON:0000178', 'CL:0000081', 'CL:0000988']"
441,"{'cell line': 'HEK293T', 'library selection': 'PolyA+', 'organism': 'Homo sapiens', 'sex': 'female'}",cell_line,"['CVCL:0063', 'UBERON:0003100', 'UBERON:0007220', 'EFO:0001184', 'UBERON:0002120', 'EFO:0001082', 'EFO:0000322', 'CL:0000010', 'UBERON:0000323']"
442,"{'cell line': 'TKO', 'cell type': 'Multiple myeloma', 'passage': '15-20', 'phenotype': 'Low levels of MMSET', 'source_name': 'Multiple myeloma'}",cell_line,"['CVCL:HE02', 'EFO:0000311', 'EFO:0000616', 'DOID:9538', 'EFO:0001642', 'EFO:0005803', 'EFO:0002427', 'EFO:0000408', 'EFO:0000540', 'DOID:14566', 'EFO:0001378', 'EFO:0000322', 'CL:0000010']"
443,"{'cell type': 'Prostate cancer', 'genotype': 'DAXX knock-down', 'source_name': 'Prostate', 'tissue': 'Prostate'}",cell_line,"['EFO:0000616', 'DOID:162', 'EFO:0000311', 'DOID:10283', 'EFO:0007355', 'EFO:0000408', 'UBERON:0002367', 'DOID:14566', 'EFO:0000512']"
444,"{'cell type': 'primary CD34+ cell', 'genotype/variation': 'control', 'source_name': 'cord blood'}",in_vitro_differentiated_cells,"['UBERON:0012168', 'UBERON:0000178']"
445,"{'BioSampleModel': 'Model organism or animal', 'age': 'not applicable', 'biomaterial_provider': 'Korea Cell Line Bank', 'breed': 'not applicable', 'cell_line': 'HepG2', 'sex': 'not applicable', 'strain': 'not applicable', 'tissue': 'not applicable', 'treatment': 'HepG2A2E'}",cell_line,"['EFO:0001187', 'CVCL:0027', 'UBERON:0003101', 'DOID:684', 'EFO:0000182', 'EFO:0000727', 'DOID:4', 'EFO:0003156', 'EFO:0000408', 'EFO:0000322', 'CL:0000010', 'UBERON:0002107']"
446,"{'sequencing protocol': 'paired-end, 36-mer sequencing', 'source_name': 'Prostate adenocarcinoma', 'tissue': 'Prostate cancer tissue', 'tumor stage': 'Gleason score 7'}",tissue,"['EFO:0006858', 'EFO:0001663', 'EFO:0000408', 'DOID:2526', 'EFO:0000673', 'EFO:0000616', 'EFO:0000311', 'EFO:0000313', 'DOID:10283', 'EFO:0007355', 'EFO:0000512', 'DOID:162', 'DOID:14566', 'DOID:299', 'EFO:0000228']"
447,{'cell_line': 'SUM-44PE'},cell_line,"['CVCL:3424', 'EFO:0001245', 'CL:0000010', 'EFO:0000322']"
448,"{'ArrayExpress-CellType': 'NOMO-1', 'ArrayExpress-Compound': 'DMSO', 'ArrayExpress-Dose': '0 uM', 'ArrayExpress-GrowthCondition': 'RPMI 20%FBS', 'ArrayExpress-OrganismPart': 'cell line', 'ArrayExpress-Phenotype': 'control', 'ArrayExpress-Species': 'Homo sapiens', 'ArrayExpress-TimePoint': '24h', 'Sample Description': 'Leukaemic cell line treated for 24h with vehicle (DMSO) or 3-butyrolactone', 'Strain': ''}",cell_line,"['EFO:0000322', 'CVCL:1609', 'CL:0000010']"
449,"{'Organism': 'Homo sapiens', 'biosource provider': 'UMR 985 INSERM, Institut Gustave Roussy, 94805 Villejuif, France', 'cell type': 'tumor', 'disease state': 'Megakaryoblastic leukemia', 'individual': 'AMKL6'}",tissue,"['DOID:1240', 'EFO:0000616', 'EFO:0000311', 'EFO:0001642', 'EFO:0000408', 'EFO:0000565', 'EFO:0000540', 'DOID:14566']"
450,"{'cell type': 'iPS cell-derived neuronal samples', 'diferentiation day': '~ day 33', 'disease': 'Healthy', 'genotype': 'GBA +/N370S', 'source_name': 'iPS cell-derived neuronal samples'}",in_vitro_differentiated_cells,"['EFO:0004905', 'CL:0000723', 'CL:0002371', 'CL:0000034', 'CL:0002248']"
451,"{'sample type': 'U937', 'source_name': 'Leukemic cell line', 'treatment': '5uM 11,12-EET for 2 hrs'}",cell_line,"['EFO:0000322', 'EFO:0000727', 'CL:0000010']"
452,"{'cell type': 'sperm', 'sequencing date': '2013-12-02', 'source site': 'Harvard', 'source_name': 'sperm'}",primary_cells,"['UBERON:0001968', 'CL:0000019']"
453,"{'cell type': 'H9 Human ESCs', 'chip antibody': 'none', 'passages': 'p21-50', 'source_name': 'H9 Human ESCs'}",stem_cells,"['CL:0002322', 'CVCL:9773', 'CL:0000034', 'EFO:0003045', 'CL:0000010']"
454,"{'source_name': 'CUTLL1 cells', 'treatment': 'Agarose alone, 24hrs'}",cell_line,['EFO:0000727']
455,"{'cell line': 'AML3', 'source_name': 'AML3', 'treatment': 'untreated'}",cell_line,"['EFO:0000322', 'CL:0000010']"
456,"{'cell type': 'Hela', 'clip antibody': 'none', 'source_name': 'Hela cells', 'treatment': 'treated with control shRNA'}",cell_line,"['EFO:0001185', 'UBERON:0003100', 'EFO:0000228', 'CVCL:0030', 'DOID:299', 'EFO:0000727', 'DOID:4', 'EFO:0000408', 'EFO:0003150', 'UBERON:0000002', 'CL:0000010']"
457,"{'cell line': 'SK-Mel-28', 'source_name': 'Melanoma cell line', 'time point': 'post infection day 3', 'treatment': 'shRNA scramble (pLKO backbone, sigma)'}",cell_line,"['DOID:1909', 'CVCL:0526', 'UBERON:0003101', 'EFO:0000756', 'UBERON:0001130', 'EFO:0000962', 'EFO:0000616', 'EFO:0000727', 'EFO:0000311', 'DOID:4', 'UBERON:0007023', 'EFO:0003081', 'UBERON:0000014', 'EFO:0000408', 'DOID:14566', 'EFO:0000322', 'CL:0000010', 'EFO:0001272']"
458,"{'barcode': 'CTTGTAA', 'cell line': 'HEK 293', 'culture medium': 'DMEM', 'source_name': 'HEK293 cell culture', 'treatment': 'Co-RNAi against RC3H1 and RC3H2, addition of 50 ug/ml ActD 2h before harvesting'}",cell_line,"['EFO:0001182', 'CVCL:0045', 'EFO:0000322', 'EFO:0000727', 'UBERON:0002113', 'CL:0000010']"
459,"{'Cell Line Name': 'JHOC-5', 'Cell Line Type': 'Ovarian Cancer'}",cell_line,"['EFO:0000311', 'EFO:0000616', 'EFO:0003893', 'DOID:2394', 'CVCL:4640', 'EFO:0000408', 'DOID:162', 'DOID:14566', 'EFO:0000322', 'CL:0000010']"
460,"{'biomaterial_provider': 'Coriell', 'biorep': '017WC', 'datatype': 'RnaSeq', 'datatype description': 'Sequencing analysis of RNA expression', 'labexpid': 'LID20745', 'labversion': 'iIDR', 'localization': 'cell', 'localization description': 'Whole cell', 'protocol': 'TAP-Only', 'protocol description': ""This kind of library was made from RNA < 200 nucleotides that were pre-treated with Tobacco Acid Pyrophosphatase to remove any 5' caps that would preclude cloning. Hence, both capped and 5' monophosphate RNAs will be cloned."", 'readtype': '1x36', 'readtype description': 'Single 36 nt reads', 'replicate': '1', 'rnaextract': 'shortTotal', 'rnaextract description': 'Rna shorter than 200 nt that has not been seperated based on Poly Adenalyation', 'source_name': 'AG04450'}",cell_line,"['UBERON:0002048', 'CL:0002553', 'CL:0000057']"
461,"{'cell line': 'HCC1599', 'cell type': 'Triple negative breast cancer cell line containing an activating Notch1 mutation, grown in suspension', 'passage': '--', 'source_name': 'HCC1599', 'treatment': 'vehicle'}",cell_line,"['EFO:0003156', 'UBERON:0003100', 'CVCL:1256', 'EFO:0005537', 'EFO:0000616', 'DOID:162', 'EFO:0000727', 'EFO:0000311', 'DOID:1612', 'DOID:4', 'EFO:0002885', 'UBERON:0007023', 'EFO:0000408', 'UBERON:0001911', 'EFO:0000430', 'EFO:0002186', 'DOID:14566', 'EFO:0000322', 'CL:0000010', 'EFO:0001272']"
462,"{'cell line': 'IMR-32', 'cell type': 'neuroblast', 'organism': 'Homo sapiens'}",cell_line,"['EFO:0000621', 'UBERON:0000955', 'UBERON:0003101', 'CL:0000047', 'EFO:0001195', 'CL:0000337', 'DOID:769', 'CVCL:0346', 'EFO:0003156', 'DOID:4', 'CL:0000031', 'CL:0000034', 'EFO:0000408', 'EFO:0000322', 'CL:0000010']"
463,"{'cell type': 'fibroblasts', 'source_name': 'BJ cells', 'sources': 'ATCC CRL-2522', 'tissue': 'skin; foreskin'}",cell_line,"['UBERON:0000014', 'EFO:0000962', 'UBERON:0001332', 'CL:0000057']"
464,"{'ArrayExpress-CellType': 'N/A', 'ArrayExpress-Compound': 'N/A', 'ArrayExpress-DevelopmentalStage': 'N/A', 'ArrayExpress-DiseaseState': 'N/A', 'ArrayExpress-Dose': 'N/A', 'ArrayExpress-Genotype': 'N/A', 'ArrayExpress-GrowthCondition': 'N/A', 'ArrayExpress-Immunoprecipitate': 'N/A', 'ArrayExpress-OrganismPart': 'N/A', 'ArrayExpress-Phenotype': 'N/A', 'ArrayExpress-Sex': 'not applicable', 'ArrayExpress-Species': 'Homo sapiens', 'ArrayExpress-TimePoint': '12H', 'Sample Description': 'RNA from TPH1', 'Strain': ''}",cell_line,[]
465,"{'cell line': 'MDA-MB-468', 'cell type': 'triple negative breast cancer cell line', 'source_name': 'MDA-MB-468-ERbeta1_DMSO_plusdox'}",cell_line,"['UBERON:0000175', 'UBERON:0003100', 'EFO:0000228', 'EFO:0000322', 'EFO:0005537', 'DOID:299', 'EFO:0000311', 'DOID:1612', 'DOID:4', 'EFO:0001216', 'EFO:0002885', 'EFO:0000408', 'EFO:0003150', 'DOID:162', 'DOID:14566', 'EFO:0000616', 'CL:0000010', 'CVCL:0419']"
466,"{'cell type': 'HEK293 cell lines', 'ip antibody': 'None', 'passages': '15-20', 'source_name': 'sh_HCV variants'}",cell_line,"['CVCL:0045', 'EFO:0000322', 'UBERON:0002113', 'EFO:0001182', 'CL:0000010']"
467,"{'cell type': 'granulocyte', 'passages': 'primary', 'source_name': 'human primary granulocytes', 'tissue': 'blood'}",primary_cells,"['CL:0000738', 'CL:0000766', 'UBERON:0000178', 'CL:0000094', 'CL:0000988', 'CL:0000010']"
468,"{'ClinicalHistory': 'Relapse', 'ClinicalInformation': 'Platinum resistant', 'DiseaseState': 'ovarian carcinoma', 'Individual': 'Patient 3', 'Organism': 'Homo sapiens'}",cell_line,"['EFO:0000311', 'DOID:4001', 'EFO:0003893', 'EFO:0000408', 'EFO:0001075', 'DOID:14566', 'EFO:0000616']"
469,"{'cell marker': 'CD24', 'cell type': 'epithelial cell', 'disease state': 'cancer', 'source_name': 'biopsy and surgery', 'tissue': 'breast'}",primary_cells,"['EFO:0000616', 'EFO:0000311', 'UBERON:0000310', 'EFO:0000408', 'DOID:162', 'DOID:14566', 'CL:0000066']"
470,"{'cell type': 'colony-forming unit-erythroid cells (CFU-E)', 'source_name': 'CFU-E cells', 'tissue': 'Cord blood'}",primary_cells,"['CL:0000763', 'CL:0000764', 'CL:0002031', 'CL:0000839', 'UBERON:0012168', 'CL:0000038', 'CL:0001066', 'UBERON:0000178', 'CL:0000988']"
471,"{'cell line': 'THP-1', 'source_name': 'human monocyte cell line', 'treatment': 'puromycin 100Âµg/ml'}",cell_line,"['CL:0000738', 'DOID:8864', 'UBERON:0003101', 'EFO:0000727', 'CL:0000766', 'CL:0000842', 'EFO:0000322', 'EFO:0001355', 'EFO:0000221', 'UBERON:0000178', 'DOID:4', 'CVCL:0006', 'EFO:0000408', 'CL:0000576', 'EFO:0001253', 'CL:0000988', 'CL:0000010']"
472,"{'BioSampleModel': 'Human', 'age': '25', 'biomaterial_provider': 'UAB colposcopy clinic', 'ethnicity': 'EA', 'isolate': 'SS115n', 'sex': 'female', 'tissue': 'FFPE'}",tissue,['UBERON:0003100']
473,"{'cell line': 'M395AR', 'cell type': 'Melanoma', 'source_name': 'Melanoma'}",cell_line,"['DOID:1909', 'EFO:0000616', 'EFO:0000311', 'EFO:0000756', 'EFO:0000408', 'DOID:14566', 'EFO:0000322', 'CL:0000010']"
474,"{'developmental stage': 'Blastocyst', 'embryo number': 'Embryo 2', 'lineage': 'Epiblast', 'source_name': 'Human Embryo'}",primary_cells,"['UBERON:0000358', 'UBERON:0002532', 'EFO:0000795', 'UBERON:0000922']"
475,"{'Age': '27 year', 'BioSourceProvider': 'NSW Tissue Resource Centre, The University of Sydney, Australia', 'Disease_Factor': 'Schizophrenia', 'Ethnic_Group': 'Caucasian', 'Organism': 'Homo sapiens', 'OrganismPart': 'Brain', 'Phenotype': 'Schizophrenia', 'Sex': 'Male', 'Viability': 'post-mortem'}",tissue,"['DOID:4', 'UBERON:0003101', 'EFO:0000692', 'EFO:1001457', 'EFO:0000677', 'UBERON:0000955', 'EFO:0003156', 'UBERON:0007023', 'EFO:0000408', 'DOID:5419', 'EFO:0001272']"
476,"{'analyte type': 'RNA', 'biospecimen repository': 'NHGRI_Sarcoma_PrecisionCancerMedicine', 'biospecimen repository sample id': 'MCTP_SI_6664', 'body site': 'Liver', 'gap_accession': 'phs000673', 'gap_consent_code': '1', 'gap_consent_short_name': 'GRU', 'gap_sample_id': '1207535', 'gap_subject_id': '942231', 'histological type': 'Breast Cancer', 'is tumor': 'Yes', 'molecular data type': 'RNA Seq (NGS)', 'sex': 'female', 'study design': 'Case Set', 'study disease': 'Neoplasms', 'study name': 'University of Michigan Clinical Sequencing Exploratory Research (CSER)', 'subject is affected': 'Yes', 'submitted sample id': 'MCTP_SI_6664', 'submitted subject id': '4', 'submitter handle': 'NHGRI_Sarcoma_PrecisionCancerMedicine'}",tissue,"['UBERON:0003100', 'EFO:0000616', 'EFO:0000311', 'DOID:1612', 'EFO:0000408', 'DOID:162', 'DOID:14566', 'UBERON:0002107']"
477,"{'biomaterial_provider': 'Cell Line from UNC Tissue Culture Facility', 'catolog number': 'L-017263-00-0005', 'cell line': 'HepG2', 'cell type': 'hepatocellular carcinoma', 'sirna vendor': 'Dharmacon', 'source_name': 'HepG2_Arid1a_siRNA'}",cell_line,"['EFO:0001187', 'DOID:684', 'UBERON:0003101', 'EFO:0006858', 'CVCL:0027', 'EFO:0003769', 'EFO:0001421', 'EFO:0000322', 'EFO:0000182', 'EFO:0000311', 'EFO:0000313', 'DOID:4', 'EFO:0003156', 'DOID:305', 'EFO:0000408', 'DOID:14566', 'EFO:0000616', 'CL:0000010', 'UBERON:0002107']"
478,"{'cell type': 'mixture of multiple cell lines', 'source_name': 'Original Agilent Human Universal Reference RNA'}",cell_line,"['EFO:0000322', 'CL:0000010']"
479,"{'cell line': 'HCC364', 'source_name': 'HCC364 cells, infected with shRNA against YAP1 & treated with Trametinib', 'tissue': 'Lung adenocarcinoma', 'treatment': 'infected with shRNA against YAP1 & treated with Trametinib'}",cell_line,"['EFO:0000684', 'EFO:0006858', 'EFO:0000228', 'EFO:0000408', 'EFO:0000571', 'DOID:299', 'EFO:0000727', 'EFO:0000311', 'EFO:0000313', 'EFO:0003818', 'EFO:0006420', 'EFO:0001071', 'DOID:3910', 'CVCL:5134', 'EFO:0003060', 'DOID:14566', 'EFO:0000616', 'CL:0000010', 'EFO:0000322']"
480,"{'cell type': 'Beta', 'donor id': 'CITH053', 'source_name': 'FACS-sorted pancreatic islet', 'tissue': 'pancreatic islets'}",primary_cells,"['UBERON:0000006', 'CVCL:R799', 'CL:0000010']"
481,"{'source_name': 'GBM Sample', 'tissue': 'brain', 'tumor stage': 'Glioma Grade IV'}",tissue,"['DOID:3070', 'EFO:0000272', 'EFO:0000616', 'DOID:3068', 'EFO:0000311', 'EFO:0000326', 'UBERON:0000955', 'EFO:0000408', 'EFO:0005543', 'DOID:14566', 'EFO:0000519']"
482,"{'cycloheximide': '0.1 mg/mL cycloheximide', 'sample type': 'ribosome footprint', 'source_name': 'MM1.S myeloma cell line', 'time point': '9h'}",cell_line,"['EFO:0001378', 'EFO:0000616', 'EFO:0000311', 'EFO:0001642', 'EFO:0005803', 'EFO:0002427', 'EFO:0000408', 'EFO:0000540', 'DOID:14566', 'DOID:0070004', 'CL:0000010', 'EFO:0000322']"
483,"{'BioSampleModel': 'Human', 'age': '0', 'biomaterial_provider': '0', 'isolate': 'HMEC-1 cells', 'sex': 'not applicable', 'tissue': 'Not applicable'}",cell_line,['EFO:0001188']
484,"{'cell line': 'MCF7', 'passage': '7', 'sirna': 'ON-TARGETplus Non-Targeting siRNA against GATA3', 'source_name': 'Human breast adenocarcinoma cell-line MCF7', 'treatment': 'GATA3 KD'}",cell_line,"['EFO:0006858', 'EFO:0000727', 'UBERON:0000310', 'DOID:3458', 'EFO:0001203', 'EFO:0005215', 'UBERON:0000175', 'UBERON:0003100', 'EFO:0000228', 'EFO:0000304', 'EFO:0000305', 'CVCL:0031', 'EFO:0000322', 'CL:0000010', 'EFO:0000616', 'DOID:4', 'EFO:0000408', 'EFO:0001272', 'EFO:0000311', 'EFO:0000313', 'EFO:0003156', 'UBERON:0007023', 'UBERON:0001911', 'DOID:14566', 'DOID:299']"
485,"{'cell line': 'T47D', 'cell type': 'breast cancer', 'source_name': 'breast cancer cell line', 'subtype': 'Luminal'}",cell_line,"['UBERON:0000175', 'UBERON:0003100', 'DOID:14566', 'EFO:0000616', 'DOID:162', 'EFO:0000311', 'DOID:1612', 'DOID:4', 'EFO:0002885', 'UBERON:0007023', 'EFO:0000408', 'UBERON:0001911', 'EFO:0000430', 'EFO:0001272', 'CVCL:0553', 'EFO:0000322', 'CL:0000010', 'EFO:0001247']"
486,"{'BioSampleModel': 'Human', 'age': '30', 'biomaterial_provider': 'Coriell', 'cell_line': 'WTC', 'isolate': 'GM25256', 'sex': 'male', 'sgRNA': 'none', 'tissue': 'iPSC', 'treatment': 'doxycycline'}",induced_pluripotent_stem_cells,"['UBERON:0003101', 'EFO:0000322', 'EFO:0000727', 'CL:0002248', 'CL:0002371', 'CL:0000723', 'CL:0000034', 'EFO:0004905', 'CL:0000010']"
487,"{'BioSampleModel': 'Human', 'age': 'not applicable', 'biomaterial_provider': 'not applicable', 'cell_line': 'H1', 'cell_subtype': 'human embryonic stem cells', 'isolate': 'not applicable', 'sex': 'not applicable', 'tissue': 'retinal pigment epithelial', 'treatement_time': '40 days', 'treatment': 'induced by three-dimensional cultures methods'}",in_vitro_differentiated_cells,"['UBERON:0001782', 'EFO:0000322', 'EFO:0000727', 'CL:0000034', 'CL:0002322', 'CL:0000010']"
488,"{'BioSampleModel': 'Human', 'age': '49', 'biomaterial_provider': 'Department of Oncology Surgery,Shantou Central Hospital,Affi liated Shantou Hospital of Sun Yat-sen University , Shantou 515041, Guangdong , China', 'cell_type': '22', 'isolate': 'esophageal squamous cell carcinoma', 'sex': 'male', 'tissue': 'esophagus'}",tissue,"['UBERON:0003101', 'UBERON:0001043', 'EFO:0005922']"
489,"{'cell line': 'HCT116', 'genotype': 'GFP', 'source_name': 'HCT116', 'tissue': 'Colorectal cancer cell line'}",cell_line,"['UBERON:0003101', 'EFO:0001639', 'EFO:0000408', 'UBERON:0001155', 'EFO:0000322', 'EFO:0000311', 'EFO:0000616', 'DOID:9256', 'EFO:0005842', 'EFO:0000313', 'DOID:4', 'EFO:0007330', 'UBERON:0007023', 'DOID:305', 'EFO:0002824', 'DOID:162', 'DOID:14566', 'CVCL:0291', 'CL:0000010', 'EFO:0001272']"
490,"{'cell type': 'GFP negative neural retina cells', 'day post induction': 'Day 90', 'source_name': 'hES derived neural retina'}",in_vitro_differentiated_cells,"['UBERON:0003902', 'CL:0009004', 'UBERON:0000966']"
491,"{'BioSampleModel': 'Human', 'age': 'adult', 'biomaterial_provider': 'Research Blood Components LLC (Boston, MA)', 'hours': '24', 'isolate': '1', 'sex': 'Male', 'tissue': 'PBMCs'}",primary_cells,"['UBERON:0003101', 'UBERON:0007023', 'EFO:0001272']"
492,"{'purification method': 'PureSperm cushion', 'source_name': 'Fertile mature sperm', 'storage method': 'Liquefied storage'}",primary_cells,"['UBERON:0001968', 'CL:0000019']"
493,"{'cell type': 'lymphoblastic cell line', 'source_name': 'Lymphoblastoid cell lines'}",cell_line,['EFO:0005292']
494,"{'barcode': 'TCAAGT', 'cell line': 'HEK293', 'genotype/variation': 'UPF1/XRN1 depletion', 'reporter gene': 'b-globin PTC39 reporter expressed from Flp-In locus', 'source_name': 'HEK293 b-39 (Flp-In T-Rex) cells'}",cell_line,"['CVCL:0045', 'EFO:0000322', 'UBERON:0002113', 'EFO:0001182', 'CL:0000010']"
495,"{'cell line': 'HeLa', 'source_name': 'HeLa cell', 'transfected construct': 'miR-494'}",cell_line,"['EFO:0001185', 'UBERON:0003100', 'EFO:0000228', 'CVCL:0030', 'EFO:0000726', 'DOID:4', 'EFO:0000408', 'EFO:0003150', 'UBERON:0000002', 'DOID:299', 'CL:0000010', 'EFO:0000322']"
496,"{'purification': 'oligo(dT)', 'source_name': 'HEK293 cell culture', 'treatment': 'no treatment (mRNA)'}",cell_line,['EFO:0000727']
497,"{'average insert size': '200 bp', 'biomaterial_provider': 'Coriell Cell Repositories http', 'cell line': 'GM17207', 'cell type': 'B-lymphocyte cell line', 'source_name': 'Coriell Institute'}",cell_line,"['CL:0000738', 'EFO:0000322', 'CL:0000236', 'CVCL:7296', 'CL:0000542', 'CL:0000988', 'CL:0000945', 'CL:0000010']"
498,"{'cell type': 'ESC', 'source_name': 'embryonic stem cells'}",stem_cells,"['CL:0002322', 'CL:0000034']"
499,"{'cell line': 'HCCLM3', 'cell type': 'Hepatocellular Carcinomar', 'organ-tropism': 'higher metastasis ability specific to lung', 'source_name': 'Human Hepatocellular Carcinomar cell line'}",cell_line,"['EFO:0006858', 'UBERON:0000170', 'EFO:0003769', 'EFO:0001421', 'EFO:0000322', 'EFO:0000182', 'EFO:0000311', 'EFO:0000313', 'UBERON:0000062', 'DOID:684', 'DOID:305', 'UBERON:0002048', 'CVCL:6832', 'DOID:14566', 'EFO:0000616', 'CL:0000010', 'EFO:0000408']"
500,"{'cell line': 'Ch-CRPC', 'induction': 'shGATA2b', 'source_name': 'DU145-DR'}",cell_line,"['EFO:0000322', 'CL:0000010']"
501,"{'biomaterial provider': 'Coriell Cell Repositories http', 'coriell cell line repository identifier': 'GM12815', 'source_name': 'lymphoblastoid cell line'}",cell_line,['EFO:0005292']
502,"{'developmental stage': '2PN zygote', 'predicted viability': 'bad', 'source_name': 'Human zygote (2PN)', 'tissue type': 'embryo'}",primary_cells,"['CL:0000365', 'UBERON:0000106', 'UBERON:0000922']"
503,"{'disease state': 'Control', 'source_name': 'postmortem brain', 'tissue': 'dorsolateral prefrontal cortex'}",tissue,"['UBERON:0000955', 'EFO:0003534', 'UBERON:0009834']"
504,"{'cell type': 'HeLa Tet-inducible INTS11 shRNA cell clone', 'source_name': 'HeLa cell line', 'treatment': 'control'}",cell_line,"['EFO:0001185', 'UBERON:0003100', 'EFO:0000228', 'CVCL:0030', 'DOID:299', 'DOID:4', 'EFO:0000408', 'EFO:0003150', 'UBERON:0000002', 'EFO:0000322', 'CL:0000010']"
505,"{'cell line': 'LCL', 'cell type': 'EBV positive B-cell', 'source_name': 'LCL_EBNA1 shRNA_RNA-seq', 'transduced with': 'shEBNA1 lentivirus'}",cell_line,"['CL:0000738', 'EFO:0000322', 'CL:0000236', 'CL:0000542', 'CL:0000988', 'CL:0000945', 'CL:0000010']"
506,"{'cell type': 'Endometrial stromal cells', 'patient': '1', 'phenotype': 'PER2 knockdown (PER2 siRNA)', 'source_name': 'Endometrial stromal cells'}",cell_line,"['CL:0000499', 'UBERON:0002337']"
507,"{'organism': 'human', 'source_name': 'Prefrontal Cortex', 'tissue': 'Prefrontal Cortex'}",tissue,"['EFO:0003534', 'UBERON:0000451']"
508,"{'cell line': 'MCF-10A', 'cell type': 'Epithelial cell', 'overexpression': 'AURKA', 'source_name': 'MCF-10A cells', 'tissue': 'Breast'}",cell_line,"['DOID:4', 'UBERON:0003100', 'EFO:0000322', 'UBERON:0000310', 'EFO:0003156', 'EFO:0001200', 'EFO:0000408', 'UBERON:0001911', 'CVCL:0598', 'CL:0000066', 'CL:0000010']"
509,"{'cell line': 'HeLa', 'data type': 'Degradome', 'rnai treatment': 'xrn-1', 'source_name': 'HeLa cell'}",cell_line,"['EFO:0001185', 'UBERON:0003100', 'EFO:0000228', 'CVCL:0030', 'DOID:299', 'EFO:0000727', 'DOID:4', 'EFO:0000408', 'EFO:0003150', 'UBERON:0000002', 'EFO:0000322', 'CL:0000010']"
510,"{'analyte type': 'total RNA', 'biospecimen repository': 'NIA', 'biospecimen repository sample id': 'AD1', 'body site': 'Posterior cingulate cortex', 'gap_accession': 'phs000745', 'gap_consent_code': '1', 'gap_consent_short_name': 'GRU', 'gap_sample_id': '1265608', 'gap_subject_id': '983516', 'histological type': 'astrocyte', 'molecular data type': 'RNA Seq (NGS)', 'sex': 'female', 'study design': 'Case-Control', 'study disease': 'Alzheimer Disease', 'study name': ""RNAseq analysis of posterior cingulate astrocytes in Alzheimer's disease"", 'subject is affected': 'Yes', 'submitted sample id': 'AD1', 'submitted subject id': 'AD1', 'submitter handle': 'NIA'}",primary_cells,"['UBERON:0003027', 'CL:0000127', 'CL:0000125', 'UBERON:0022353', 'EFO:0003534', 'UBERON:0003100']"
511,"{'cell type': 'human colon cancer cell', 'serum': 'starved', 'source_name': 'Colon cancer cell line', 'strain': 'HCT116', 'targeted by': 'scramble shRNA', 'treatment': 'DMSO for 1 hour'}",cell_line,"['UBERON:0001977', 'EFO:0001639', 'EFO:0005842', 'EFO:0000616', 'EFO:0000727', 'EFO:0000311', 'DOID:219', 'EFO:0007330', 'EFO:0000408', 'DOID:162', 'DOID:14566', 'EFO:0004288']"
512,"{'barcode': 'TGACCA', 'cell type': 'Choriocarcinoma trophoblast', 'source_name': 'BeWo trophoblast cells', 'status': 'exposed to 8-bromo-cAMP', 'treatment': 'OVOL1 shRNA'}",in_vitro_differentiated_cells,"['EFO:0007441', 'EFO:0000727', 'DOID:3594', 'EFO:0000616', 'UBERON:0000088', 'EFO:0000311', 'CL:0000349', 'EFO:0000512', 'EFO:0002893', 'CL:0000351', 'DOID:14566', 'EFO:0000795', 'EFO:0000408']"
513,"{'cell culture condition': '80nM PMA for 72h', 'cell line': 'THP1 monocytic cells', 'lentivirus-introduced modification': 'Stably transduced with shRNA to SREBF1', 'source_name': 'THP1 cell line'}",cell_line,"['DOID:8864', 'UBERON:0003101', 'EFO:0000322', 'EFO:0001355', 'EFO:0000221', 'UBERON:0000178', 'DOID:4', 'CVCL:0006', 'EFO:0000408', 'CL:0000576', 'EFO:0001253', 'CL:0000010']"
514,"{'cell subtype': 'CD1c+ myleoid dendirtic cells (mDC)', 'cell type': 'Dendritic cell', 'donor id': 'Donor 36', 'group': 'Healthy controls', 'source_name': 'Blood derived APC_CD1c+ mDC', 'tissue': 'Blood'}",primary_cells,"['CL:0000738', 'CL:0000782', 'UBERON:0000178', 'CL:0000145', 'CL:0000451', 'CL:0000988']"
515,"{'diagnosis': 'adenocarcinoma', 'source_name': 'cervical cancer', 'tissue': 'tumor'}",tissue,"['EFO:0006858', 'EFO:0000228', 'DOID:299', 'EFO:0000311', 'EFO:0000313', 'DOID:4362', 'EFO:0000408', 'DOID:162', 'DOID:14566', 'EFO:0000616']"
516,"{'cell line': 'JEKO-1', 'genotype': 'parental', 'source_name': 'MCL cell line', 'treatment': 'control'}",cell_line,"['UBERON:0003100', 'EFO:0003971', 'EFO:0000408', 'EFO:0000322', 'DOID:0050746', 'UBERON:0000178', 'DOID:4', 'CVCL:1865', 'CL:0000010', 'EFO:0000574', 'EFO:0005387', 'DOID:0060058']"
517,"{'cell line': 'stable adriamycin-resistant  cell line  variant (K562/ADM)', 'source_name': 'K562/ADM cell line'}",cell_line,"['EFO:0000322', 'CVCL:3827', 'CL:0000010']"
518,"{'cell_type': 'MCF7', 'sex': 'female'}",cell_line,"['EFO:0003156', 'UBERON:0000175', 'UBERON:0003100', 'EFO:0000228', 'CVCL:0031', 'DOID:299', 'EFO:0001203', 'UBERON:0000310', 'DOID:4', 'UBERON:0007023', 'EFO:0000408', 'UBERON:0001911', 'CL:0000010', 'EFO:0001272']"
519,"{'source_name': 'donor1', 'tissue': 'retina'}",tissue,['UBERON:0000966']
520,"{'cell type': 'early promyelocytes', 'source_name': 'Bone marrow, early promyelocytes', 'tissue': 'Bone Marrow, Iliac Crest'}",primary_cells,"['CL:0002191', 'UBERON:0014437', 'UBERON:0002371', 'CL:0002031', 'EFO:0001929', 'CL:0000839', 'CL:0002154', 'CL:0000988', 'CL:0000836']"
521,"{'BioSampleModel': 'Human', 'age': 'embryonic', 'biomaterial_provider': 'ATCC', 'cell_line': '293L', 'cell_type': 'HEK', 'isolate': '293L cell line + KSHV', 'sex': 'not determined', 'tissue': 'HEK'}",cell_line,"['CVCL:M775', 'EFO:0000322', 'EFO:0002612', 'CL:0000010', 'CVCL:M624']"
522,"{'knockdown': 'None', 'knockout': 'None', 'source_name': 'human_input', 'tissue/cell line': 'Hek293', 'treatment': 'input'}",cell_line,"['EFO:0001182', 'CVCL:0045', 'EFO:0000322', 'EFO:0000727', 'UBERON:0002113', 'CL:0000010']"
523,"{'age': '1', 'cell_type': 'embryonic stem cells derived human intestinal organoids', 'growth condition': 'CHIR99021/FGF4-enriched media', 'isolate': 'not applicable', 'organism': 'Homo sapiens'}",in_vitro_differentiated_cells,"['CL:0002322', 'CL:0000034', 'CL:0000010']"
524,"{'prognosis': 'UNCLEAR', 'source_name': 'NF', 'stromal signature': 'NF signature', 'tissue': 'Soft Tissue', 'tissue archive method': 'FFPE'}",tissue,[]
525,"{'cell type': 'mural granulosa cells', 'etiology of infertility': 'male factor', 'source_name': 'mural granulosa cells', 'stimulation protocol': 'GnRH antagonist, rFSH, hCG'}",primary_cells,"['CL:0000501', 'DOID:5223', 'EFO:0000512', 'EFO:0000408', 'EFO:0000545']"
526,"{'cell type': 'RNA extracted from B Lymphoblastoid cell lines established by Epstein-Barr Virus, with equimolar concentrations of ERCC spike-in standards at 5 % of total RNA', 'source_name': 'RNA extracted from B Lymphoblastoid cell lines established by Epstein-Barr Virus, with equimolar concentrations of ERCC spike-in standards at 5 % of total RNA'}",cell_line,['EFO:0005292']
527,"{'cell line': 'C-33A', 'source_name': 'Cervix', 'treatment': 'HPV1 E2'}",cell_line,"['EFO:0003156', 'UBERON:0003100', 'CVCL:1094', 'DOID:768', 'EFO:0000322', 'EFO:0000727', 'DOID:305', 'EFO:0000313', 'DOID:4', 'UBERON:0007023', 'EFO:0002120', 'EFO:0000408', 'UBERON:0000002', 'CL:0000010', 'EFO:0001272']"
528,"{'BioSampleModel': 'Human', 'age': 'not applicable', 'biomaterial_provider': 'not collected', 'cell_line': 'SW480', 'isolate': 'RNeasy Mini Kit', 'sex': 'not applicable', 'tissue': 'Colon Cell Line'}",cell_line,"['EFO:0000365', 'UBERON:0003101', 'DOID:0050861', 'UBERON:0001155', 'EFO:0000322', 'DOID:4', 'EFO:0003156', 'EFO:0000408', 'CVCL:0546', 'EFO:0002083', 'CL:0000010']"
529,"{'batch': '2', 'cell type': 'iPSC (GM8330-8)-derived NPC', 'passages': '7', 'shRNA target gene and trc accession': 'CHD8 (TRCN0000016511)', 'source_name': 'human NPCs'}",in_vitro_differentiated_cells,"['CL:0000034', 'CL:0002248', 'CL:0002371', 'CL:0000723', 'EFO:0004905', 'CL:0000010']"
530,"{'cell line': 'HepG2', 'source_name': 'HepG2_treated_BMP6'}",cell_line,"['EFO:0001187', 'CVCL:0027', 'UBERON:0003101', 'DOID:684', 'EFO:0000182', 'DOID:4', 'EFO:0003156', 'EFO:0000408', 'EFO:0000322', 'CL:0000010', 'UBERON:0002107']"
531,"{'source_name': 'Metastatic melanoma to skin, formalin-fixed paraffin embedded', 'tissue': 'metastatic melanoma to skin'}",tissue,"['UBERON:0000014', 'EFO:0002617', 'EFO:0000962']"
532,"{'cell type': 'iPSC-derived neural progenitors', 'donor id': '03-04', 'number of days in vitro in terminal differentiation conditions': '31', 'source_name': 'iPSC-derived neural progenitors, day 31, non-ASD'}",in_vitro_differentiated_cells,"['CL:0000034', 'CL:0002248', 'UBERON:0002924', 'CL:0002371', 'CL:0000723', 'EFO:0004905']"
533,"{'chip antibody': 'NA', 'genotype': 'NA', 'source_name': 'RAMOS', 'tissue': ""Burkitt's lymphoma cell line""}",cell_line,"['EFO:0000322', 'EFO:0000309', 'CL:0000010']"
534,"{'gender': 'female', 'organ': 'endometrium', 'sample donor': 'donor No.2', 'source_name': 'endometrial tumor', 'tissue': 'endometrial tumor'}",tissue,"['UBERON:0003100', 'EFO:0000616', 'UBERON:0000062', 'EFO:0000408', 'UBERON:0001295', 'DOID:14566']"
535,"{'cell type': 'skin epithelial cells', 'genotype': 'WT', 'source_name': 'skin biopsy of eye lids'}",in_vitro_differentiated_cells,"['UBERON:0000014', 'EFO:0000962', 'CL:0000066', 'UBERON:0001711', 'UBERON:0000970']"
536,"{'cell cycle phase': 'S-phase', 'cell_line': 'Hela', 'replicate': '2', 'sample_type': 'ribosome footprint'}",cell_line,"['EFO:0001185', 'UBERON:0003100', 'EFO:0000228', 'CVCL:0030', 'DOID:299', 'DOID:4', 'EFO:0000408', 'EFO:0003150', 'UBERON:0000002', 'EFO:0000322', 'CL:0000010']"
537,"{'activation stimuli': 'TNFa+PGE2+P3C', 'cell type': 'monocyte derived macrophages', 'date': 'Date 4', 'donor': 'Donor 10', 'initial differentiation': 'GM-CSF', 'source_name': 'peripheral blood', 'time': '72h'}",in_vitro_differentiated_cells,"['CL:0000738', 'CL:0000766', 'UBERON:0000178', 'CL:0000235', 'CL:0000988', 'UBERON:0001359']"
538,"{'cell line': 'Calu-3', 'cell type': 'lung adenocarcinoma', 'source_name': 'Lung adenocarcinoma cells_knockdown_control', 'treatment- reagent': 'Silencer select negative control siRNA #2 (Ambion)'}",cell_line,"['EFO:0006858', 'EFO:0000727', 'EFO:0001071', 'EFO:0000571', 'UBERON:0000175', 'EFO:0000684', 'EFO:0000228', 'DOID:299', 'CVCL:0609', 'EFO:0003060', 'EFO:0002819', 'CL:0000010', 'EFO:0000616', 'UBERON:0003101', 'DOID:4', 'EFO:0000408', 'EFO:0000311', 'EFO:0000313', 'EFO:0003818', 'EFO:0003156', 'DOID:3910', 'DOID:14566', 'CL:0000066', 'EFO:0000322']"
539,"{'cell line': '293S', 'source_name': '293S cell line'}",cell_line,"['CVCL:A784', 'EFO:0000322', 'CL:0000010']"
540,"{'cell type': 'monocyte-derived macrophages', 'donor identifier': '8', 'source_name': 'macrophages, mock', 'treatment': 'mock'}",primary_cells,"['CL:0000738', 'EFO:0000727', 'CL:0000235', 'CL:0000988', 'CL:0000766']"
541,"{'cell type': 'Primary blood-specific endothelial cells', 'passage': '7 to 12', 'source_name': 'neonatal dermal microvasculature'}",cell_line,"['UBERON:0002067', 'EFO:0001372', 'CL:0000010', 'CL:0000115', 'UBERON:0000178']"
542,"{'cell line': 'Hermes 3A', 'cell type': 'melanocyte', 'source_name': 'Hermes 3A'}",cell_line,"['CL:0000148', 'EFO:0000322', 'CL:0000010']"
543,"{'cell line': 'A549', 'cell type': 'Non-small-cell lung cancer (NSCLC) cells', 'genotype': 'Wild type', 'group_tag': 'Control', 'source_name': 'Lung cells'}",cell_line,"['EFO:0003156', 'UBERON:0003101', 'EFO:0000684', 'EFO:0006858', 'UBERON:0000170', 'EFO:0000616', 'EFO:0000311', 'EFO:0000313', 'EFO:0003818', 'DOID:4', 'EFO:0001071', 'DOID:305', 'UBERON:0002048', 'EFO:0001086', 'CVCL:0023', 'EFO:0003060', 'DOID:3908', 'DOID:14566', 'EFO:0000322', 'CL:0000010', 'EFO:0000408']"
544,"{'age': '63', 'cell type': 'follicular lymphoma', 'gender': 'female', 'previously treated for nhl': 'no', 'source_name': 'CD19+ B cells', 'tissue': 'LN', 'tumor': 'FL1-2'}",primary_cells,"['EFO:0000096', 'UBERON:0003100', 'CL:0000542', 'CL:0000988', 'EFO:0000616', 'EFO:0000311', 'EFO:0001642', 'CL:0000236', 'CL:0000738', 'EFO:0000408', 'EFO:0005952', 'DOID:0050873', 'EFO:0000540', 'EFO:0000574', 'DOID:14566', 'CL:0000945', 'DOID:0060058']"
545,"{'cell_line': 'A549', 'label': 'A549 BF211'}",cell_line,"['EFO:0003156', 'UBERON:0003101', 'EFO:0000322', 'EFO:0000313', 'DOID:4', 'DOID:305', 'UBERON:0002048', 'EFO:0001086', 'CVCL:0023', 'CL:0000010', 'EFO:0000408']"
546,"{'sex': 'female', 'source_name': 'liver', 'tissue': 'liver'}",tissue,"['UBERON:0003100', 'UBERON:0002107']"
547,"{'Sex': 'Female', 'disease': 'patient matched uninvolved colon', 'location': 'Ascending colon', 'source_name': 'Colon'}",tissue,"['DOID:4', 'UBERON:0003100', 'UBERON:0001156', 'EFO:0000408', 'UBERON:0001155']"
548,"{'biomaterial provider': 'Coriell Cell Repositories http', 'cell line': 'GM19193', 'cell type': 'Lymphoblastoid Cell', 'source_name': 'Lymphoblastoid Cells'}",cell_line,"['EFO:0005292', 'EFO:0000322', 'EFO:0005351', 'CL:0000010', 'CVCL:E126']"
549,"{'cell line': 'H1', 'cell type': 'ES-derived neural progenitor cells', 'source_name': 'H1-derived neural progenitor cells', 'time': 'Day 11'}",in_vitro_differentiated_cells,"['EFO:0000322', 'CL:0000034', 'CL:0000010', 'CL:0000047']"
550,"{'cell composition': 'majority in proerythroblast stage', 'cell type': 'in vitro differentiated erythroid cells', 'differentiation day': 'D8', 'source_name': 'in vitro differentiated erythroid cells'}",in_vitro_differentiated_cells,"['CL:0000988', 'CL:0000547', 'CL:0000763', 'CL:0000764']"
551,"{'phenotype': ""Cushing's"", 'source_name': 'Adipose', 'tissue': 'Adipose'}",tissue,['UBERON:0001013']
552,"{'cell type': 'ER32 + 40HT IMR90', 'source_name': 'IMR90 human fiboblasts', 'treatment': 'tamoxifen'}",cell_line,"['EFO:0001196', 'UBERON:0003100', 'CL:0000057', 'EFO:0000727', 'EFO:0003156', 'CVCL:0347', 'UBERON:0002048', 'CL:0000010']"
553,"{'fusion type': 'METOPIC', 'gender': 'male', 'source_name': 'Osteoblast growth in culture from skull'}",primary_cells,"['UBERON:0003129', 'CL:0000062', 'UBERON:0003101']"
554,"{'age': '52', 'gender': 'M', 'source_name': 'hepatocyte', 'tissue': 'liver', 'tumor status': 'Tumor'}",tissue,"['UBERON:0003101', 'EFO:0000616', 'EFO:0000408', 'DOID:14566', 'CL:0000182', 'UBERON:0002107']"
555,"{'cell type': 'M1-polarized IPSDM', 'source_name': 'Macrophage'}",in_vitro_differentiated_cells,"['CL:0000738', 'CL:0000988', 'CL:0000235', 'CL:0000766']"
556,"{'cell line': 'Hep3B', 'cell type': 'hepatocellular carcinoma cell line', 'source_name': 'Hep3B', 'strategy': 'RNC-mRNA'}",cell_line,"['EFO:0002205', 'DOID:684', 'UBERON:0003101', 'EFO:0006858', 'EFO:0003150', 'EFO:0003769', 'EFO:0001421', 'EFO:0000322', 'EFO:0000182', 'EFO:0000311', 'EFO:0000313', 'DOID:4', 'UBERON:0007021', 'DOID:305', 'EFO:0000408', 'CVCL:0326', 'DOID:14566', 'EFO:0000616', 'CL:0000010', 'UBERON:0002107']"
557,"{'analyte type': 'RNA', 'biospecimen repository': 'Cloud Testing', 'biospecimen repository sample id': 'HG00154', 'body site': 'Lymphoblastoid cell line', 'gap_accession': 'phs000710', 'gap_consent_code': '99', 'gap_consent_short_name': 'UR', 'gap_sample_id': '1820605', 'gap_subject_id': '1374991', 'is tumor': 'No', 'molecular data type': 'RNA Seq (NGS)', 'study design': 'Cross-Sectional', 'study name': '1000 Genomes Used for Cloud Testing', 'submitted sample id': 'HG00154', 'submitted subject id': 'HG00154', 'submitter handle': 'Cloud Testing'}",cell_line,['EFO:0005292']
558,"{'antibody': 'AGO2', 'cell line': 'HeLa', 'sample fraction': 'immunoprecipitation', 'sample type': 'Chromatin', 'source_name': 'HeLa cells (ATCC)'}",cell_line,"['EFO:0001185', 'UBERON:0003100', 'EFO:0000228', 'CVCL:0030', 'DOID:299', 'DOID:4', 'EFO:0000408', 'EFO:0003150', 'UBERON:0000002', 'EFO:0000322', 'CL:0000010']"
559,"{'growth time': '0.5hr', 'modulating agent': 'UM171+SR1', 'source_name': 'CD34+ human cord blood-derived cells'}",primary_cells,"['UBERON:0012168', 'UBERON:0000178']"
560,"{'antibody': 'none', 'cell line': 'HepG2', 'source_name': 'HepG2 cells', 'treatment': 'IFNg (200ng/ml)'}",cell_line,"['EFO:0001187', 'CVCL:0027', 'UBERON:0003101', 'DOID:684', 'EFO:0000182', 'EFO:0000727', 'DOID:4', 'EFO:0003156', 'EFO:0000408', 'EFO:0000322', 'CL:0000010', 'UBERON:0002107']"
561,"{'o-methyl spike-in hsa-mir-211': '10', 'o-methyl spike-in hsa-mir-219-5p': '0.1', 'o-methyl spike-in hsa-mir-429': '0.1', 'precursor spike-in hsa-mir-147': '1', 'precursor spike-in hsa-mir-338-3p': '1', 'precursor spike-in hsa-mir-383': '10', 'source_name': 'placenta', 'spike-in hsa-mir-147': '0', 'spike-in hsa-mir-211': '0', 'spike-in hsa-mir-219-5p': '0', 'spike-in hsa-mir-338-3p': '0', 'spike-in hsa-mir-383': '0', 'spike-in hsa-mir-429': '0'}",tissue,['UBERON:0001987']
562,"{'cell line': 'HEK293T cells', 'par-clip antibody': 'hnRNPC (sc-32308, Santa Cruz)', 'source_name': 'Embryonic kidney cells', 'treatment': 'wild type'}",cell_line,"['CVCL:0063', 'EFO:0001184', 'CL:1000497', 'UBERON:0007220', 'EFO:0000727', 'UBERON:0002120', 'EFO:0001082', 'EFO:0000322', 'CL:0000010', 'UBERON:0000323']"
563,"{'cell line': 'HEK293T', 'guide rna': 'IL1RN', 'replicate': '2', 'source_name': 'HEK293T cells transiently transfected with Cas9 and IL1RN guide RNA expressing plasmids'}",cell_line,"['CVCL:0063', 'EFO:0001184', 'UBERON:0007220', 'EFO:0000726', 'UBERON:0000323', 'CL:0000010', 'EFO:0001082', 'EFO:0000322', 'UBERON:0002120']"
564,"{'cell line': 'HeLa', 'chromosome': 'highly polyploid', 'rna': 'polyAplus RNA', 'source_name': 'HeLa cells'}",cell_line,"['EFO:0001185', 'UBERON:0003100', 'EFO:0000228', 'CVCL:0030', 'DOID:299', 'DOID:4', 'EFO:0000408', 'EFO:0003150', 'UBERON:0000002', 'EFO:0000322', 'CL:0000010']"
565,"{'Sex': 'Female', 'age': '69', 'biomaterial provider': 'ATCC', 'cell': 'AdERbeta+SiERalpha', 'cell line': 'MCF-7', 'cell subtype': 'Adenocarcinoma', 'cell type': 'Epithelial', 'culture collection': 'ATCC', 'source_name': 'Breast', 'treatment': '1 uM S-equol'}",cell_line,"['EFO:0006858', 'EFO:0000727', 'UBERON:0000310', 'EFO:0001203', 'UBERON:0000175', 'UBERON:0003100', 'EFO:0000228', 'CVCL:0031', 'EFO:0000322', 'CL:0000010', 'EFO:0000616', 'DOID:4', 'EFO:0000408', 'DOID:299', 'EFO:0001272', 'EFO:0000311', 'EFO:0000313', 'EFO:0003156', 'UBERON:0007023', 'UBERON:0001911', 'DOID:14566', 'CL:0000066']"
566,"{'analyte type': 'RNA', 'biospecimen repository': 'NINDS Multiple Sclerosis', 'biospecimen repository sample id': '3276', 'body site': 'frontal white matter', 'gap_accession': 'phs000715', 'gap_consent_code': '1', 'gap_consent_short_name': 'GRU', 'gap_sample_id': '1244274', 'gap_subject_id': '968109', 'histological type': 'brain', 'is tumor': 'No', 'molecular data type': 'RNA Seq (NGS)', 'sex': 'male', 'study design': 'Case-Control', 'study name': 'NINDS MS and ADEM Deep Sequencing Studies', 'subject is affected': 'No', 'submitted sample id': '3276', 'submitted subject id': '3276', 'submitter handle': 'NINDS Multiple Sclerosis'}",tissue,"['UBERON:0000955', 'UBERON:0000209', 'UBERON:0003101', 'UBERON:0002316', 'UBERON:0004866']"
567,"{'source_name': 'subcutaneous adipose tissue', 'time': 'T0', 'type of surgical procedure': 'Roux-en-Y gastric bypass'}",tissue,"['UBERON:0001013', 'EFO:0005244', 'EFO:0002571', 'UBERON:0002190']"
568,"{'source_name': 'kidney normal tissue', 'tissue': 'kidney normal'}",tissue,['UBERON:0002113']
569,"{'phenotype': 'non-tumor', 'source_name': 'liver tissue, non-tumor', 'tissue': 'liver'}",tissue,"['EFO:0000616', 'DOID:14566', 'EFO:0000408', 'UBERON:0002107']"
570,"{'cell line': 'SMS-KCN', 'organism': 'Homo sapiens'}",cell_line,"['EFO:0000322', 'CL:0000010', 'CVCL:7133']"
571,"{'cell line': 'A549', 'cell type': 'lung adenocarcinoma cell line', 'knockdown': 'H1TetO-shRNA-Con', 'source_name': 'A549 cell line'}",cell_line,"['EFO:0006858', 'EFO:0001071', 'EFO:0000571', 'CVCL:0023', 'UBERON:0003101', 'EFO:0000684', 'EFO:0000228', 'DOID:299', 'UBERON:0002048', 'DOID:305', 'EFO:0003060', 'CL:0000010', 'EFO:0000616', 'DOID:4', 'EFO:0000408', 'EFO:0001086', 'EFO:0000311', 'EFO:0000313', 'EFO:0003818', 'EFO:0003156', 'DOID:3910', 'DOID:14566', 'EFO:0000322']"
572,"{'cell line': 'FLP143', 'cell line specificity': 'HEK293-T-Rex inducible cell line expressing ZNF143', 'source_name': 'derived from HEK293, human embryonic kidney cells', 'treatment': '0h Induction with 1Âµg/mL ofdoxycycline'}",cell_line,"['EFO:0001182', 'CVCL:0045', 'EFO:0000322', 'EFO:0000727', 'UBERON:0002113', 'CVCL:D585', 'CL:0000010']"
573,"{'cell line': 'SUM159PT', 'cell type': 'breast cancer cells', 'source_name': 'breast cancer cells', 'transfection': 'control siRNA'}",cell_line,"['EFO:0000616', 'CVCL:5423', 'EFO:0000311', 'EFO:0000726', 'DOID:1612', 'EFO:0000408', 'DOID:162', 'EFO:0001241', 'DOID:14566', 'EFO:0000322', 'CL:0000010']"
574,"{'barcode': 'ATCACG', 'cell line': 'BJ (ATCC CRL-2522)', 'cell type': 'foreskin fibroblast cell line', 'lane number': '7', 'source_name': 'human foreskin fibroblast, scramble siRNA', 'transfection': 'scramble siRNA'}",cell_line,"['UBERON:0001332', 'CL:0000057', 'EFO:0000726', 'CL:1001608', 'EFO:0000322', 'CL:0000010']"
575,"{'cell line': 'HeLa (Human cervical carcinoma cell line)', 'protocol': 'Untreated', 'source_name': 'Hela'}",cell_line,"['EFO:0001185', 'UBERON:0003100', 'EFO:0006858', 'EFO:0000228', 'CVCL:0030', 'DOID:299', 'EFO:0000311', 'EFO:0000313', 'DOID:4', 'EFO:0001061', 'EFO:0005218', 'DOID:305', 'EFO:0000408', 'EFO:0003150', 'UBERON:0000002', 'DOID:14566', 'EFO:0000616', 'CL:0000010', 'EFO:0000322']"
576,"{'cell line': 'U-251MG', 'fraction type': 'cytoplasmic RNA', 'source_name': 'U-251MG'}",cell_line,"['EFO:0000322', 'EFO:0006498', 'CL:0000010', 'CVCL:0021']"
577,"{'Sex': 'male', 'source_name': 'prefrontal cortex (PFC)'}",tissue,"['EFO:0003534', 'UBERON:0003101', 'UBERON:0000451']"
578,"{'cell_line': 'KBM-7', 'description': 'KBM-7-NuKO  (derivative of KBM-7, P01289H04)', 'genotype': 'NUDT2 inactivated', 'isolate': 'not applicable', 'organism': 'human'}",cell_line,"['EFO:0005903', 'CVCL:A426', 'EFO:0000322', 'CL:0000010']"
579,"{'analyte type': 'RNA', 'biospecimen repository': 'NCI_TARGET', 'biospecimen repository sample id': 'TARGET-51-PAEALX-01A-01R', 'body site': 'Primary Solid Tumor', 'gap_accession': 'phs000466', 'gap_consent_code': '1', 'gap_consent_short_name': 'PCR', 'gap_parent_phs': 'phs000218', 'gap_sample_id': '1065401', 'gap_subject_id': '590918', 'histological type': 'Kidney Tumors', 'is tumor': 'Yes', 'sex': 'male', 'study design': 'Tumor vs. Matched-Normal', 'study name': 'TARGET', 'submitted sample id': 'TARGET-51-PAEALX-01A-01R', 'submitted subject id': 'TARGET-51-PAEALX', 'submitter handle': 'NCI_TARGET'}",tissue,"['EFO:0000616', 'DOID:14566', 'UBERON:0003101', 'UBERON:0002113', 'EFO:0000408']"
580,"{'cell line': 'HuH28', 'cell type': 'Intrahepatic cholangiocarcinoma', 'sirna knockdown': 'Control siRNA', 'source_name': 'Intrahepatic cholangiocarcinoma', 'time': '48h'}",cell_line,"['EFO:0006858', 'EFO:0000228', 'CVCL:2955', 'EFO:0000616', 'EFO:0000311', 'EFO:0000313', 'DOID:4947', 'EFO:0005221', 'EFO:0000408', 'DOID:4928', 'EFO:0005540', 'DOID:14566', 'EFO:0000322', 'CL:0000010']"
581,"{'Stage': 'IB', 'age': '53 years', 'disease': 'Adenocarcinoma, NSCLC', 'patient': '3', 'sex': 'female', 'smoker': 'non-smoker', 'source_name': 'Non-smoker female, NSCLC', 'tissue': 'normal'}",tissue,"['EFO:0000228', 'UBERON:0003100', 'EFO:0006858', 'EFO:0000684', 'EFO:0000616', 'EFO:0000311', 'EFO:0000313', 'EFO:0003818', 'DOID:4', 'EFO:0001071', 'UBERON:0007023', 'EFO:0000408', 'EFO:0003060', 'DOID:3908', 'DOID:14566', 'DOID:299', 'EFO:0001272']"
582,"{'source_name': 'normal thymus', 'tissue': 'normal thymus'}",primary_cells,['UBERON:0002370']
583,"{'cell line': 'HeLa', 'source_name': 'Infected 6 hours'}",cell_line,"['EFO:0001185', 'UBERON:0003100', 'EFO:0000228', 'CVCL:0030', 'DOID:299', 'DOID:4', 'EFO:0000408', 'EFO:0003150', 'UBERON:0000002', 'EFO:0000322', 'CL:0000010']"
584,"{'cell line': 'IMR90', 'passage': '16', 'source_name': 'Primary fibroblast', 'tissue': 'Lung'}",cell_line,"['EFO:0001196', 'UBERON:0003100', 'CL:0000057', 'UBERON:0000170', 'EFO:0000322', 'EFO:0003156', 'CVCL:0347', 'UBERON:0002048', 'CL:0000010']"
585,"{'agent': 'PKC412', 'cell line': 'MDAMB468', 'source_name': 'Breast cancer cell line (basal)', 'subtype': 'basal'}",cell_line,"['UBERON:0000175', 'UBERON:0003100', 'EFO:0000228', 'EFO:0000322', 'DOID:299', 'EFO:0000311', 'DOID:1612', 'DOID:4', 'EFO:0001216', 'EFO:0002885', 'EFO:0000408', 'EFO:0003150', 'DOID:162', 'DOID:14566', 'EFO:0000616', 'CL:0000010', 'CVCL:0419']"
586,"{'cell types': 'HeLa cells transduced with anti-ASCC3 shRNA', 'passages': '16-18', 'source_name': 'HeLa cells transduced with anti-ASCC3 shRNA', 'treatment': 'Anti-ASCC3 shRNA'}",cell_line,"['EFO:0001185', 'UBERON:0003100', 'EFO:0000228', 'CVCL:0030', 'DOID:299', 'EFO:0000727', 'DOID:4', 'EFO:0000408', 'EFO:0003150', 'UBERON:0000002', 'CL:0000010']"
587,"{'cell line': 'MDA-MB-231', 'cell type': 'Breast Adenocarcinoma', 'organism': 'Homo sapiens', 'specimen with known storage state': 'fresh specimen'}",cell_line,"['CVCL:0062', 'UBERON:0000175', 'UBERON:0003100', 'EFO:0006858', 'EFO:0000228', 'EFO:0000304', 'EFO:0000305', 'EFO:0000322', 'DOID:299', 'EFO:0000311', 'EFO:0003156', 'EFO:0000313', 'EFO:0001209', 'DOID:4', 'DOID:3458', 'UBERON:0007023', 'EFO:0000408', 'DOID:14566', 'EFO:0000616', 'CL:0000010', 'EFO:0001272']"
588,"{'BioSampleModel': 'Human', 'age': 'missing', 'biomaterial_provider': 'The Richard Fields Center for FSHD Research, Prof. Dr. Rabi Tawil, Department of Neurology, University of Rochester, USA', 'cell_line': 'primary', 'cell_subtype': 'differentiated myoblast', 'cell_type': 'myoblast', 'dev_stage': 'adult', 'disease': 'Facioscapulohumeral Muscular Dystrophy', 'isolate': 'FSHD_1_2_BFP', 'phenotype': 'muscular dystrophy', 'sample_type': 'RNA', 'sex': 'male', 'tissue': 'muscle'}",in_vitro_differentiated_cells,"['DOID:11727', 'UBERON:0003101', 'EFO:0002970', 'CL:0000056', 'EFO:0000322', 'EFO:0004145', 'DOID:4', 'UBERON:0007023', 'DOID:9884', 'EFO:0000408', 'UBERON:0001015', 'UBERON:0005090', 'CL:0002321', 'UBERON:0001630', 'CL:0000010', 'EFO:0001272']"
589,"{'cell line': 'IMR90', 'growth protocol': 'RS_Proliferating', 'population doubling': 'PD38', 'source_name': 'IMR90 human fiboblasts'}",cell_line,"['EFO:0001196', 'UBERON:0003100', 'CL:0000057', 'EFO:0000322', 'EFO:0003156', 'CVCL:0347', 'UBERON:0002048', 'CL:0000010']"
590,"{'cell type': 'aortic valve interstitial cells', 'condition': 'Static', 'source_name': 'Static AVIC'}",cell_line,"['UBERON:0002137', 'CL:0000178']"
591,"{'cell line': 'INOF', 'cell type': 'immortalized normal ovarian fibroblast', 'growth protocol': 'grown in OSE medium (Wisent) , supplemented with 10 % fetal bovine serum and 2 mM L-glutamine, cells passaged as recommended by ATCC', 'source_name': 'INOF cell line', 'treatment': 'none'}",cell_line,"['UBERON:0001977', 'CL:0000057', 'CL:2000063', 'UBERON:0007220', 'UBERON:0000323', 'CVCL:0T67', 'EFO:0000973', 'EFO:0000322', 'CL:0000010']"
592,"{'source_name': 'LFB_HOXA1KD_miseq_repC', 'tissue': 'lung fibroblasts', 'transfection': 'HOXA1 knockdown'}",cell_line,"['EFO:0000726', 'CL:0000057', 'CL:0002553']"
593,"{'cell line': 'NCC-24', 'cell type': 'human gastric cancer cell line with natural EBV infection', 'ebv infection status': 'EBV(+); naturally infected with EBV', 'source_name': 'human gastric carcinoma_naturally infected with EBV'}",cell_line,"['EFO:0006858', 'EFO:0003897', 'EFO:0000178', 'EFO:0000616', 'EFO:0001639', 'EFO:0000311', 'EFO:0000313', 'CVCL:8899', 'DOID:305', 'EFO:0000408', 'DOID:162', 'EFO:0000769', 'DOID:14566', 'DOID:5517', 'CL:0000010', 'EFO:0000322']"
594,"{'cell line': 'SH-SY5Y/6TR(EU)/pTrex-Dest-30/MYCN (SY5Y-MYCN)', 'organism': 'Homo sapiens'}",cell_line,"['EFO:0000621', 'UBERON:0003100', 'DOID:769', 'UBERON:0002371', 'DOID:4', 'EFO:0000408', 'CVCL:0019', 'EFO:0002717', 'EFO:0000322', 'CL:0000010']"
595,"{'race': 'Caucasian', 'source_name': 'Pterygium', 'tissue': 'Pterygia'}",cell_line,"['EFO:0003966', 'EFO:0000678', 'EFO:0000618', 'EFO:0003156', 'EFO:0000408', 'DOID:0002116', 'EFO:0001058']"
596,"{'barcode': 'GATCAGCAG', 'cell line': 'HeLa', 'source_name': 'HeLa', 'treatment': 'Mtr4 knock down (exosome)'}",cell_line,"['EFO:0001185', 'UBERON:0003100', 'EFO:0000228', 'CVCL:0030', 'DOID:299', 'EFO:0000727', 'DOID:4', 'EFO:0000408', 'EFO:0003150', 'UBERON:0000002', 'EFO:0000322', 'CL:0000010']"
597,"{'cell line': 'DU145', 'condition': 'ETS1 shRNA', 'source_name': 'brain metastasis of grade IV prostate cancer'}",cell_line,"['UBERON:0000955', 'UBERON:0003101', 'EFO:0003156', 'EFO:0000408', 'EFO:0000616', 'DOID:162', 'EFO:0000311', 'CVCL:0105', 'EFO:0000313', 'DOID:4', 'EFO:0007355', 'EFO:0005441', 'DOID:305', 'EFO:0000512', 'UBERON:0002367', 'DOID:14566', 'EFO:0000322', 'CL:0000010', 'DOID:10283']"
598,"{'cell cycle timepoint': 'G1', 'cell synchronization': 'Cells were treated with 6 micromolar RO-3306 for 18 hr. RO-3306 was then removed and mitotic cells were collected 45 min later through mitotic shake-off and replated to allow normal mitotic exit. 3hr later G1 cells were harvested.', 'cell type': 'RPE-1 cells immortalized with hTERT', 'drug pre-treatment': 'cells were pretreated with cycloheximide', 'source_name': 'Human Retinal pigment epithelial cells immortalized with hTERT'}",cell_line,"['UBERON:0001782', 'UBERON:0003100', 'CVCL:4388', 'EFO:0000727', 'UBERON:0000970', 'DOID:4', 'CL:0002586', 'EFO:0000408', 'UBERON:0000966', 'CL:0000066', 'CL:0000010']"
599,"{'cell line': 'Caco-2', 'sample type': 'mRNA', 'source_name': 'Caco-2 cell line'}",cell_line,"['EFO:0000365', 'UBERON:0003101', 'DOID:0050861', 'EFO:0001099', 'UBERON:0001155', 'EFO:0000322', 'DOID:4', 'EFO:0003156', 'CVCL:0025', 'EFO:0000408', 'CL:0000010']"
600,"{'donor': '2', 'fraction': '40-100 nucleotide fraction', 'source_name': 'exosomes isolated from cell-free seminal fluid'}",tissue,['UBERON:0006530']
601,"{'analyte type': 'RNA', 'biospecimen repository': 'Hyperdiploid_Pediatric_ALL', 'biospecimen repository sample id': 'Hyperdiploid_ALL_5', 'body site': 'bone marrow', 'gap_accession': 'phs000522', 'gap_consent_code': '1', 'gap_consent_short_name': 'PCRGM', 'gap_sample_id': '785052', 'gap_subject_id': '643411', 'histological type': 'Acute Lymphoblastic Leukemia', 'is tumor': 'Yes', 'molecular data type': 'RNA Seq (NGS)', 'study design': 'Case Set', 'study disease': 'Precursor B-Cell Lymphoblastic Leukemia-Lymphoma', 'study name': 'Hyperdiploid Acute Lymphoblastic Leukemia RNA-Seq', 'subject is affected': 'Yes', 'submitted sample id': 'Hyperdiploid_ALL_5', 'submitted subject id': 'Hyperdiploid_ALL_5', 'submitter handle': 'Hyperdiploid_Pediatric_ALL'}",primary_cells,"['DOID:14566', 'EFO:0000616', 'EFO:0000311', 'EFO:0000220', 'EFO:0001642', 'UBERON:0002371', 'EFO:0000565', 'EFO:0000540', 'DOID:9952', 'EFO:0000408']"
602,"{'antibody': 'N/A', 'cell line': 'HCT116', 'source_name': 'HCT116 cell culture'}",cell_line,"['UBERON:0003101', 'UBERON:0001155', 'EFO:0000322', 'EFO:0002824', 'EFO:0000313', 'DOID:4', 'UBERON:0007023', 'DOID:305', 'EFO:0000408', 'CVCL:0291', 'CL:0000010', 'EFO:0001272']"
603,"{'cell type': 'fibroblast', 'passage number': '3', 'source_name': 'fibroblast'}",cell_line,"['CL:0000057', 'CL:0000010']"
604,"{'source_name': 'BJ cells', 'treatment': 'VP55+IFN'}",cell_line,['EFO:0000727']
605,"{'BioSampleModel': 'Human', 'age': '69', 'biomaterial_provider': 'Bioresource Collection and Research Center (Hsinchu, Taiwan)', 'cell_line': 'MCF-7', 'isolate': 'MCF-7 cells are grown during reoxygenation.Sample 3.', 'sex': 'female', 'tissue': 'breast cancer cell'}",cell_line,
606,"{'cell type': 'neural stem cells', 'lentivirus': '', 'source_name': 'neural stem cells'}",stem_cells,"['CL:0000034', 'CL:0000047']"
607,"{'extraction protocol': 'Hard spin, Washed twice', 'lactation stage': 'Mature', 'source_name': 'Milk Fat Layer', 'subject id': '179'}",tissue,"['UBERON:0001013', 'UBERON:0000119', 'EFO:0000735', 'UBERON:0022303', 'UBERON:0001913']"
608,"{'cell surface markers': 'CD4+CD45RA-TCRb+PD-1hiCXCR5hiPSGL-1lo', 'source_name': 'TFH T cell', 't cell type': 'TFH', 'tissue': 'Human tonsil'}",primary_cells,"['CL:0000084', 'CL:0000738', 'CL:0000988', 'UBERON:0002372', 'CL:0000542']"
609,"{'disease state': 'Tumor', 'source_name': 'thyroid tissue', 'tissue': 'thyroid'}",tissue,"['EFO:0000616', 'UBERON:0002046', 'DOID:14566', 'EFO:0000408']"
610,"{'cell type': 'surrounding non-tumoral tissue', 'material type': 'fresh-frozen', 'source_name': 'iCCA patient, liver', 'tissue': 'liver'}",tissue,['UBERON:0002107']
611,{'label': 'A549 cells treated by TNFa time course'},cell_line,[]
612,"{'cell type': 'SGBS adipocyte D10', 'source_name': 'adipocyte_RNA TNF', 'treated with': '10ng/ml TNFÎ± for 90min'}",in_vitro_differentiated_cells,"['CVCL:H945', 'CVCL:GS28', 'CL:0000010', 'CL:0000136']"
613,"{'cell_line': 'primary breast', 'pheno': 'NA'}",cell_line,"['EFO:0000322', 'CL:0000010', 'UBERON:0000310']"
614,"{'analyte type': 'RNA', 'biospecimen repository': 'NCI_SolitaryFibrousTumor', 'biospecimen repository sample id': 'MCTP_UM-SFT-13', 'body site': 'Left parapharyngeal', 'gap_accession': 'phs000567', 'gap_consent_code': '1', 'gap_consent_short_name': 'CRM', 'gap_sample_id': '888943', 'gap_subject_id': '704117', 'is tumor': 'Yes', 'molecular data type': 'RNA Seq (NGS)', 'sex': 'female', 'study design': 'Case Set', 'study disease': 'Solitary Fibrous Tumors', 'study name': 'NAB2-STAT6 Gene Fusions in Solitary Fibrous Tumor by Integrative Sequencing', 'subject is affected': 'Yes', 'submitted sample id': 'MCTP_UM-SFT-13', 'submitted subject id': '19', 'submitter handle': 'NCI_SolitaryFibrousTumor'}",tissue,"['EFO:0000616', 'UBERON:0003100', 'DOID:14566', 'EFO:0000408']"
615,"{'sample comment': ""Hela cells which were cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum under a humidified atmosphere with 5% CO2 at 37??C."", 'sample_name': 'DRS000577'}",cell_line,"['UBERON:0007220', 'UBERON:0001977', 'UBERON:0000323', 'CL:0000010']"
616,"{'bacterial infection': 'M. abscessus Smooth (MAB-S)-infected', 'source_name': 'THP-1-derived macrophage'}",in_vitro_differentiated_cells,"['CL:0000738', 'UBERON:0002434', 'CL:0000235', 'CL:0000988', 'CL:0000766']"
617,"{'cell type': 'human embryonic kidney (HEK) 293 T-REx Flp-In cell lines', 'rna subset': 'poly A RNA', 'source_name': 'Ctrl_RBM10.KD.24h_RNA-Seq'}",cell_line,"['CVCL:0063', 'EFO:0001184', 'EFO:0001082', 'UBERON:0007220', 'CVCL:B501', 'UBERON:0002120', 'CVCL:M624', 'CVCL:6D58', 'EFO:0000322', 'CL:0000010', 'UBERON:0000323']"
618,"{'cancer': 'Breast adenocarcinoma', 'cell line': 'MDA-MB-231', 'source_name': 'RNA_Compound A 4h_1', 'type': 'TNBC'}",cell_line,"['EFO:0006858', 'DOID:3458', 'EFO:0001209', 'UBERON:0000175', 'UBERON:0003100', 'EFO:0000228', 'EFO:0000304', 'EFO:0000305', 'EFO:0000322', 'CL:0000010', 'EFO:0000616', 'DOID:4', 'EFO:0000408', 'DOID:162', 'EFO:0001272', 'CVCL:0062', 'EFO:0000311', 'EFO:0000313', 'EFO:0003156', 'UBERON:0007023', 'DOID:14566', 'DOID:299']"
619,"{'cell line': 'Caco-2', 'cell type': 'colon cancer line', 'source_name': 'Caco-2_induced'}",cell_line,"['EFO:0000365', 'UBERON:0003101', 'DOID:0050861', 'EFO:0001099', 'UBERON:0001155', 'EFO:0000311', 'EFO:0000616', 'EFO:0005842', 'EFO:0007330', 'DOID:4', 'EFO:0003156', 'CVCL:0025', 'EFO:0000408', 'DOID:219', 'DOID:162', 'DOID:14566', 'EFO:0000322', 'CL:0000010', 'EFO:0004288']"
620,"{'cell line': 'HEK293T', 'cell type': 'human embryonic kidney cells', 'source_name': 'AFF3 shRNA RNA-seq', 'transfected with': 'AFF3 SMARTpool siRNA duplex'}",cell_line,"['CVCL:0063', 'EFO:0001184', 'EFO:0001182', 'CVCL:0045', 'UBERON:0007220', 'EFO:0000726', 'UBERON:0002113', 'UBERON:0002120', 'EFO:0001082', 'EFO:0000322', 'CL:0000010', 'UBERON:0000323']"
621,"{'cell line': 'H9', 'cell type': 'ES-derived CD271+CD73+ neural crest-like progeny', 'passages': '6 to 7', 'source_name': 'Neural crest-like progeny', 'treatment': 'FGF2'}",in_vitro_differentiated_cells,"['EFO:0000727', 'EFO:0003045', 'EFO:0000322', 'CVCL:9773', 'UBERON:0002342', 'EFO:0000795', 'CL:0000010']"
622,"{'cell line': 'HeLa', 'construct': 'empty', 'source_name': 'HeLa cell line, control shRNA'}",cell_line,"['EFO:0001185', 'UBERON:0003100', 'EFO:0000228', 'CVCL:0030', 'DOID:299', 'DOID:4', 'EFO:0000408', 'EFO:0003150', 'UBERON:0000002', 'EFO:0000322', 'CL:0000010']"
623,"{'cell type': 'macrophage', 'organism': 'Homo sapiens'}",primary_cells,"['CL:0000738', 'CL:0000988', 'CL:0000235', 'CL:0000766']"
624,"{'cell line': 'HeLa', 'source_name': 'HeLa cell line', 'treatment': 'non-targeting siRNA pool'}",cell_line,"['EFO:0001185', 'UBERON:0003100', 'EFO:0000228', 'CVCL:0030', 'DOID:299', 'EFO:0000727', 'DOID:4', 'EFO:0000408', 'EFO:0003150', 'UBERON:0000002', 'EFO:0000322', 'CL:0000010']"
625,"{'cell line': 'H1', 'extract_protocol': 'Standard mRNA-seq', 'source_name': 'hES cell, treated with sh control, ND 6d', 'treatment': 'lentiviral infection with sh control'}",in_vitro_differentiated_cells,"['EFO:0000322', 'EFO:0000727', 'CL:0000010']"
626,"{'origin': 'WA09 human embryonic stem cells', 'replicate': '1', 'sorted fraction': 'Early G1', 'source_name': 'Early G1 human embryonic stem cells'}",stem_cells,"['CL:0002322', 'CL:0000034']"
627,"{'source_name': 'dox-treated tet-shLbc hESCs', 'strain': 'tet-shLbc', 'treatment': 'dox-treated'}",stem_cells,"['CL:0002322', 'EFO:0000727', 'CL:0000034']"
628,"{'cell type': 'Induced pluripotent stem cells (iPSC)', 'passage': 'P20', 'source_name': 'iPSC culture', 'subject_id': 'Q3', 'subline_id': 'SC'}",induced_pluripotent_stem_cells,"['CL:0000034', 'CL:0002248', 'CL:0002371', 'CL:0000723', 'EFO:0004905', 'CL:0000010']"
629,"{'cell line': 'HEK 293T', 'cell type': 'non-malignant cell line', 'source_name': 'HEK 293T cells, control cells with no drug'}",cell_line,"['CVCL:0063', 'EFO:0001184', 'UBERON:0007220', 'UBERON:0002120', 'EFO:0001082', 'EFO:0000322', 'CL:0000010', 'UBERON:0000323']"
630,"{'cell type': 'iPSC derived motor neuron', 'source_name': 'iPSC derived motor neuron', 'treatment': 'none'}",in_vitro_differentiated_cells,"['CL:0000100', 'CL:0000034', 'CL:0002248', 'CL:0002371', 'CL:0000723', 'CL:0000540', 'EFO:0004905']"
631,"{'biomaterial_provider': 'Norwegian Stem Cell Center', 'cell line': '--', 'cell type': 'normal primary dermal fibroblasts', 'source_name': 'normal primary dermal fibroblasts'}",primary_cells,['CL:0000057']
632,"{'cell line': 'HCT15', 'source_name': 'colon cancer cells'}",cell_line,"['EFO:0000365', 'UBERON:0003101', 'DOID:0050861', 'EFO:0000408', 'UBERON:0001155', 'EFO:0000311', 'EFO:0000616', 'EFO:0005842', 'DOID:219', 'DOID:4', 'EFO:0007330', 'CL:0000010', 'DOID:162', 'EFO:0004288', 'DOID:14566', 'EFO:0002188', 'CVCL:0292', 'EFO:0000322']"
633,"{'genotype': 'SOD1 WT', 'source_name': 'motor neurons derived from iPSCs'}",in_vitro_differentiated_cells,"['CL:0002371', 'CL:0000100', 'CL:0000034', 'CL:0002248', 'CL:0000540', 'CL:0000723', 'EFO:0004905']"
634,"{'antibody': 'V5 (Sigma V8137)', 'antibody catalog number': 'V8137', 'antibody manufactuer': 'Sigma', 'cell line': 'HEK293', 'source_name': 'human LIN28-V5 293 stable cells'}",cell_line,"['CVCL:0045', 'EFO:0000322', 'UBERON:0002113', 'EFO:0001182', 'CL:0000010']"
635,"{'BioSampleModel': 'Human', 'age': 'Under 18 yrs', 'biomaterial_provider': 'Cellular Dynamics', 'cell_type': 'cortical neurons', 'health_state': 'normal', 'isolate': 'RNA', 'karyotype': 'normal', 'race': 'Caucasian', 'sample_type': 'cortical neurons', 'sex': 'female', 'tissue': 'fibroblast', 'treatment': 'plated for 72hrs'}",in_vitro_differentiated_cells,"['UBERON:0003100', 'CL:0000057', 'EFO:0003534', 'EFO:0000727', 'EFO:0003156', 'CL:0000540', 'CL:0002609']"
636,"{'cell line': 'KYSE70', 'cell type': 'human esophageal squamous carcinoma cells', 'genotype/variation': 'stably expressing pLKO-Tet-On-shSOX2', 'source_name': 'KYSE70_shSOX2_Day 0', 'treated with': 'none'}",cell_line,"['EFO:0000707', 'EFO:0006858', 'CVCL:1356', 'DOID:1749', 'EFO:0006633', 'EFO:0000311', 'EFO:0000313', 'DOID:305', 'EFO:0000408', 'DOID:14566', 'EFO:0000616', 'CL:0000010', 'EFO:0000322']"
637,"{'Organism': 'Homo sapiens', 'cell type': 'islet cell', 'developmental stage': 'adult'}",in_vitro_differentiated_cells,"['UBERON:0007023', 'EFO:0001272']"
638,"{'BATCH': 'BioSAli 1893', 'BIOMATERIAL_PROVIDER': 'Harvard', 'BIOMATERIAL_TYPE': 'Cell Line', 'DIFFERENTIATION_METHOD': 'adherence', 'DIFFERENTIATION_STAGE': 'intermediate', 'DISEASE': 'presumed normal', 'LINE': 'CD56+ mesoderm', 'LINEAGE': 'mesoderm', 'MEDIUM': 'CD56 mesoderm - Day 0-1', 'MOLECULE': 'genomic DNA', 'PASSAGE': '23', 'SEX': 'Male', 'sample_term_id': 'CL_0000222'}",in_vitro_differentiated_cells,"['UBERON:0000926', 'EFO:0000322', 'UBERON:0003101', 'DOID:4', 'EFO:0000408', 'EFO:0000795', 'CL:0000010']"
639,"{'cell type': 'induced pluripotent stem cells', 'disease': 'Control (euploid)', 'source_name': 'Twin_euploid_iPSC'}",induced_pluripotent_stem_cells,"['CL:0002371', 'DOID:4', 'CL:0002248', 'CL:0000034', 'EFO:0000408', 'CL:0000723', 'EFO:0004905']"
640,"{'barcode': 'ATGACAG', 'cell type': 'iPSC derived motor neuron culture', 'disease state': 'Normal control', 'source_name': 'iPSC derived motor neuron culture'}",in_vitro_differentiated_cells,"['CL:0002371', 'CL:0000100', 'CL:0000034', 'CL:0002248', 'CL:0000540', 'CL:0000723', 'EFO:0004905']"
641,"{'cell line': 'H9', 'growth': '14 days of neural induction', 'source_name': 'Human embryonic stem cells upon 14 days of neural induction. No doxycycline as added. Serve as a control to sample 1-3', 'treatment': 'No doxycycline'}",in_vitro_differentiated_cells,"['EFO:0000727', 'EFO:0003045', 'EFO:0000322', 'CVCL:9773', 'CL:0000034', 'CL:0002322', 'CL:0000010']"
642,"{'cell type': 'Neuronal Progeny', 'experiment': 'Experiment number 3', 'genotype': 'Differentiated from FTD3#6-PGRN', 'source_name': 'Neuronal progeny differentiated from FTD3#6-PGRN'}",in_vitro_differentiated_cells,['EFO:0002694']
643,"{'cell type': 'hemoangiogenic progenitors', 'source_name': 'patient-specific iPSCs'}",in_vitro_differentiated_cells,"['EFO:0004905', 'CL:0002371', 'CL:0000723', 'CL:0000034', 'CL:0002248']"
644,"{'cell line': 'YH', 'cell type': 'lymphoblastoid cells', 'source_name': 'lymphoblastoid cells'}",cell_line,"['EFO:0005292', 'EFO:0000322', 'CL:0000010']"
645,"{'cell type': 'HEK 293', 'parn knock down': 'Knock down', 'parn mutational status': 'NA', 'source_name': 'HEK 293'}",cell_line,"['CVCL:0045', 'UBERON:0002113', 'EFO:0001182', 'CL:0000010']"
646,"{'cell type': 'CD14 cells', 'individual identifier': 'T31', 'monozygotic twin relationship': 'MZ twin of T32', 'source_name': 'T31, 3rd pair, 1st individual'}",primary_cells,[]
647,"{'cell type': 'TRA-1-60(+) cells on day 11', 'source_name': 'Intermediate reprogrammed cells'}",induced_pluripotent_stem_cells,[]
648,"{'cell line': 'IMR90', 'passages': '7-9', 'source_name': 'IMR90 human lung fibroblasts', 'transfection': 'control siRNA'}",cell_line,"['EFO:0001196', 'UBERON:0003100', 'CL:0000057', 'CL:0002553', 'EFO:0000322', 'EFO:0003156', 'CVCL:0347', 'UBERON:0002048', 'EFO:0000726', 'CL:0000010']"
649,"{'cell line': 'SKNO-1 cell line', 'source_name': 'SKNO-1(leukemic)', 'treatment': 'no'}",cell_line,"['UBERON:0003101', 'CVCL:2196', 'CVCL:0462', 'CL:0000010', 'EFO:0000322']"
650,"{'Stage': 'Pluripotency', 'cell type': 'hESC (WA-09)', 'run id': 'Cortecon', 'source_name': 'in vitro_hESC_cortecon_day 0'}",stem_cells,"['CL:0002322', 'CL:0000034']"
651,"{'cell type': 'c-Kit+ cells', 'passage': 'passage 2', 'source_name': 'c-Kit+ cell_atrial appendages', 'tissue': 'heart; atrial appendages'}",cell_line,"['UBERON:0006618', 'UBERON:0000948', 'CL:0000010']"
652,"{'cell line': 'HeLa', 'source_name': 'Cervical cancer cells transfected with siRNAs against TUT7, TUT4, and TUT2 two times over a 4~5 day period (rep 1).', 'transfection': 'siTUTs'}",cell_line,"['EFO:0001185', 'UBERON:0003100', 'EFO:0000228', 'CVCL:0030', 'DOID:299', 'EFO:0000311', 'EFO:0000726', 'DOID:4', 'DOID:4362', 'EFO:0000408', 'EFO:0003150', 'DOID:162', 'UBERON:0000002', 'DOID:14566', 'EFO:0000616', 'CL:0000010', 'EFO:0000322']"
653,"{'cell origin': 'CML17', 'cell type': 'lin-CD34+CD45+', 'source_name': 'induced pluripotent stem cell-derived hematopoietic cells', 'treatment': 'DMSO'}",in_vitro_differentiated_cells,"['EFO:0000727', 'CL:0000034', 'CL:0002248', 'CL:0002371', 'CL:0000723', 'EFO:0004905', 'CL:0000988']"
654,"{'cell line': 'H1', 'cell type': 'human embryonic stem cells differentiated to ""stage 6"" containing insulin-expressing cells', 'sample type': 'live', 'source_name': 'H1 human embryonic stem cells differentiated to insulin-expressing cells, live'}",in_vitro_differentiated_cells,"['CL:0002322', 'EFO:0000322', 'CL:0000034', 'CL:0000010']"
655,"{'biomaterial_provider': 'http', 'cell line source': 'Personal Genome Project iPS cell line PGP1 (hu43860C)', 'cell subtype': 'Fibroblast derived iPS cells, differentiated neurons', 'cell type': 'Fibroblast derived iPS cells', 'genotype/variation': 'harboring doxycycline inducible Neurogenin vectors', 'source_name': 'PGP1 iPS cells_Day 3 post NGN induction', 'time point': 'Day 3 post NGN induction', 'treated with': '0.5ug/ml doxycycline'}",in_vitro_differentiated_cells,"['CL:0000057', 'EFO:0000322', 'EFO:0004905', 'CL:0000034', 'CL:0002248', 'CL:0002371', 'CL:0000723', 'CL:0000540', 'CL:0000010']"
656,"{'cell line': 'LLC12PH', 'cell type': 'Human Parthenogenic Stem Cells', 'source_name': 'Human Parthenogenic Stem Cells'}",stem_cells,"['EFO:0000322', 'CL:0000034', 'CL:0000010']"
657,"{'cell type': 'Undifferentiated H9 Stem Cells', 'organism': 'Homo sapiens'}",stem_cells,"['CVCL:9773', 'CL:0000034', 'EFO:0003045', 'CL:0000010']"
658,"{'cell type': 'Hepatic stem cells', 'source_name': 'Hepatic stem cells'}",stem_cells,"['CL:0002195', 'CL:0000034']"
659,"{'eb formation method': 'Single cell', 'embryoid body size': '500', 'source_name': 'Embryoid Body', 'stem cell lines': 'WA09'}",in_vitro_differentiated_cells,"['EFO:0003045', 'UBERON:0014374', 'EFO:0000322', 'CVCL:9773', 'CL:0000034', 'EFO:0000795', 'CL:0000010']"
660,"{'cell type': 'NTera2/D1', 'source_name': 'NTera2/D1 cells', 'treatment': 'RA'}",cell_line,"['DOID:3308', 'UBERON:0003101', 'CVCL:3407', 'EFO:0000727', 'DOID:4', 'EFO:0003156', 'EFO:0004986', 'UBERON:0002048', 'UBERON:0000473', 'EFO:0005236', 'CL:0000010', 'EFO:0000408']"
661,"{'cell line': 'TSU-1621-MT', 'source_name': 'TSU-1621-MT_RNA-seq control'}",cell_line,"['EFO:0000322', 'CVCL:A455', 'CL:0000010']"
662,"{'cell type': 'pluripotent human embryonic stem cells (hESCs)', 'source_name': 'human embryonic stem cell 1', 'transfection': 'LIN-41 siRNA #1'}",stem_cells,"['CL:0002322', 'EFO:0000726', 'CL:0000034']"
663,"{'cell line': 'H1 embryonic stem cells', 'cell type': 'day 2 ES cells differentiating along the cardiac lineage', 'genotype/variation': 'NKX2-5 shRNA knockdown', 'source_name': 'H1-NKX2-5-shRNA-day2'}",in_vitro_differentiated_cells,"['CL:0002322', 'EFO:0000322', 'CL:0000034', 'CL:0000010']"
664,"{'age of subjects': 'about 25 years', 'source_name': 'skin', 'subjects': '10 healthy female volunteers', 'tissue': 'skin (epidermal suction blister samples)'}",tissue,"['UBERON:0000014', 'UBERON:0003100', 'UBERON:0007023', 'EFO:0000962', 'EFO:0001272']"
665,"{'cell characterization': 'Single cells were sorted using anti-A2B5 MicroBeads (130-093-388, Miltenyi Biotec) according to manufacturerâ€™s protocol. In brief, live cells were incubated first with FcR Blocking Reagent (Miltenyi) for 10 mins then A2B5 antibody for 15 min at 4oC (2.5 Âµg A2B5 antibody per million cells). Cells positive for A2B5 were double enriched by passing through magnetic field (MACS Separator) twice. Both A2B5 positive and negative fractions were collected, lysed with TRIzol (Invitrogen) for RNA isolation. A population of A2B5+ cells were plated and allowed to attach overnight before fixing and staining with standard immunofluorescence techniques. A2B5+ cells stained positive for GFAP (DAKO, 1', 'growth protocol': ""Normal, non-neoplastic cells were derived from patient tissue specimens of neurosurgical resection in accordance with a Cleveland Clinic Institutional Review Board-approved protocol. Informed consent was obtained by the tissue bank, which provided de-identified excess tissue to the laboratory immediately following surgical resection. Specimens used for cell culture were dissociated with a Papain dissociation kit (Worthington). Cells were cultured adherently in media containing 50% Neurobasal medium (Gibco) and 50% Dulbecco's modified Eagle medium (DMEM) with B27 (without vitamin A, Invitrogen, basic fibroblast growth factor (10 ng/ml), epidermal growth factor (10 ng/ml), sodium pyruvate and L-glutamine, and 5% FBS. All cultured cells were used within five passages of dissociation."", 'source_name': 'Primary Epilepsy tissued derived progenitor cells'}",cell_line,"['UBERON:0007688', 'EFO:0000618', 'DOID:1826', 'EFO:0000474', 'EFO:0000408', 'EFO:0005774', 'CL:0000010']"
666,"{'disease state': ""Huntington's Disease"", 'source_name': 'post-mortem prefrontal cortex (Brodman Area 9)', 'tissue': 'prefrontal cortex (Brodman Area 9)'}",tissue,"['EFO:0000618', 'EFO:0003534', 'DOID:4', 'DOID:12858', 'EFO:0000408', 'EFO:0005772', 'UBERON:0000451']"
667,"{'cell type': 'H1-embryonic stem cells', 'source_name': 'H1-embryonic stem cells (p59)', 'time point': '15 days post LV-sh transduction', 'transduction': 'LV sh-empty'}",stem_cells,"['CL:0002322', 'CL:0000034']"
668,"{'antibody 1': 'catalog #', 'antibody 2': 'catalog #', 'source_name': 'Human brain', 'tissue': 'brain'}",tissue,['UBERON:0000955']
669,"{'cell type': 'Pre-adipocytes', 'differentiation state': 'Non-proliferating, differentiated for 3 days', 'passages': 'Cells in passage 5-7', 'source_name': 'Pre-adipocytes from liposuction material, cultured, 3 days after adipogenic stimulation (Day 3).', 'time': '3 days after adipogenic stimulation (Day 3)', 'treatment': 'adipogenic stimulation'}",in_vitro_differentiated_cells,"['EFO:0000727', 'CL:0002334', 'CL:0000010']"
670,"{'antibody/capture': 'poly(A) selection (Oligotex mRNA Mini Kit, QIAGEN)', 'source_name': 'HCT116 with homozygous deletion of DNMT3b and DNMT1 (Rhee et al Nature 2002)', 'starting molecule': 'RNA', 'technique': 'ds-cDNA-sequencing'}",cell_line,"['EFO:0004187', 'EFO:0004014']"
671,"{'age': '54-57 days post conception (gestation)', 'developmental stage': 'fetus', 'source_name': 'Human fetal pancreata', 'tissue': 'pancreas'}",tissue,"['UBERON:0001264', 'UBERON:0007220', 'UBERON:0000323']"
672,"{'cell type': 'iPS-derived cardiomyocytes', 'differentiation stage': 'Day 30 post-differentiation', 'source_name': 'Cardiomyocytes derived from PLN-R41del iPSC cells infected with AAV6-EGFP-miR-PLN'}",in_vitro_differentiated_cells,"['CL:0002371', 'CL:0000746', 'CL:0002494', 'CL:0002248', 'CL:0000034', 'CL:0000723', 'EFO:0004905', 'CL:0000187']"
673,"{'cell line': 'H9', 'cell type': 'embryonic stem cells', 'passages': '29', 'source_name': 'embryonic stem cells'}",stem_cells,"['EFO:0003045', 'EFO:0000322', 'CVCL:9773', 'CL:0000034', 'CL:0002322', 'CL:0000010']"
674,"{'cell type': 'naive hESC', 'source_name': 'Embryonic stem cells'}",stem_cells,"['CL:0002322', 'CL:0000034']"
675,"{'cell line': 'H9', 'source_name': 'human H9 cell lines'}",stem_cells,"['EFO:0000322', 'CVCL:9773', 'EFO:0003045', 'CL:0000010']"
676,"{'BioSampleModel': 'Human', 'age': 'missing', 'biomaterial_provider': 'Stormy Chamberlain', 'isolate': 'iPS cells derived from anonymous Angelman syndrome patient', 'sex': 'missing', 'tissue': 'skin'}",in_vitro_differentiated_cells,"['DOID:1932', 'EFO:0000962', 'EFO:0004905', 'CL:0002248', 'CL:0000034', 'EFO:0000408', 'CL:0000723', 'UBERON:0000014', 'CL:0002371', 'EFO:0000508']"
677,"{'cell line': '1-38G', 'derived cell typed': 'motor neurons', 'source_name': 'Type I SMA patient-specific iPSC line (1-38G)'}",in_vitro_differentiated_cells,"['CL:0000100', 'EFO:0000322', 'EFO:0004905', 'CL:0000034', 'CL:0002248', 'CL:0002371', 'CL:0000723', 'CL:0000540', 'CL:0000010']"
678,"{'cell line': 'HeLa', 'sirna': 'siLuc', 'source_name': 'Cervical cancer cells transfected with siRNA against luciferase two times over a 5 day period.', 'treatment': 'transfected with 42nM of siLuciferase'}",cell_line,"['EFO:0001185', 'UBERON:0003100', 'EFO:0000228', 'CVCL:0030', 'DOID:299', 'EFO:0000727', 'EFO:0000311', 'EFO:0000726', 'DOID:4', 'DOID:4362', 'EFO:0000408', 'EFO:0003150', 'DOID:162', 'UBERON:0000002', 'DOID:14566', 'EFO:0000616', 'CL:0000010', 'EFO:0000322']"
679,"{'cell type': 'induced pluripotent stem cell', 'source_name': 'induced pluripotent stem cell'}",induced_pluripotent_stem_cells,"['EFO:0004905', 'CL:0002371', 'CL:0000723', 'CL:0000034', 'CL:0002248']"
680,"{'cell line': 'H1', 'cell type': 'embryonic stem cells', 'genotype/variation': 'LV sh-empty transduced', 'source_name': 'Embryonic stem cells (H1)', 'time point': 'Cells at passage 69 (p69)'}",stem_cells,"['CL:0002322', 'EFO:0000322', 'CL:0000034', 'CL:0000010']"
681,"{'developmental stage': 'day 34', 'individual': '1', 'organism': 'Homo sapiens'}",in_vitro_differentiated_cells,[]
682,"{'nickname': 'hESC RNA r1', 'plasmid': 'none', 'source_name': 'embryonic stem cells', 'transchromosomic': 'no'}",stem_cells,"['CL:0002322', 'CL:0000034']"
683,"{'cell line': 'H9', 'cell type': 'embryonic stem cells', 'passage': 'p27', 'source_name': 'hESC', 'xist expression': 'XIST-'}",stem_cells,"['EFO:0003045', 'EFO:0000322', 'CVCL:9773', 'CL:0000034', 'CL:0002322', 'CL:0000010']"
684,"{'cell type': 'in vivo differentiated B cell', 'development stage': 'Adult', 'genotype/variation': 'wild type', 'source_name': 'Blood', 'tissue': 'blood'}",primary_cells,"['CL:0000738', 'UBERON:0000178', 'CL:0000236', 'UBERON:0007023', 'CL:0000542', 'CL:0000988', 'CL:0000945', 'EFO:0001272']"
685,"{'cell line': 'H9', 'cell type': 'human embryonic stem cells', 'passages': '56', 'ploidy': 'diploid', 'rna polyadenylation': 'minus', 'source_name': 'hES h9 cells, poly(A)-'}",stem_cells,"['EFO:0003045', 'EFO:0000322', 'CVCL:9773', 'CL:0000034', 'CL:0002322', 'CL:0000010']"
686,"{'cell line': 'H1', 'source_name': 'stem cells'}",stem_cells,"['EFO:0000322', 'CL:0000034', 'CL:0000010']"
687,"{'cell line': 'GBM1A', 'cell type': 'glioblastoma cell line', 'source_name': 'RNA from glioblastoma stem cells'}",stem_cells,"['EFO:0000311', 'EFO:0000616', 'DOID:3068', 'EFO:0000519', 'CL:0000034', 'EFO:0000408', 'EFO:0005543', 'DOID:14566', 'EFO:0000272', 'EFO:0000322', 'CL:0000010']"
688,"{'age': '31y', 'cell type': 'corneal endothelial cells', 'source_name': 'corneal endothelial cells'}",primary_cells,['CL:0000132']
689,"{'cell type': 'hESC cells', 'source_name': 'H9 hESCs transfected with a control, non targeting siRNA pool'}",stem_cells,"['CL:0002322', 'EFO:0000726', 'CL:0000034']"
690,"{'cell type': 'HUES64 derived hepatoblast', 'chip antibody': 'NA', 'source_name': 'in vitro derived hepatoblast'}",in_vitro_differentiated_cells,"['EFO:0007089', 'CL:0005026', 'CVCL:B199', 'CL:0000010']"
691,"{'cell type': 'CD34+ cells', 'rna subtype': 'small RNA', 'source_name': 'CD34+ cells'}",primary_cells,[]
692,"{'donor': 'adult donor 1', 'source_name': 'Sperm_RNAseq', 'tissue': 'sperm'}",primary_cells,"['UBERON:0001968', 'EFO:0001272', 'UBERON:0007023', 'CL:0000019']"
693,"{'cell type': 'primary neural progenitors', 'development stage': '17 week', 'genotype/variation': 'lentiviral-mediated knockdown of RBFOX1', 'source_name': 'primary neural progenitors', 'tissue': 'brain'}",in_vitro_differentiated_cells,['UBERON:0000955']
694,"{'BioSampleModel': 'Human', 'age': 'not applicable', 'biomaterial_provider': 'Benjamin Freedman, 850 Republican St, Room S565, Seattle, WA 98109', 'cell_line': 'WA09', 'cell_subtype': 'BF85-34', 'cell_type': 'embryonic stem cell', 'dev_stage': 'epiblast', 'health_state': 'unmodified', 'isolate': 'WA09', 'karyotype': '46, XX', 'sample_type': 'RNA from cell culture', 'sex': 'female', 'tissue': 'blastocyst', 'treatment': '3D culture1'}",stem_cells,"['UBERON:0002532', 'EFO:0003045', 'EFO:0000727', 'EFO:0000322', 'CVCL:9773', 'UBERON:0000358', 'UBERON:0003100', 'CL:0000034', 'CL:0002322', 'EFO:0000795', 'CL:0000010']"
695,"{'source_name': 'Human Cerebellum total RNA', 'tissue': 'Cerebellum'}",tissue,['UBERON:0002037']
696,"{'antibody': 'Flag M2', 'crosslinker and crosslinking wavelength': '4-SU / 365 nm', 'immunoprecipitated protein': 'LIN28A', 'source_name': 'HEK 293'}",cell_line,[]
697,"{'cell line': 'HeLa', 'source_name': 'HeLa cell'}",cell_line,"['EFO:0001185', 'UBERON:0003100', 'EFO:0000228', 'CVCL:0030', 'DOID:299', 'DOID:4', 'EFO:0000408', 'EFO:0003150', 'UBERON:0000002', 'EFO:0000322', 'CL:0000010']"
698,"{'cell line': 'HEK293', 'source_name': 'HEK 293 cells inducibly expressing FLAG/HA tagged LIN28B; transgene expression not induced; mock transfected; replicate 1'}",cell_line,"['EFO:0001182', 'CVCL:0045', 'EFO:0000322', 'UBERON:0002113', 'EFO:0000726', 'CL:0000010']"
699,"{'cell line': 'U251', 'source_name': 'U251 cells', 'transfection': 'control'}",cell_line,"['EFO:0000322', 'EFO:0006498', 'CL:0000010', 'CVCL:0021']"
700,"{'age': '16 weeks', 'cell type': 'cKIT+ FACS sort', 'source_name': 'Fetal Testis', 'tissue': 'testis'}",primary_cells,"['UBERON:0000473', 'UBERON:0007220', 'UBERON:0000323']"
701,"{'cell type': 'H1 embryonic stem cells', 'source_name': 'RNA-seq H1-hESC'}",stem_cells,"['CL:0002322', 'CL:0000034']"
702,"{'cell line': 'Huh7-C', 'source_name': 'hepatic cancer stem cells'}",cell_line,"['EFO:0003769', 'EFO:0001421', 'EFO:0000616', 'DOID:162', 'EFO:0000311', 'CL:0000034', 'EFO:0000408', 'DOID:3571', 'CVCL:0336', 'DOID:14566', 'EFO:0005384', 'CL:0000010', 'EFO:0000322']"
703,"{'cell line': 'MDA-MB-231', 'cell type': 'epithelial cell', 'disease': 'adenocarcinoma', 'ethnicity': 'caucasian', 'source_name': 'Breast cancer cells', 'transfection': 'oct4 plasmid'}",cell_line,"['EFO:0006858', 'EFO:0000726', 'EFO:0001209', 'UBERON:0000175', 'UBERON:0003100', 'EFO:0000228', 'EFO:0000322', 'DOID:1612', 'CL:0000010', 'EFO:0000616', 'DOID:4', 'EFO:0000408', 'DOID:162', 'EFO:0001272', 'CVCL:0062', 'EFO:0000311', 'EFO:0000313', 'CL:0000066', 'EFO:0003156', 'UBERON:0007023', 'DOID:14566', 'DOID:299']"
704,"{'cell line': 'MCF7', 'culture condition': 'monolayer (m) cultured cell', 'knock down': 'wild type (WT)', 'source_name': 'breast cancer cell line, MCF7', 'type of cd24': 'CD24+'}",cell_line,"['DOID:4', 'UBERON:0000175', 'UBERON:0003100', 'EFO:0000228', 'EFO:0000322', 'CVCL:0031', 'DOID:299', 'UBERON:0001911', 'EFO:0000311', 'DOID:162', 'DOID:1612', 'EFO:0003156', 'EFO:0002885', 'UBERON:0007023', 'EFO:0000408', 'EFO:0001203', 'UBERON:0000310', 'DOID:14566', 'EFO:0000616', 'CL:0000010', 'EFO:0001272']"
705,"{'ID': 'P352_141', 'age': '48', 'bmi': '24', 'gender': 'female', 'source_name': 'vastus lateralis muscle_female', 'tissue': 'vastus lateralis muscle'}",in_vitro_differentiated_cells,"['EFO:0001073', 'UBERON:0003100', 'DOID:4', 'UBERON:0001379', 'EFO:0000408', 'UBERON:0001015', 'UBERON:0001630']"
706,"{'age': '7 Year old', 'batch': '1L', 'condition': 'Disomic', 'gender': 'female', 'source_name': 'Lymphoblastoid'}",cell_line,"['EFO:0005292', 'UBERON:0003100']"
707,"{'cell type': 'iPS derived endothelial cells from CD', 'condition': '3D culture of endothelial cells in 50% MMP degradable PEG-NB hydrogel, day3', 'passage': '3', 'source_name': 'Day 3'}",in_vitro_differentiated_cells,"['CL:0000115', 'CL:0000010']"
708,"{'BioSampleModel': 'Human', 'age': '25', 'biomaterial_provider': 'Department of Urology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, 1630 Dongfang Road,', 'isolate': 'Sertoli_cells_replicate_1', 'sex': 'male', 'tissue': 'testis'}",primary_cells,"['UBERON:0000473', 'UBERON:0003101']"
709,"{'cell-type': 'Monocyte-derived dendritic cells', 'condition': 'Non-infected', 'source_name': 'Dendritic cells'}",primary_cells,"['CL:0000576', 'CL:0000738', 'CL:0000766', 'CL:0000842', 'CL:0000451', 'CL:0000988']"
710,"{'cell line': 'MDA-MB-231', 'cell type': 'mesenchymal-like breast cancer cells', 'genotype/variation': 'reduced miR-26a activity', 'source_name': 'MDA-MB-231_sponge-miR-26a', 'stably transfected with': 'miR-26a with specific sponge vector'}",cell_line,"['CVCL:0062', 'UBERON:0000175', 'UBERON:0003100', 'EFO:0001209', 'EFO:0000228', 'UBERON:0003104', 'EFO:0000322', 'DOID:299', 'EFO:0000311', 'EFO:0000726', 'DOID:1612', 'DOID:4', 'EFO:0003156', 'UBERON:0007023', 'EFO:0000408', 'DOID:162', 'DOID:14566', 'EFO:0000616', 'CL:0000010', 'EFO:0001272']"
711,"{'source_name': 'Treated Patient-Derived Xenograft (PDX)', 'tissue': 'Human ovarian PDX tumor'}",tissue,"['EFO:0000616', 'EFO:0003942', 'DOID:14566', 'EFO:0000408']"
712,"{'cell line': 'MDA-parental', 'fraction': 'RPF', 'overexpression': 'control', 'rep': '1', 'source_name': 'MDA-parental'}",cell_line,"['EFO:0000322', 'CL:0000010']"
713,"{'bacterial community type': 'Gardnerella dominant', 'cell type': 'Antigen presenting cells', 'collection site and cell type': 'PBMC APC', 'source_name': 'Peripheral blood'}",primary_cells,"['CL:0000145', 'UBERON:0000178']"
714,"{'cell line': 'A375R', 'cell type': 'melanoma cell line', 'drug treatment': 'vemurafenib_10 doses_75mg/kg', 'origin': 'xenograft tumours', 'source_name': 'melanoma'}",tissue,"['DOID:1909', 'EFO:0000616', 'EFO:0000727', 'EFO:0000311', 'EFO:0000756', 'EFO:0000408', 'EFO:0003942', 'DOID:14566', 'EFO:0000322', 'CL:0000010']"
715,"{'4oht factor': 'No', 'n11cd factor': 'Yes', 'sample group': 'N1ICD', 'source_name': 'IMR90 cells', 'vec factor': 'No'}",cell_line,[]
716,"{'cell type': 'HUVEC', 'passage': 'Passage 5', 'source_name': 'HUVEC', 'treatment': 'Angiopoietin2 in the presence of Angiopoietin2 Blocking Antibody'}",cell_line,"['EFO:0000727', 'CL:0000115', 'CL:0000010']"
717,"{'BioSampleModel': 'Human', 'age': 'derived from wild-type (WT) T47D cells', 'biomaterial_provider': 'Dr. Gurmit Singh, McMaster University, 1280 Main Street West, Hamilton, ON L8S 4L8 Canada', 'cell_line': 'T47D resistant to SH-4-54', 'health_state': 'breast cancer', 'isolate': 'T47D Clone biological replicate 1; derived from wild-type (WT) T47D cells', 'sex': 'female', 'tissue': 'breast', 'treatment': 'SH-4-54 STAT3/5 inhibitor'}",cell_line,"['UBERON:0000175', 'UBERON:0003100', 'CVCL:0553', 'EFO:0000616', 'DOID:162', 'EFO:0000727', 'EFO:0000311', 'DOID:1612', 'DOID:4', 'UBERON:0007023', 'EFO:0000408', 'UBERON:0001911', 'EFO:0000430', 'UBERON:0000310', 'EFO:0001272', 'DOID:14566', 'EFO:0000322', 'CL:0000010', 'EFO:0001247']"
718,"{'cell type': 'H9 ESC', 'passages': '40-50', 'source_name': 'ESCs', 'strain': 'H9'}",stem_cells,"['CL:0002322', 'CVCL:9773', 'CL:0000034', 'EFO:0003045', 'CL:0000010']"
719,"{'cell line background': 'MiaPaca2', 'cell type': 'original Pancreatic Ductal Adenocarcinoma (PDAC) cell line', 'source_name': 'MiaPaca2'}",cell_line,"['UBERON:0003101', 'EFO:0006858', 'EFO:0000228', 'EFO:0000408', 'EFO:0003769', 'EFO:0000616', 'EFO:0000311', 'EFO:0003860', 'EFO:0002618', 'EFO:0001379', 'EFO:0002517', 'EFO:0000313', 'EFO:1000044', 'DOID:3498', 'DOID:14566', 'CVCL:0462', 'CL:0000010', 'EFO:0000322']"
720,"{'exposure time': '16h', 'modulating agent': 'SR1_500nM+BIO_1ÂµM', 'source_name': 'AML patient sample', 'tissue': 'peripheral blood'}",primary_cells,"['EFO:0000487', 'EFO:0000222', 'UBERON:0000178']"
721,"{'cell line': 'GM12878', 'source_name': 'GM12878', 'treatment': 'eluate (m6A positive) fraction of m6A-LAIC-seq'}",cell_line,"['CVCL:7526', 'EFO:0000322', 'EFO:0000727', 'EFO:0002784', 'CL:0000010']"
722,"{'source_name': 'Stomach', 'tissue': 'Stomach'}",tissue,['UBERON:0000945']
723,"{'phenotype': 'acromegaly', 'source_name': 'Adipose, acromegaly', 'tissue': 'adipose'}",tissue,"['DOID:2449', 'UBERON:0001013', 'EFO:1000973', 'EFO:0001379', 'EFO:0000408']"
724,"{'cell line': 'TK6', 'cell type': 'human lymphoblastoid cells', 'exposed to': 'static (control)', 'genotype/variation': 'heterozygous at the thymidine kinase (TK) locus', 'source_name': 'TK6_control'}",cell_line,"['EFO:0005292', 'UBERON:0003101', 'DOID:12971', 'EFO:0000322', 'DOID:4', 'CL:0000010', 'CVCL:0561', 'UBERON:0002106', 'EFO:0000408']"
725,"{'cell type': 'Blastocyst single cell', 'sample type': 'Control embryo b', 'source_name': 'Human preimplantation embryo'}",primary_cells,"['UBERON:0000358', 'EFO:0000795', 'UBERON:0000922']"
726,"{'cell line source': 'H9 human embryonic stem cells', 'cell type': 'human embryonic stem cells', 'differentiation state': 'undifferentiated', 'source_name': 'H9 human embryonic stem cells_undifferentiated_60kPa', 'substrate stiffness': '60kPa'}",stem_cells,"['EFO:0003045', 'EFO:0000322', 'CVCL:9773', 'CL:0000034', 'CL:0002322', 'CL:0000010']"
727,"{'cell line': 'HeLa', 'source_name': 'Human HeLa cells'}",cell_line,"['EFO:0001185', 'UBERON:0003100', 'EFO:0000228', 'CVCL:0030', 'DOID:299', 'DOID:4', 'EFO:0000408', 'EFO:0003150', 'UBERON:0000002', 'EFO:0000322', 'CL:0000010']"
728,"{'diagnosis': 'mesial temporal lobe epilepsy', 'gender': 'female', 'source_name': 'dentate granule cells'}",primary_cells,"['EFO:0000474', 'CL:0000120', 'UBERON:0003100', 'EFO:0000618', 'EFO:0004263', 'DOID:3328', 'UBERON:0011306', 'EFO:0003511', 'DOID:1826', 'EFO:0000773', 'EFO:0000408', 'EFO:0005774']"
729,"{'median tin score': '60.71188767', 'rin score': '2.4', 'source_name': 'Prostate cancer (Bone metastasis)', 'tissue': 'Bone', 'tumor stage': 'metastatic castration resistant'}",tissue,"['EFO:0000311', 'EFO:0000616', 'UBERON:0002481', 'UBERON:0001474', 'DOID:10283', 'EFO:0007355', 'EFO:0000512', 'UBERON:4000162', 'DOID:162', 'EFO:0000298', 'DOID:14566', 'EFO:0000408']"
730,"{'age at death': '75', 'gender': 'male', 'microarray study': 'P_27', 'proteomics study': 'yes', 'proteomics sv1': '-0.1683601219', 'proteomics sv2': '-0.1233597', 'proteomics sv3': '-0.482172644', 'source_name': 'BA9 prefrontal cortex', 'tissue': 'brain (BA9 prefrontal cortex)'}",tissue,"['UBERON:0000955', 'EFO:0003534', 'UBERON:0003101', 'UBERON:0013540', 'UBERON:0000451']"
731,"{'Sex': 'male', 'age': '28', 'biopsytime': '4mo', 'diagnosis': 'Ulcerative colitis', 'ethnicity': 'Caucasian', 'patient': 'P500', 'prognosis': 'Pouchitis', 'source_name': 'P500.5', 'tissue': 'Ileal pouch'}",tissue,"['UBERON:0003101', 'EFO:0000729', 'EFO:0003767', 'UBERON:0009856', 'EFO:0003921', 'DOID:8577', 'EFO:0003872', 'EFO:0003156', 'EFO:0000408', 'EFO:0000405', 'DOID:0060180']"
732,"{'organoid culture': 'cerebral organoids', 'source_name': 'C12, d26', 'time': '26 days from the beginning of organoid culture'}",in_vitro_differentiated_cells,[]
733,"{'cell line': 'MR49F', 'source_name': 'Prostate Cancer Cell Line', 'treatment': 'Vehicle'}",cell_line,"['DOID:14566', 'EFO:0000616', 'EFO:0000727', 'EFO:0000311', 'DOID:10283', 'EFO:0007355', 'EFO:0000512', 'DOID:162', 'EFO:0001639', 'EFO:0000322', 'CL:0000010', 'EFO:0000408']"
734,"{'cell line': 'BT474', 'cell type': 'breast cancer cell line', 'source_name': 'breast cancer cell line'}",cell_line,"['EFO:0003156', 'UBERON:0003100', 'CVCL:0179', 'EFO:0000616', 'DOID:162', 'EFO:0000311', 'DOID:1612', 'DOID:4', 'EFO:0002885', 'UBERON:0007023', 'EFO:0000408', 'UBERON:0001911', 'EFO:0000430', 'EFO:0001093', 'DOID:14566', 'EFO:0000322', 'CL:0000010', 'EFO:0001272']"
735,"{'cell line': 'Human lung cancer cell lines NCI-H1975 and HCC827', 'mixture cell line hcc827': '25', 'mixture cell line nci-h1975': '75', 'replicate': '2', 'source_name': 'Human lung cancer cell lines NCI-H1975 and HCC827', 'strain': 'R2D'}",cell_line,"['EFO:0003137', 'CVCL:1511', 'CVCL:2063', 'UBERON:0003100', 'EFO:0000228', 'EFO:0000322', 'UBERON:0002048', 'DOID:1324', 'EFO:0002271', 'CL:0000010', 'EFO:0000616', 'DOID:4', 'EFO:0000684', 'EFO:0000408', 'DOID:162', 'EFO:0002934', 'EFO:0001272', 'EFO:0000311', 'EFO:0003818', 'EFO:0003156', 'UBERON:0007023', 'DOID:14566', 'DOID:299']"
736,"{'ArrayExpress-CellType': 'BPH1', 'ArrayExpress-Species': 'Homo Sapien', 'sample_description': '', 'strain': ''}",cell_line,"['CVCL:1091', 'CL:0000010']"
737,"{'cell type': 'Peripheral blood monocytes', 'disease': 'Health control', 'source_name': 'Monocytes'}",primary_cells,"['CL:0000738', 'CL:0000766', 'CL:0000842', 'UBERON:0000178', 'DOID:4', 'EFO:0000408', 'CL:0000576', 'CL:0000988']"
738,"{'BioSampleModel': 'Human', 'age': '0d', 'biomaterial_provider': ""Melissa Little, Murdoch Childrens Research Institute, Royal Children's Hospital, Flemington Road, Parkville Victoria 3052 Australia"", 'cell_line': 'C32 iPSC (Briggs et al, 2013)', 'isolate': 'mini-kidney, day 0, pellet 5', 'sex': 'not applicable', 'tissue': 'mini-kidney generated from human pluripotent stem cells'}",in_vitro_differentiated_cells,"['UBERON:0002113', 'EFO:0000322', 'CL:0000034', 'CL:0002248', 'CL:0002371', 'CL:0000723', 'EFO:0004905', 'CL:0000010']"
739,"{'cell collection details': 'Sample from 1 individual', 'passage': 'passage 5', 'protocol': 'AdSlit2 48h', 'replicate': 'biological replicate #1', 'source_name': 'human umbilical vein endothelial cells'}",cell_line,"['CL:0000115', 'CL:0000010']"
740,"{'cell type': 'PBMC_TM', 'sorting phenotype': 'TM(CD3+CD14/CD11c-CD8-CD56/CD20/TCRgammadelta-CD27+CD45RO+CCR7-)', 'source_name': 'LIR_01', 'status': 'ex vivo; unstimulated'}",primary_cells,[]
741,"{'BioSampleModel': 'Human', 'Sample_ID': 'Sample_B20_1002', 'age': '36', 'biomaterial_provider': 'The Barbara Ann Kamanos Cancer Institute', 'cell_line': 'MCF10neoT', 'isolate': 'MCF10neoT is a premalignant clonal breast cancer cell line derived from a xenograft originating from normal mammary epithelial MCF10A cells that were HRAS transformed and injected into severe combined immune-deficient mice', 'sex': 'female', 'tissue': 'mammary gland; breast'}",cell_line,"['UBERON:0002530', 'UBERON:0003100', 'CVCL:5554', 'CL:0000066', 'EFO:0000616', 'DOID:162', 'EFO:0000311', 'DOID:1612', 'EFO:0002885', 'EFO:0000408', 'UBERON:0001911', 'UBERON:0000310', 'EFO:0003942', 'DOID:14566', 'EFO:0000322', 'CL:0000010']"
742,"{'BioSampleModel': 'Human', 'age': '72', 'biomaterial_provider': 'James Brugarolas, 2201 Inwood Road Dallas, Texas 75390-9125', 'isolate': 'XP373', 'sample_type': 'Sample6_XP373', 'sex': 'female', 'tissue': 'tumor thrombus'}",tissue,"['EFO:0000616', 'UBERON:0003100', 'DOID:14566', 'EFO:0000408', 'UBERON:0010210']"
743,"{'source_name': 'Histamine blockade subject biopsy immediately after exercise', 'subject group': 'received combined H1/H2-histamine receptor blockade prior to exercise', 'subject id': 'subject 11', 'time point': 'immediately after exercise', 'tissue': 'vastus lateralis muscle'}",tissue,"['UBERON:0001630', 'UBERON:0001379', 'EFO:0000483', 'UBERON:0001015']"
744,"{'cell line': 'K562', 'passage': '3-5', 'source_name': 'K562 cells'}",cell_line,"['EFO:0000339', 'UBERON:0003100', 'EFO:0000322', 'UBERON:0002371', 'DOID:4', 'EFO:0000408', 'DOID:8552', 'EFO:0002067', 'CL:0000010', 'CVCL:0004']"
745,"{'cell type': 'CD3+CD4+CD45RA-CCR7+CD25-CCR4+ T cells', 'disease group': 'Allergic rhinitis', 'source_name': 'Blood PBMCs', 'tissue': 'blood'}",primary_cells,"['EFO:0000684', 'CL:0000542', 'EFO:0005854', 'UBERON:0000178', 'DOID:4', 'CL:0000084', 'CL:0000738', 'EFO:0000408', 'DOID:4481', 'EFO:0003956', 'CL:0000988']"
746,"{'antibody': 'non', 'cell line': 'U2OS', 'source_name': 'U2OS cells'}",cell_line,"['EFO:0000637', 'DOID:3347', 'UBERON:0003100', 'UBERON:0002481', 'EFO:0000322', 'EFO:0002869', 'UBERON:0001474', 'CVCL:0042', 'DOID:4', 'EFO:0003156', 'EFO:0000408', 'EFO:0000298', 'CL:0000010']"
747,"{'cell type': 'Epithelial', 'disease': 'Pancreatic ductal adenocarcinoma', 'knockdown': 'igf2bp3', 'source_name': 'PL45 cells'}",cell_line,"['EFO:0003860', 'EFO:0006858', 'EFO:0000228', 'EFO:0000408', 'EFO:0003769', 'EFO:0000616', 'EFO:0000311', 'EFO:0002618', 'CL:0000066', 'DOID:4', 'EFO:0002517', 'EFO:0000313', 'EFO:1000044', 'DOID:14566', 'EFO:0001379', 'DOID:3498']"
748,"{'cell line': 'SH-SY5Y', 'cell type': 'neuroblastoma cell line', 'source_name': 'RNA from SH-SY5Y FUS KO cells. A4 clone.'}",cell_line,"['EFO:0000621', 'EFO:0007392', 'UBERON:0003100', 'EFO:0000322', 'EFO:0002717', 'DOID:769', 'EFO:0000311', 'UBERON:0002371', 'DOID:4', 'EFO:0000408', 'CVCL:0019', 'DOID:14566', 'EFO:0000616', 'CL:0000010', 'EFO:0005214']"
749,"{'analyte type': 'RNA', 'biospecimen repository': 'NHLBI_MZ_Asthma', 'biospecimen repository sample id': 'KN4905_WTS', 'body site': 'Blood', 'gap_accession': 'phs000886', 'gap_consent_code': '1', 'gap_consent_short_name': 'GRU', 'gap_sample_id': '1479935', 'gap_subject_id': '1148190', 'histological type': 'Peripheral Blood Mononuclear Cells', 'is tumor': 'No', 'molecular data type': 'RNA Seq (NGS)', 'sex': 'male', 'study design': 'Case-Control', 'study disease': 'Asthma', 'study name': 'An Omics View of Asthma through Monozygotic Twins', 'subject is affected': 'Yes', 'submitted sample id': 'KN4905_WTS', 'submitted subject id': 'KN4905', 'submitter handle': 'NHLBI_MZ_Asthma'}",primary_cells,"['UBERON:0003101', 'CL:0000738', 'CL:0000842', 'CL:2000001', 'UBERON:0000178', 'CL:0000081', 'CL:0000988']"
750,"{'cell line': 'HEK293', 'rna fraction': 'nuclear RNA', 'source_name': 'Human Embryonic Kidney_soluble_nuclear_extract (sne)'}",cell_line,"['CVCL:0045', 'EFO:0000322', 'UBERON:0002113', 'EFO:0001182', 'CL:0000010']"
751,"{'cell line': 'vorinostat-resistant HCT116', 'source_name': 'colorectal carcinoma cell line', 'timepoint': '4hr', 'treatment': 'mock DMSO'}",cell_line,"['UBERON:0003101', 'EFO:0006858', 'EFO:0000408', 'UBERON:0001155', 'EFO:0000322', 'EFO:0000616', 'EFO:0000727', 'EFO:0000311', 'EFO:0000313', 'DOID:4', 'UBERON:0007023', 'DOID:305', 'EFO:0002824', 'DOID:14566', 'CVCL:0291', 'CL:0000010', 'EFO:0001272']"
752,"{'BioSampleModel': 'Human', 'DIS3L': 'WT', 'RNA_analyzed_in_RACE_seq': 'vault', 'age': 'not applicable', 'biomaterial_provider': 'Laboratory of RNA Biology and Functional Genomics PAS, Warsaw, Pawinskiego 5A, 01-106 Poland', 'cell_line': 'HEK293', 'isolate': 'not applicable', 'sex': 'not applicable', 'tissue': 'Human Embryonic Kidney'}",cell_line,"['CVCL:0045', 'EFO:0000322', 'UBERON:0002113', 'EFO:0001182', 'CL:0000010']"
753,"{'cell cycle phase': 'G1 (1c)', 'cell line': 'h-pES10', 'cell type': 'Haploid NCAM1+ pES10-NPCs', 'differentiation status': 'Differentiated', 'passage': '21', 'source_name': 'Haploid NCAM1+ pES10-NPCs in G1 (1c)'}",in_vitro_differentiated_cells,"['EFO:0000322', 'CVCL:AX68', 'CL:0000010']"
754,"{'age': '49', 'bmi': '42.4', 'source_name': 'Liver tissue of obese patient', 'tissue': 'Liver'}",tissue,"['EFO:0001073', 'UBERON:0002107']"
755,"{'cell line': 'HeLa F-17', 'cell treatment': 'siRNA knockdown by nucleofection + 48hours growth', 'ectopic expression construct': 'murine FLAG-Bmi1 overexpression', 'source_name': 'SCR knockdown'}",cell_line,"['EFO:0001185', 'UBERON:0003100', 'EFO:0000228', 'CVCL:0030', 'DOID:299', 'EFO:0000727', 'DOID:4', 'EFO:0000408', 'EFO:0003150', 'UBERON:0000002', 'EFO:0000322', 'CL:0000010']"
756,"{'differential stage': 'day 10', 'knockdown': 'wild type', 'source_name': 'embryonic stem cells', 'strain': 'H9'}",in_vitro_differentiated_cells,"['CL:0002322', 'CL:0000034']"
757,"{'RNAi': 'nELAVL', 'cell line': 'IMR-32', 'cell type': 'neuroblastoma cells', 'sample group': 'non-stressed', 'source_name': 'RNAseq_IMR-32_nELAVL_noUV', 'treated with': 'nELAVL RNAi for 96hrs'}",cell_line,"['EFO:0000621', 'UBERON:0000955', 'UBERON:0003101', 'EFO:0003156', 'EFO:0001195', 'DOID:769', 'CVCL:0346', 'EFO:0000311', 'EFO:0007392', 'DOID:4', 'CL:0000031', 'EFO:0000408', 'DOID:14566', 'EFO:0000616', 'CL:0000010', 'EFO:0000322']"
758,"{'agent': 'SCH772984', 'cell line': 'melanoma cell line A375P', 'source_name': 'A375p cells'}",cell_line,"['DOID:1909', 'EFO:0003156', 'UBERON:0003100', 'DOID:14566', 'EFO:0000616', 'EFO:0000311', 'DOID:4', 'EFO:0000756', 'EFO:0000408', 'UBERON:0000014', 'CVCL:6233', 'EFO:0000962', 'EFO:0000322', 'CL:0000010']"
759,"{'source_name': 'placenta', 'tissue': 'placental villus parenchyma'}",tissue,"['UBERON:0000353', 'UBERON:0007106', 'UBERON:0001987', 'EFO:0000795']"
760,"{'cell type': 'luminal epithelial cells', 'patient age': '74', 'patient number': 'HPCa177N', 'source_name': 'Freshly purified human benign prostatic luminal cells', 'tissue': 'Prostate'}",primary_cells,"['CL:0000066', 'UBERON:0002367']"
761,"{'BioSampleModel': 'Human', 'age': 'not collected', 'biomaterial_provider': 'not collected', 'cell_line': 'SH-SY5Y', 'isolate': 'SH-SY5Y', 'label': 'contorl_1', 'sex': 'not collected', 'tissue': 'not collected'}",cell_line,"['EFO:0000621', 'UBERON:0003100', 'DOID:769', 'UBERON:0002371', 'DOID:4', 'EFO:0000408', 'CVCL:0019', 'EFO:0002717', 'EFO:0000322', 'CL:0000010']"
762,"{'cell line': 'CRL2097', 'cell type': 'large live', 'source_name': 'Primary foreskin fibroblast cells'}",cell_line,"['EFO:0000322', 'UBERON:0001332', 'CL:1001608', 'CL:0000010', 'CL:0000057']"
763,"{'cell type': 'induced pluripotent stem cells', 'genotype/variation': 'PAPD5 KD', 'source_name': 'induced pluripotent stem cells'}",induced_pluripotent_stem_cells,"['EFO:0004905', 'CL:0002371', 'CL:0000723', 'CL:0000034', 'CL:0002248']"
764,"{'cell type': 'TMNP', 'donor id': 'LH068', 'source_name': 'Donor LH068 TMNP cells'}",primary_cells,[]
765,"{'culture condition': '3 day in vitro culture for Th0, treatment (IL27)', 'genotype': 'STAT1 GOF patient 2', 'lab data id': '797', 'source_name': 'human primary CD4+ T cells'}",primary_cells,"['CL:0000738', 'CL:0000895', 'EFO:0000727', 'CL:0000084', 'CL:0000624', 'CL:0000542', 'CL:0000988']"
766,"{'AML status': 'cd34n', 'cell type': 'CD34-CD244+CD117+', 'disease': 'AML', 'individual': '#230', 'leukaemic stem cells': 'positive', 'organism': 'Homo sapiens', 'phenotype': 'CD34-CD244+CD117+'}",primary_cells,"['DOID:4', 'CL:0000034', 'EFO:0000408', 'EFO:0000222']"
767,"{'cell line': 'Hermes 3A', 'cell type': 'melanocyte', 'knockdown': 'shBRG1', 'source_name': 'Hermes 3A'}",cell_line,"['CL:0000148', 'EFO:0000322', 'CL:0000010']"
768,"{'cell line': 'HCT116', 'clone': 'Control Clone 4', 'source_name': 'Human colorectal cancer cell-line HCT116', 'time point': 'RNA extracted on day A'}",cell_line,"['UBERON:0003101', 'EFO:0001639', 'EFO:0000408', 'UBERON:0001155', 'EFO:0000322', 'EFO:0000311', 'EFO:0000616', 'DOID:9256', 'EFO:0005842', 'EFO:0000313', 'DOID:4', 'EFO:0007330', 'UBERON:0007023', 'DOID:305', 'EFO:0002824', 'DOID:162', 'DOID:14566', 'CVCL:0291', 'CL:0000010', 'EFO:0001272']"
769,"{'cell line': 'LNCaP', 'cell type': 'prostate cancer cells', 'passages': '32-34', 'source_name': 'LNCaP-SiControl'}",cell_line,"['CVCL:0395', 'EFO:0000616', 'EFO:0000311', 'DOID:10283', 'EFO:0007355', 'EFO:0002071', 'EFO:0000512', 'DOID:162', 'DOID:14566', 'EFO:0000322', 'CL:0000010', 'EFO:0000408']"
770,"{'cell line': 'H7 derived', 'source_name': 'differentiated from H7 hESCs'}",in_vitro_differentiated_cells,"['CVCL:HA52', 'EFO:0000322', 'CVCL:9772', 'CL:0000010', 'EFO:0005904']"
771,"{'genotype': 'histone H3.3 K36M mutant', 'source_name': 'patient tumor sample', 'tumor type': 'chondroblastoma'}",tissue,"['DOID:2649', 'EFO:0000331', 'EFO:0000311', 'EFO:0000408', 'DOID:14566', 'EFO:0000616']"
772,"{'cell type': 'PBMC', 'disease state': 'Lyme disease', 'individual': 'patient 01-20', 'source_name': 'PBMCs', 'time': 'acute Lyme pre-treatment (V1)'}",primary_cells,"['DOID:4', 'EFO:0000701', 'EFO:0000727', 'DOID:11729', 'EFO:0005741', 'EFO:0000408']"
773,"{'library type': 'Ovation RNASeq System V2', 'passage number': 'Passage 31', 'source_name': 'Primed SSEA4+ UCLA1 hESCs'}",stem_cells,"['CL:0002322', 'CL:0000034', 'CL:0000010']"
774,"{'donor': 'Human (donor A)', 'source_name': 'Tissue', 'tissue type': 'Prostate'}",tissue,['UBERON:0002367']
775,"{'cell line': 'HCT116', 'source_name': 'HCT116 p21-/- cells'}",cell_line,"['UBERON:0003101', 'EFO:0000408', 'UBERON:0001155', 'EFO:0000322', 'EFO:0000313', 'DOID:4', 'UBERON:0007023', 'DOID:305', 'EFO:0002824', 'CVCL:0291', 'CL:0000010', 'EFO:0001272']"
776,"{'BioSampleModel': 'Human', 'age': '1', 'biomaterial_provider': 'Karolinska Institutet', 'cell_line': 'THP-1', 'cell_type': 'monocyte', 'disease': 'acute monocytic leukemia', 'isolate': 'monoisolate', 'sample_type': 'cell culture', 'sex': 'male', 'time_h': '12', 'tissue': 'peripheral blood', 'treatment': 'Control'}",cell_line,"['DOID:8864', 'CL:0000738', 'EFO:0001253', 'CL:0000576', 'UBERON:0003101', 'EFO:0000322', 'EFO:0000221', 'UBERON:0000178', 'CL:0000010', 'CL:0000766', 'EFO:0000616', 'EFO:0001355', 'EFO:0001642', 'DOID:4', 'EFO:0000408', 'EFO:0000565', 'EFO:0000540', 'CL:0000988', 'CL:0000842', 'EFO:0000311', 'CVCL:0006', 'DOID:14566']"
777,"{'BioSampleModel': 'Human', 'Paired frozen tumor': 'M980', 'RNA quality group': '2', 'RNA_seq_ID': 'S962', 'age': '85', 'biomaterial_provider': 'French Sarcoma Group', 'cell_type': 'Sarcoma', 'disease': 'Undifferentiated pleomorphic sarcoma', 'isolate': 'Monoisolate', 'sample_type': 'FFPE block extraction', 'sex': 'male', 'tissue': 'Lower limb'}",tissue,"['UBERON:0003101', 'EFO:0000691', 'DOID:1115', 'EFO:0000616', 'EFO:0000311', 'DOID:4', 'EFO:0000408', 'UBERON:0002101', 'UBERON:0002103', 'DOID:14566']"
778,"{'age': 'adult', 'cell line': 'primary tissue', 'cell type': '80% hepatocyte', 'disease': 'healthy', 'isolate': 'not applicable', 'organism': 'human', 'organism part': 'liver', 'sex': 'male'}",tissue,"['UBERON:0003101', 'EFO:0000322', 'UBERON:0007023', 'CL:0000010', 'UBERON:0002107', 'CL:0000182', 'EFO:0001272']"
779,"{'source_name': 'Heart (Left Ventricle)', 'tissue': 'Heart'}",tissue,"['UBERON:0002082', 'UBERON:0002084', 'UBERON:0000948']"
780,"{'cell line': 'SUM159R', 'drug treatment': 'JQ1', 'duration': '3h', 'source_name': 'SUM159R'}",cell_line,"['EFO:0000322', 'EFO:0000727', 'CL:0000010']"
781,"{'disease': 'treated Kawasaki Disease', 'source_name': 'coronary artery', 'tissue': 'coronary artery'}",tissue,"['DOID:4', 'UBERON:0001637', 'UBERON:0001621', 'EFO:0000408', 'EFO:0004246']"
782,"{'cell type': 'A549 cells', 'source_name': 'Lung adenocarcinoma cells', 'treatment': 'Transient overexpression (20 nM)'}",cell_line,"['EFO:0006858', 'EFO:0000727', 'EFO:0001071', 'EFO:0000571', 'CVCL:0023', 'UBERON:0003101', 'EFO:0000684', 'EFO:0000228', 'DOID:299', 'UBERON:0002048', 'DOID:305', 'EFO:0003060', 'CL:0000010', 'EFO:0000616', 'DOID:4', 'EFO:0000408', 'EFO:0001086', 'EFO:0000311', 'EFO:0000313', 'EFO:0003818', 'EFO:0003156', 'DOID:3910', 'DOID:14566']"
783,"{'cell type': 'established lung cancer cell line', 'growth condition': 'mitogen-rich media (MRM)', 'growth time': '48hr', 'original cell line': 'H2087', 'source_name': 'H2087, parental, MRM, 48hr'}",cell_line,"['EFO:0003156', 'UBERON:0003101', 'EFO:0000684', 'EFO:0000228', 'EFO:0000408', 'EFO:0002277', 'UBERON:0000029', 'DOID:299', 'EFO:0000311', 'EFO:0003818', 'DOID:4', 'EFO:0000322', 'UBERON:0002048', 'DOID:162', 'DOID:1324', 'EFO:0002934', 'DOID:14566', 'EFO:0000616', 'CL:0000010', 'CVCL:1524']"
784,"{'cell type': 'HCC', 'rna source': 'cell line', 'source_name': 'cell line'}",stem_cells,"['EFO:0006858', 'EFO:0003769', 'EFO:0001421', 'EFO:0000182', 'EFO:0000311', 'EFO:0000313', 'DOID:684', 'EFO:0000408', 'DOID:14566', 'EFO:0000616', 'CL:0000010', 'EFO:0000322']"
785,"{'cell line': 'BJ Fibroblasts', 'genotype': 'WT', 'sorting': 'Tra-160 negative', 'source_name': 'BJ Fibroblasts', 'treatment': 'BJ Fibroblasts 16 days post induced OSKM viral Expression and treated with non-targeting siRNA.'}",cell_line,"['EFO:0000322', 'EFO:0000727', 'CL:0000057', 'CL:0000010']"
786,"{'source_name': 'Leiomyosarcoma', 'subtypes': 'II', 'tissue': 'Soft Tissue', 'tissue archive method': 'FFPE'}",tissue,"['EFO:0002970', 'EFO:0007384', 'DOID:1967', 'EFO:0000616', 'EFO:0000311', 'EFO:0000408', 'EFO:0000564', 'DOID:14566']"
787,"{'cell type': 'Human embryonic kidney', 'expression of rbfox1 and hnrnp m': 'do not express hnRNP M and Rbfox1', 'source_name': 'Flp-In T-REx 293, Rbfox2 knockout cells (clone 7)'}",cell_line,"['CL:0000010', 'CVCL:M624']"
788,"{'cell line': 'MIHA', 'source_name': 'Liver', 'transfection': 'empty vector control'}",cell_line,"['EFO:0000726', 'EFO:0000322', 'CL:0000010', 'UBERON:0002107']"
789,"{'analyte type': 'RNA', 'biospecimen repository': 'NCI_TARGET', 'biospecimen repository sample id': 'TARGET-52-PAVVIT-01A-01R', 'body site': 'Primary Solid Tumor', 'gap_accession': 'phs000470', 'gap_consent_code': '1', 'gap_consent_short_name': 'PCR', 'gap_parent_phs': 'phs000218', 'gap_sample_id': '1425012', 'gap_subject_id': '1092234', 'histological type': 'Kidney Tumors', 'is tumor': 'Yes', 'molecular data type': 'Targeted Exome (NGS)', 'sex': 'male', 'study design': 'Tumor vs. Matched-Normal', 'study name': 'TARGET', 'submitted sample id': 'TARGET-52-PAVVIT-01A-01R', 'submitted subject id': 'TARGET-52-PAVVIT', 'submitter handle': 'NCI_TARGET'}",tissue,"['UBERON:0002113', 'UBERON:0003101', 'DOID:14566', 'EFO:0000616', 'EFO:0000408']"
790,"{'cell line': 'TOV21G', 'source_name': 'Human Ovarian Cancer Cell Line', 'treatment': 'Control siRNA transfection for 48 h'}",cell_line,"['EFO:0000228', 'UBERON:0000992', 'CVCL:3613', 'EFO:0000311', 'DOID:299', 'EFO:0000727', 'EFO:0003893', 'DOID:2394', 'EFO:0000726', 'DOID:4', 'UBERON:0003100', 'EFO:0000408', 'EFO:0000348', 'DOID:162', 'EFO:0002394', 'EFO:0000973', 'DOID:14566', 'EFO:0000616', 'CL:0000010', 'EFO:0000322']"
791,"{'analyte type': 'RNA', 'biospecimen repository': 'NCI_AntisenseGeneExpression_Cancers', 'biospecimen repository sample id': 'MCTP_SAMPLE_149', 'body site': 'lung', 'gap_accession': 'phs000937', 'gap_sample_id': '1842837', 'gap_subject_id': '1393926', 'histological type': 'lung_carcinoma', 'is tumor': 'Yes', 'molecular data type': 'RNA Seq (NGS)', 'study design': 'Prospective Longitudinal Cohort', 'study name': 'The Landscape of Antisense Gene Expression in Human Cancers', 'submitted sample id': 'MCTP_SAMPLE_149', 'submitted subject id': '149', 'submitter handle': 'NCI_AntisenseGeneExpression_Cancers'}",tissue,"['EFO:0000684', 'EFO:0006858', 'UBERON:0000170', 'EFO:0000616', 'EFO:0000311', 'EFO:0000313', 'EFO:0003818', 'EFO:0001071', 'DOID:305', 'UBERON:0002048', 'DOID:3905', 'DOID:14566', 'EFO:0000408']"
792,"{'biomaterial_provider': 'https', 'cell type': 'forebrain neural progenitor cells (NPCs)', 'diagnosis': 'Schizophrenia (SZ)', 'gender': 'female', 'patient id': 'SZ3', 'repository source fibroblast id': 'GM01835', 'source_name': 'SZ_hiPSC forebrain NPCs', 'transduced with': 'RV-miR-9'}",in_vitro_differentiated_cells,"['UBERON:0003100', 'CL:0000057', 'EFO:0000692', 'EFO:1001457', 'EFO:0004905', 'EFO:0000677', 'CL:0000047', 'CL:0002248', 'UBERON:0001890', 'CL:0000034', 'EFO:0000408', 'DOID:5419', 'CL:0000723', 'CL:0002371']"
793,"{'cell type': 'keratinocyte', 'culture protocols': 'Human keratinocyte was cultured with DermaLife K serum-free human keratinocyte medium (Lifeline Cell Technology, LL-0007) per manufacturerÂ¡Ã…â„¢s instruction.', 'harvest time': '80% confluence', 'lentiviral transgenes': 'no', 'passage number': 'passage 4', 'source_name': 'human keratinocyte from donor'}",cell_line,"['UBERON:0001977', 'UBERON:0034674', 'CL:0000010', 'CL:0000312', 'CL:0000066', 'CL:0000362']"
794,{'source_name': 'SKBR3'},cell_line,[]
795,"{'analyte type': 'RNA', 'biospecimen repository': 'OD_HeLaCells', 'biospecimen repository sample id': 'SRS1046069', 'body site': 'cervix', 'gap_accession': 'phs001029', 'gap_consent_code': '1', 'gap_consent_short_name': 'HMB', 'gap_parent_phs': 'phs000640', 'gap_sample_id': '1838859', 'gap_subject_id': '791085', 'histological type': 'Cervix_carcinoma', 'is tumor': 'Yes', 'molecular data type': 'RNA Seq (NGS)', 'sex': 'female', 'study design': 'Case Set', 'study name': 'Full-Length Single-Cell RNA-seq Applied to HeLa S3 Cells', 'submitted sample id': 'SRS1046069', 'submitted subject id': 'HeLa_1', 'submitter handle': 'OD_HeLaCells'}",cell_line,"['UBERON:0003100', 'EFO:0000616', 'EFO:0000311', 'EFO:0001061', 'EFO:0000408', 'DOID:2893', 'UBERON:0000002', 'DOID:14566']"
796,"{'cell type': 'T47D', 'source_name': 'T47D breast cancer cells', 'treatment': 'AKT inhibitor MK2206'}",cell_line,"['UBERON:0000175', 'UBERON:0003100', 'DOID:14566', 'EFO:0000616', 'DOID:162', 'EFO:0000727', 'EFO:0000311', 'DOID:1612', 'DOID:4', 'UBERON:0007023', 'EFO:0000408', 'UBERON:0001911', 'EFO:0000430', 'EFO:0001272', 'CVCL:0553', 'CL:0000010', 'EFO:0001247']"
797,"{'cell type': 'HEK Gibco', 'source_name': 'HEK'}",cell_line,"['CL:0000010', 'CVCL:M624']"
798,"{'assayed molecule': 'mRNA', 'cell line id': '20', 'cell type': 'Embryonic stem cell-derived neurons', 'genotype/variation': 'TSC2-/-', 'source_name': 'TSC2-/- cells (number 20) treated with Rapamycin, total RNA', 'treatment': 'Rapamycin'}",in_vitro_differentiated_cells,"['EFO:0000322', 'EFO:0000727', 'CL:0000034', 'CL:0002322', 'CL:0000540', 'CL:0000010']"
799,"{'cell line': 'foreskin HDF', 'passage': 'p2', 'source_name': 'Foreskin-derived fibroblasts'}",cell_line,"['EFO:0000322', 'UBERON:0001332', 'CL:0000057', 'CL:0000010']"
800,"{'BioSampleModel': 'Human', 'age': '53', 'alias': 'HTERT-HME1', 'biomaterial_provider': 'ATCC', 'cell_line': 'NCI-PBCF-CRL4010', 'cell_type': 'EPITHELIAL-LIKE', 'culture_collection': 'ATCC', 'disease': 'NORMAL', 'isolate': 'ATCC', 'karyotype': 'This is a pseudo-diploid cell line of female origin with a modal chromosome count of 46 and a low-to-moderate rate of polyploidy. However, even though the line generally has 46 chromosomes per cell, several of those 46 were derivative or marker chromosomes. There were two copies of a karyotypically normal X-chromosome present in 50-60% of the cells. Other features included a normal variation in the heterochromatic region of chromosome 1 (1qh+), a consistent derivative-10 marker chromosome (present in most cells) and 2 other markers', 'sample_type': 'cell culture', 'sex': 'female', 'tissue': 'BREAST'}",cell_line,"['UBERON:0003100', 'EFO:0000322', 'UBERON:0000310', 'DOID:4', 'EFO:0000408', 'CL:0000066', 'CL:0000010', 'CL:0000415']"
801,"{'cell type': 'pDCs', 'donor': '1', 'gender': 'female', 'source_name': 'plasmacytoid dendritic cells', 'stimulus': 'UT', 'tissue': 'blood'}",primary_cells,"['CL:0000738', 'CL:0000784', 'UBERON:0000178', 'UBERON:0003100', 'CL:0000451', 'CL:0000988']"
802,"{'cell line': 'PrEC', 'source_name': 'normal prostate epithelial cells PrEC', 'tissue': 'prostate'}",cell_line,"['CVCL:0061', 'CL:0002231', 'EFO:0000322', 'UBERON:0002367', 'CL:0000066', 'CL:0000010']"
803,"{'patient cohort': 'Control', 'source_name': 'Colon', 'tissue': 'Control right colon'}",tissue,"['UBERON:0008972', 'UBERON:0001155']"
804,"{'BioSampleModel': 'Human', 'age': '40 years', 'biomaterial_provider': 'Agilent Technologies', 'isolate': 'Lot no.', 'sex': 'female', 'tissue': 'Lung'}",tissue,"['UBERON:0003100', 'EFO:0001272', 'UBERON:0007023', 'UBERON:0002048', 'UBERON:0000170']"
805,"{'cell line': 'HEK293T-Rex', 'source_name': 'HEK293T-Rex DMSO (Vh)', 'tissue': 'kidney', 'treatment': 'DMSO'}",cell_line,"['CVCL:0063', 'EFO:0000727', 'CVCL:6D58', 'UBERON:0007220', 'CVCL:B501', 'EFO:0001184', 'UBERON:0002113', 'UBERON:0002120', 'EFO:0001082', 'EFO:0000322', 'CL:0000010', 'UBERON:0000323']"
806,"{'anatomical location': 'R neck, SC', 'anti-pd-1 response': 'Progressive Disease', 'biopsy time': 'pre-treatment', 'braf': 'V600E', 'disease status': 'M1c', 'gender': 'female', 'nf1': 'R2349C', 'patient id': 'Pt14', 'previous mapki': 'N', 'source_name': 'tumor biopsy_Progressive Disease', 'study site': 'UCLA', 'tissue': 'Melanoma biopsies', 'treatment': 'Pembrolizumab', 'vital status': 'Alive'}",tissue,"['DOID:1909', 'UBERON:0003100', 'EFO:0000727', 'EFO:0000616', 'UBERON:0000974', 'EFO:0000311', 'DOID:4', 'EFO:0000756', 'EFO:0000408', 'DOID:14566']"
807,"{'cell line': 'Parkin-expressing MRC5 fibroblasts', 'cell state': 'Proliferating', 'source_name': 'Prolif'}",cell_line,"['EFO:0003156', 'UBERON:0003101', 'CL:0000057', 'EFO:0000322', 'DOID:4', 'EFO:0002835', 'UBERON:0002048', 'CVCL:0440', 'CL:0000010', 'EFO:0000408']"
808,"{'cell type': 'CD8+ T cells', 'source_name': 'blood', 'subpopulation': 'CD62L+CX3CR1+'}",primary_cells,"['CL:0000738', 'UBERON:0000178', 'CL:0000084', 'CL:0000625', 'CL:0000542', 'CL:0000988']"
809,"{'cell line': 'IMR-32', 'cell type': 'neuroblastoma cells', 'degenerate linker': '25nt', 'source_name': 'HITS-CLIP_IMR-32_UV2', 'treatment': 'UV stressed'}",cell_line,"['EFO:0000621', 'CVCL:0346', 'UBERON:0003101', 'EFO:0003156', 'EFO:0001195', 'DOID:769', 'EFO:0000727', 'EFO:0000311', 'EFO:0007392', 'DOID:4', 'CL:0000031', 'UBERON:0000955', 'EFO:0000408', 'DOID:14566', 'EFO:0000616', 'CL:0000010', 'EFO:0000322']"
810,"{'diagnosis': 'papillary thyroid carcinoma', 'sample type': 'Tumor sample', 'source_name': 'Thyroid', 'tissue': 'thyroid'}",tissue,"['DOID:3963', 'EFO:0006858', 'EFO:0003769', 'EFO:0003841', 'EFO:0000616', 'EFO:0000311', 'EFO:0000313', 'DOID:3969', 'EFO:0000641', 'DOID:305', 'EFO:0000408', 'EFO:0002892', 'UBERON:0002046', 'DOID:14566', 'EFO:0001379']"
811,"{'cell type': 'H1', 'differentiation stage': 'mesoderm committed cells', 'differentiation time': '2 days', 'source_name': 'human embryonic stem cells (H1)'}",in_vitro_differentiated_cells,"['CL:0002322', 'CL:0000034', 'UBERON:0000926', 'EFO:0000795']"
812,"{'assayed molecule': 'ribo-RNA', 'cell line': 'H9 human embryonic stem cells (hESCs) (Day 0)', 'source_name': 'H9 nascent 4sU-labeled 60min ribo-RNA technical replicate 1', 'treatment': '3 h DRB 60 min 4sU-labeling'}",stem_cells,"['EFO:0000727', 'EFO:0003045', 'EFO:0000322', 'CVCL:9773', 'CL:0000034', 'CL:0002322', 'CL:0000010']"
813,"{'BioSampleModel': 'Human', 'age': 'not applicable', 'biomaterial_provider': 'Santiago Costantino', 'cell_line': 'ARPE-19', 'isolate': 'SC_F09_G_C36', 'sample_type': 'Single cell', 'sex': 'not determined', 'tissue': 'RPE', 'treatment': 'Non tagged'}",cell_line,"['UBERON:0001782', 'UBERON:0003101', 'CVCL:0145', 'EFO:0000322', 'EFO:0000727', 'UBERON:0000970', 'UBERON:0000966', 'EFO:0006271', 'CL:0000010']"
814,"{'cell type': 'Laser Capture microdissected MNs from post-mortem spinal cord', 'source_name': 'Human Lumbar spinal cord motor neurons'}",primary_cells,"['CL:0000100', 'CL:0011001', 'UBERON:0002792', 'CL:0000540', 'UBERON:0002240']"
815,"{'BioSampleModel': 'Human', 'age': '27', 'biomaterial_provider': 'not applicable', 'disease': 'leishmaniasis', 'disease_duration_days': '30', 'disease_stage': 'late', 'health_state': 'infected', 'hpgl_id': 'L6', 'infection_status': 'late_infection', 'isolate': 'not applicable', 'lesion_size_mm2': '252', 'library_prep_date': '5/4/2014', 'sample_type': 'biopsy', 'sex': 'male', 'tissue': 'skin', 'treatment': 'infected with Leishmania braziliensis MHOMBR75M2904 (late infection)'}",tissue,"['EFO:0005741', 'UBERON:0003101', 'DOID:9065', 'EFO:0000727', 'EFO:0005044', 'DOID:4', 'EFO:0000408', 'EFO:0001067', 'UBERON:0000014', 'EFO:0000962']"
816,"{'BioSampleModel': 'Human', 'age': '53', 'biomaterial_provider': 'Giuseppe Fiume', 'isolate': 'K562', 'sex': 'male', 'tissue': 'leukemia'}",cell_line,"['UBERON:0003101', 'DOID:1240', 'EFO:0000616', 'EFO:0000311', 'EFO:0001642', 'EFO:0000408', 'EFO:0000565', 'EFO:0000540', 'DOID:14566']"
817,"{'cell line': 'MOLM-14', 'shRNAi': 'shControl', 'source_name': 'MOLM-14 cells transduced with lentivirus encoding shRNAs targeting LacZ'}",cell_line,"['CVCL:7916', 'EFO:0000322', 'CL:0000010']"
818,"{'assayed molecule': 'nascent RNA', 'cell line': 'A375', 'cell type': 'malignant melanoma', 'source_name': 'A375 cells, 25 Î¼M A771726'}",cell_line,"['DOID:1909', 'UBERON:0003100', 'EFO:0000962', 'EFO:0000616', 'EFO:0000311', 'EFO:0002103', 'DOID:4', 'CVCL:0132', 'EFO:0000756', 'EFO:0000408', 'UBERON:0000014', 'DOID:14566', 'EFO:0000322', 'CL:0000010']"
819,"{'cell type': 'beta cell', 'donor': '1', 'source_name': 'Pancreas', 'subtype': '2', 'tissue': 'Pancreas'}",primary_cells,"['UBERON:0001264', 'CL:0000639', 'CL:0000169']"
820,"{'cell line': 'MCF10A', 'cell type': 'Non-tumorigenic immortalized breast epithelia line', 'source_name': 'MCF10A Cell Line', 'treatment': 'infection with adenovirus with MEK'}",cell_line,"['DOID:4', 'UBERON:0003100', 'UBERON:0008367', 'EFO:0000322', 'EFO:0000727', 'UBERON:0000310', 'EFO:0003156', 'EFO:0001200', 'EFO:0000408', 'UBERON:0001911', 'CVCL:0598', 'CL:0000066', 'CL:0000010']"
821,"{'age': '51', 'diabetes status': 'no', 'patient gender': 'male', 'patient race': 'white', 'patient survival status': 'Dead', 'source_name': 'pancreatic adenocarcinoma cancer tissue'}",tissue,"['EFO:0003860', 'EFO:0006858', 'EFO:0000228', 'EFO:0003769', 'EFO:0000616', 'DOID:299', 'EFO:0000311', 'UBERON:0003101', 'EFO:0000313', 'EFO:0003156', 'EFO:0002618', 'DOID:162', 'EFO:1000044', 'DOID:14566', 'EFO:0001379', 'DOID:4074', 'EFO:0000408']"
822,"{'age': '66', 'gender': 'male', 'source_name': 'Nasopharyngeal', 'tissue': 'Tumor', 'who class': 'III'}",tissue,"['UBERON:0003101', 'DOID:14566', 'EFO:0000616', 'EFO:0000408']"
823,"{'cell type': 'aortic vascular smooth muscle cells', 'source_name': 'Human aortic vascular smooth muscle cells', 'treatment': 'Cytosolic Hsp60 normal and TNF-alpha positive'}",cell_line,"['CL:0000359', 'CL:0000192', 'CL:0000187', 'EFO:0000727', 'CL:0008000']"
824,"{'BioSampleModel': 'Human', 'age': 'missing', 'biomaterial_provider': 'ATCC', 'cell_line': 'HK2', 'cell_subtype': 'empty stable', 'cell_type': 'Human', 'disease': 'normal cell line', 'isolate': 'Cell line', 'sample_type': 'cell line', 'sex': 'missing', 'tissue': 'kidney', 'treatment': 'HK2 Stable empty vector (pcDNA3.1) experiment 1 run 2'}",cell_line,"['UBERON:0003101', 'EFO:0000408', 'DOID:2615', 'EFO:0000322', 'EFO:0000727', 'DOID:4', 'UBERON:0007023', 'UBERON:0002113', 'CL:0000010', 'CVCL:0302', 'EFO:0002694', 'EFO:0002922', 'EFO:0001272']"
825,"{'analyte type': 'DNA; RNA', 'biospecimen repository': 'NCI_ProstateCancer_MetastaticCastrationResistant', 'biospecimen repository sample id': '01115244-TA4', 'gap_accession': 'phs000915', 'gap_consent_code': '1', 'gap_consent_short_name': 'DS-PC-MDS', 'gap_sample_id': '1739138', 'gap_subject_id': '1329202', 'is tumor': 'Yes', 'molecular data type': 'Whole Exome (NGS)', 'sex': 'male', 'study design': 'Case Set', 'study name': 'Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability', 'submitted sample id': '01115244-TA4', 'submitted subject id': '01115244', 'submitter handle': 'NCI_ProstateCancer_MetastaticCastrationResistant'}",tissue,"['UBERON:0003101', 'DOID:14566', 'EFO:0000616', 'EFO:0000408']"
826,"{'BioSampleModel': 'Human', 'age': 'not determined', 'biomaterial_provider': 'Cell Systems', 'isolate': 'human retinal microvascular endothelial cells', 'sex': 'not determined', 'tissue': 'retinal endothelial cell'}",cell_line,"['CL:0000115', 'CL:2000008']"
827,"{'BioSampleModel': 'Human', 'age': 'not applicable', 'biomaterial_provider': 'not applicable', 'isolate': 'not applicable', 'sex': 'not applicable', 'tissue': 'lung 17'}",tissue,"['UBERON:0002048', 'UBERON:0000170']"
828,"{'cell type': 'Neural Progenitor cells', 'infection status': 'mock infected', 'source_name': 'human Neural Progenitor cells'}",in_vitro_differentiated_cells,"['CL:0000034', 'CL:0000047']"
829,"{'cell condition': 'senescent', 'cell line': 'IMR90', 'cell type': 'fetal lung fibroblasts', 'source_name': 'IMR90 human fibrobasts', 'treatment': '100nM JQ1 48h', 'viral transduction': 'cotransduced with pWZL HRASV12 and shRen'}",cell_line,"['EFO:0001196', 'UBERON:0003100', 'CL:0000057', 'CL:0002553', 'UBERON:0007220', 'EFO:0000727', 'EFO:0003156', 'CVCL:0347', 'UBERON:0002048', 'EFO:0000322', 'CL:0000010', 'UBERON:0000323']"
830,"{'dek status': 'Control', 'diagnosis': 'Head and Neck Squamous Cell Carcinoma', 'hpv status': 'HPV+', 'source_name': 'HPV+ RNA-Seq Control'}",cell_line,"['EFO:0000181', 'EFO:0000616', 'EFO:0000311', 'EFO:0001668', 'UBERON:0001639', 'EFO:0000408', 'DOID:14566', 'DOID:5520']"
831,"{'cancer type': 'Non-small cell lung cancer (NSCLC)', 'perfusion group': 'high', 'source_name': 'Lung tumor'}",tissue,"['EFO:0000684', 'EFO:0000702', 'UBERON:0000170', 'EFO:0000616', 'EFO:0000311', 'EFO:0000313', 'EFO:0003818', 'EFO:0001071', 'UBERON:0002048', 'DOID:162', 'EFO:0006858', 'EFO:0003060', 'DOID:3908', 'DOID:14566', 'EFO:0000408']"
832,"{'BioSampleModel': 'Human', 'age': '31', 'biomaterial_provider': 'n/a', 'cell_line': 'Hela', 'cell_type': 'epithelial', 'disease': 'adenocarcinoma', 'ethnicity': 'black', 'isolate': 'shSmad3 replicate 2', 'race': 'African-American', 'sample_type': 'RNA', 'sex': 'female', 'tissue': 'cervix', 'treatment': 'untreated, replicate 2'}",cell_line,"['EFO:0001185', 'UBERON:0003100', 'EFO:0006858', 'EFO:0000228', 'CVCL:0030', 'EFO:0000322', 'EFO:0000727', 'EFO:0000311', 'EFO:0000313', 'CL:0000066', 'DOID:4', 'EFO:0000408', 'EFO:0003150', 'DOID:299', 'UBERON:0000002', 'DOID:14566', 'EFO:0000616', 'CL:0000010']"
833,"{'cell line': 'HepG2', 'gender': 'male', 'source_name': 'HepG2 cell line', 'tissue': 'hepatocellular carcinoma'}",cell_line,"['EFO:0001187', 'DOID:684', 'UBERON:0003101', 'EFO:0006858', 'CVCL:0027', 'EFO:0003769', 'EFO:0001421', 'EFO:0000322', 'EFO:0000182', 'EFO:0000311', 'EFO:0000313', 'DOID:4', 'EFO:0003156', 'DOID:305', 'EFO:0000408', 'DOID:14566', 'EFO:0000616', 'CL:0000010', 'UBERON:0002107']"
834,"{'cell type': 'acute myeloid leukemia, pre-leukemic hematopoietic stem cell', 'donorid': 'SU654', 'sample type': 'primary human leukemia cell from cryopreserved sample', 'source_name': 'pHSC'}",stem_cells,"['DOID:9119', 'DOID:1240', 'DOID:14566', 'EFO:0000616', 'CL:0000037', 'EFO:0000311', 'EFO:0001642', 'EFO:0000222', 'EFO:0000198', 'CL:0000034', 'EFO:0000408', 'EFO:0000565', 'EFO:0000540', 'CL:0000988']"
835,"{'BioSampleModel': 'Human', 'age': 'adult', 'biomaterial_provider': 'Clontech', 'isolate': 'mixture', 'sex': 'pooled male and female', 'tissue': 'kidney'}",tissue,"['UBERON:0003101', 'UBERON:0003100', 'UBERON:0002113', 'EFO:0001272', 'UBERON:0007023']"
836,"{'sample group': 'Control', 'source_name': 'IMR90 cells'}",primary_cells,[]
837,"{'cell type': 'hES/hiPS-derived neuron', 'source_name': 'hES/hiPS-derived neuron'}",in_vitro_differentiated_cells,"['EFO:0001929', 'CL:0000540', 'UBERON:0001464']"
838,"{'individual': 'patient 5 (low-grade glioma)', 'source_name': 'patient 5 (low-grade glioma), RNA-Seq of brain tumor tissue', 'tissue': 'brain'}",tissue,"['DOID:3070', 'EFO:0000616', 'EFO:0000311', 'EFO:0000326', 'UBERON:0000955', 'EFO:0000408', 'EFO:0005543', 'EFO:0003833', 'DOID:14566']"
839,"{'cell line': '1833', 'knockdown': 'Arg', 'metastasis': 'Bone metastasis', 'source_name': 'breast cancer cells', 'subtype': 'Triple negative'}",cell_line,"['EFO:0000311', 'EFO:0000616', 'UBERON:0002481', 'UBERON:0001474', 'DOID:1612', 'EFO:0000408', 'DOID:162', 'EFO:0000298', 'DOID:14566', 'EFO:0000322', 'CL:0000010']"
840,"{'clinical information': 'Control', 'gender': 'male', 'source_name': 'Amnion', 'tissue type': 'Amnion'}",tissue,"['UBERON:0003101', 'UBERON:0000305']"
841,"{'replicate': '1', 'source_name': 'Human Intestinal Epithelial Cells (HIECs)', 'time point': '72H', 'treatment': 'Mock'}",cell_line,"['CL:0002563', 'UBERON:0001277', 'CL:0000066', 'EFO:0000727']"
842,"{'BioSampleModel': 'Human', 'age': 'not applicable', 'biomaterial_provider': 'American Type Culture Collection', 'cell_line': 'Jijoye', 'cell_type': ""Burkitt's lymphoma"", 'isolate': 'not applicable', 'sex': 'not applicable', 'tissue': ""cell line, derived from Burkitt's lymphoma"", 'virus': 'Epstein-Barr virus, type 2'}",cell_line,"['DOID:4', 'UBERON:0003101', 'EFO:0000408', 'EFO:0000616', 'EFO:0000309', 'EFO:0000311', 'EFO:0001642', 'CL:0000236', 'CVCL:1317', 'EFO:0003150', 'EFO:0004561', 'EFO:0000540', 'EFO:0000574', 'EFO:0002215', 'DOID:14566', 'EFO:0000322', 'CL:0000010', 'DOID:0060058']"
843,"{'cell type': 'H7 hESC cell line', 'source_name': 'H7', 'time point': '20 days'}",in_vitro_differentiated_cells,"['EFO:0005738', 'CVCL:HA52', 'CVCL:9772', 'CL:0000010', 'EFO:0005904']"
844,"{'BioSampleModel': 'Human', 'age': 'three monthes', 'biomaterial_provider': 'hust', 'isolate': 'hela cells', 'sex': 'not applicable', 'tissue': 'Vagina'}",cell_line,['UBERON:0000996']
845,"{'cell line': 'H1', 'source_name': 'H1 human embryonic stem cells', 'treatment': 'ETOH'}",in_vitro_differentiated_cells,"['CL:0002322', 'EFO:0000322', 'EFO:0000727', 'CL:0000034', 'CL:0000010']"
846,"{'disease status': 'small cell lung cancer', 'source_name': 'tumor'}",tissue,"['DOID:4', 'EFO:0000702', 'EFO:0000616', 'DOID:14566', 'EFO:0000408']"
847,"{'BioSampleModel': 'Human', 'age': '2', 'biomaterial_provider': 'Telethon BioBank, C. Besta Institute, Milan, Italy', 'cell_type': 'Myotubes Upon Induction of Differentiation', 'dev_stage': 'infant', 'health_state': 'Healthy', 'internal_sample_id': '16', 'isolate': 'Cytosolic_RNA', 'race': 'Caucasian', 'sex': 'male', 'tissue': 'Muscle tissue'}",in_vitro_differentiated_cells,"['UBERON:0003101', 'UBERON:0002385', 'EFO:0001355', 'EFO:0003156', 'UBERON:0001015', 'CL:0002372', 'UBERON:0001630']"
848,"{'cell type': 'mixture of several clones', 'patient': 'csc3', 'source_name': 'mixture of several clones'}",tissue,[]
849,"{'analyte type': 'DNA; RNA', 'biospecimen repository': 'NHGRI_Melanoma_Garraway', 'biospecimen repository sample id': 'IPI_punch_tumor_Pat38', 'gap_accession': 'phs000452', 'gap_consent_code': '2', 'gap_consent_short_name': 'DS-M', 'gap_sample_id': '1786720', 'gap_subject_id': '1362400', 'is tumor': 'Yes', 'molecular data type': 'Whole Exome (NGS)', 'sex': 'male', 'study design': 'Case Set', 'study name': 'Melanoma Genome Sequencing Project', 'submitted sample id': 'IPI_punch_tumor_Pat38', 'submitted subject id': 'IPI_Pat38', 'submitter handle': 'NHGRI_Melanoma_Garraway'}",tissue,"['UBERON:0003101', 'DOID:14566', 'EFO:0000616', 'EFO:0000408']"
850,"{'cell_line': 'A2780', 'cell_type': 'ovarian cancer cell lines', 'isolate': 'not applicable', 'organism': 'Homo sapiens'}",cell_line,"['EFO:0003893', 'EFO:0000616', 'EFO:0000311', 'DOID:2394', 'EFO:0002394', 'EFO:0006362', 'EFO:0000408', 'DOID:162', 'DOID:14566', 'EFO:0000322', 'CL:0000010', 'CVCL:0134']"
851,"{'age category': '-', 'cell type': 'HFF', 'population doublings': '26', 'source_name': 'total RNA extracted from HFF cells'}",cell_line,[]
852,"{'cell line': 'U2OS', 'sample treatment': 'PUM2 plasmid', 'source_name': 'U2OS cells'}",cell_line,"['EFO:0000637', 'DOID:3347', 'UBERON:0003100', 'UBERON:0002481', 'EFO:0000322', 'EFO:0000727', 'EFO:0002869', 'UBERON:0001474', 'CVCL:0042', 'DOID:4', 'EFO:0003156', 'EFO:0000408', 'EFO:0000298', 'CL:0000010']"
853,"{'body_site': 'stomach_2', 'disease': 'gastrointestinal stromal tumor_2', 'geo_loc_name': 'South Korea', 'sample_type': 'tissue sample', 'specimen_voucher': 'Samsung Medical Center'}",tissue,"['EFO:0000616', 'EFO:0000311', 'DOID:9253', 'DOID:4', 'UBERON:0000945', 'EFO:0000408', 'DOID:14566']"
854,"{'cell line': 'Human osteosarcoma U2OS cells', 'source_name': 'shCac_C, repl 2', 'time': '48h', 'treatment': 'shRNA transfection'}",cell_line,"['UBERON:0001474', 'EFO:0000637', 'DOID:3347', 'UBERON:0003100', 'EFO:0000691', 'UBERON:0002481', 'EFO:0000616', 'EFO:0000727', 'EFO:0002869', 'EFO:0000311', 'EFO:0000726', 'CVCL:0042', 'DOID:4', 'EFO:0003156', 'EFO:0003820', 'EFO:0000298', 'DOID:14566', 'EFO:0000322', 'CL:0000010', 'EFO:0000408']"
855,{'cell_line': 'HeLa'},cell_line,"['EFO:0001185', 'UBERON:0003100', 'EFO:0000228', 'CVCL:0030', 'DOID:299', 'DOID:4', 'EFO:0000408', 'EFO:0003150', 'UBERON:0000002', 'EFO:0000322', 'CL:0000010']"
856,"{'BioSampleModel': 'Human', 'age': '62 years old', 'biomaterial_provider': 'ATCC', 'disease': 'pancreatic cancer', 'isolate': 'pancreatic adenocarcinoma cells', 'sample_type': 'replicate 1', 'sex': 'female', 'tissue': 'pancreatic adenocarcinoma cells', 'treatment': 'DMSO', 'treatment length': '6 hours'}",cell_line,"['EFO:0003860', 'DOID:1793', 'EFO:0006858', 'EFO:0000228', 'EFO:0000408', 'EFO:0003769', 'UBERON:0003100', 'EFO:0000616', 'DOID:299', 'EFO:0000727', 'EFO:0000311', 'EFO:0002618', 'DOID:4', 'UBERON:0007023', 'EFO:0000313', 'DOID:162', 'EFO:1000044', 'DOID:14566', 'EFO:0001379', 'DOID:4074', 'EFO:0001272']"
857,"{'cell or tumor type': 'synovial sarcoma', 'model': 'Fuji Xenograft model', 'source_name': 'Fuji Xenograft model', 'xenograft or pdx': 'xenograft'}",tissue,"['EFO:0000616', 'EFO:0000311', 'EFO:0001376', 'EFO:0000408', 'EFO:0003942', 'DOID:14566', 'DOID:5485']"
858,"{'cell type': 'cerebral organoid', 'source_name': 'human embryonic stem cells'}",in_vitro_differentiated_cells,"['CL:0002322', 'CL:0000034']"
859,"{'cell line': 'MCF7', 'passages': '14-17', 'sample type': 'Pleural effusion', 'source_name': 'Breast cancer cells', 'time': '80 min', 'treatment': 'E2'}",cell_line,"['DOID:4', 'UBERON:0000175', 'UBERON:0003100', 'EFO:0000228', 'EFO:0000322', 'EFO:0000311', 'DOID:299', 'UBERON:0001911', 'EFO:0000727', 'DOID:162', 'DOID:1612', 'EFO:0003156', 'UBERON:0007023', 'EFO:0000408', 'EFO:0001203', 'CVCL:0031', 'UBERON:0000310', 'DOID:14566', 'EFO:0000616', 'CL:0000010', 'EFO:0001272']"
860,"{'cell line': 'A1847', 'source_name': 'Ovarian Cancer Cell Line'}",cell_line,"['CVCL:9724', 'EFO:0000311', 'EFO:0000616', 'EFO:0003893', 'DOID:2394', 'EFO:0002394', 'EFO:0000408', 'DOID:162', 'DOID:14566', 'EFO:0000322', 'CL:0000010']"
861,"{'cell line': 'MCF-7', 'cell type': 'human breast cancer cells', 'gender': 'female', 'source_name': 'RNA-seq in MCF7 cells with shRNA-mediated knockdown of Luciferase as a control'}",cell_line,"['DOID:4', 'UBERON:0000175', 'UBERON:0003100', 'EFO:0000228', 'EFO:0000322', 'CVCL:0031', 'DOID:299', 'UBERON:0001911', 'EFO:0000311', 'DOID:162', 'DOID:1612', 'EFO:0003156', 'UBERON:0007023', 'EFO:0000408', 'EFO:0001203', 'UBERON:0000310', 'DOID:14566', 'EFO:0000616', 'CL:0000010', 'EFO:0001272']"
862,"{'cell line': 'HeLa', 'source_name': 'HeLa S3', 'treatment': 'MeOH'}",cell_line,"['EFO:0001185', 'UBERON:0003100', 'EFO:0000228', 'CVCL:0030', 'DOID:299', 'EFO:0000727', 'DOID:4', 'EFO:0000408', 'EFO:0003150', 'UBERON:0000002', 'EFO:0000322', 'CL:0000010']"
863,"{'cell type': 'Innate Lymphoid Cell 3', 'days post hiv-infection': '1', 'hiv status': 'HIV+', 'individual': '0450-318', 'source_name': 'Peripheral Blood', 'treatment': 'Untreated'}",primary_cells,"['UBERON:0000178', 'EFO:0005741', 'EFO:0000763', 'EFO:0000764', 'EFO:0000408', 'DOID:526']"
864,"{'medication': 'none', 'source_name': 'colorectal biopsy, sigma', 'tissue': 'benign'}",tissue,[]
865,"{'cell line': 'Kasumi-1', 'source_name': 'leukemic cell line derived from peripheral blood (contains t(8;21) chromosome translocation)', 'tissue': 'peripheral blood derived', 'transduction': 'Not transduced'}",cell_line,"['UBERON:0000178', 'UBERON:0003101', 'DOID:9119', 'EFO:0003164', 'EFO:0006607', 'EFO:0000222', 'DOID:4', 'EFO:0000408', 'EFO:0004024', 'CL:0000835', 'CVCL:0589', 'CL:0000010', 'EFO:0000322']"
866,"{'gender': 'female', 'hpv-status': 'Neg', 'source_name': 'squamous cell carcinoma', 'tumor stage': 'IVa'}",tissue,"['EFO:0000707', 'UBERON:0003100', 'EFO:0006858', 'DOID:1749', 'EFO:0000311', 'EFO:0000313', 'DOID:305', 'EFO:0000408', 'DOID:14566', 'EFO:0000616']"
867,"{'cell line': 'BT474', 'number of cells': '2 million', 'source_name': 'BT474 cells', 'tissue of origin': 'breast'}",cell_line,"['EFO:0003156', 'UBERON:0003100', 'CVCL:0179', 'EFO:0000322', 'UBERON:0000310', 'DOID:4', 'UBERON:0007023', 'EFO:0000408', 'UBERON:0001911', 'EFO:0000430', 'EFO:0001093', 'CL:0000010', 'EFO:0001272']"
868,"{'diagnosis': 'normal', 'patient': 'Patient 10', 'patient treatment status': 'Treatment-naÃ¯ve', 'sample type': 'Whole tissue', 'source_name': 'Colonic mucosa', 'tissue': 'Colonic mucosa'}",tissue,"['UBERON:0000317', 'UBERON:0000344', 'EFO:0000727', 'UBERON:0001155']"
869,"{'BioSampleModel': 'Human', 'age': 'not applicable', 'biomaterial_provider': 'not applicable', 'cell_line': 'SMMC-7721-2', 'isolate': 'not applicable', 'sex': 'not applicable', 'tissue': 'not applicable'}",cell_line,"['EFO:0000322', 'CL:0000010']"
870,"{'compound': '5,6-Dichloro-1-ÃŸ-D-ribofuranosylbenzimidazole', 'source_name': 'HeLa cells', 'treatment': 'Chemical treatment'}",cell_line,['EFO:0000727']
871,"{'BioSampleModel': 'Human', 'age': '68-year-old', 'biomaterial_provider': 'Erik W Thompson, Institute of Health and Biomedical Innovation and School of Biomedical Sciences, Queensland University of Technology, 60 Musk Avenue, Kelvin Grove, QLD 4059, Australia', 'cell_line': 'PMC42-ET', 'cell_subtype': 'parental', 'cell_type': 'breast cancer', 'disease': 'adenocarcinoma', 'disease_stage': 'metastatic', 'ethnicity': 'Caucasian', 'isolate': 'not applicable', 'replicate': 'biological replicate 3', 'sample_type': 'cell culture', 'sex': 'female', 'tissue': 'mammary gland/breast cancer; derived from metastatic site', 'treatment': 'control'}",cell_line,"['UBERON:0002530', 'UBERON:0003100', 'EFO:0006858', 'EFO:0000228', 'CVCL:5215', 'EFO:0000322', 'DOID:299', 'DOID:162', 'EFO:0000311', 'EFO:0000313', 'DOID:1612', 'DOID:4', 'EFO:0003156', 'UBERON:0007023', 'EFO:0000408', 'UBERON:0001911', 'DOID:14566', 'EFO:0000616', 'CL:0000010', 'EFO:0001272']"
872,"{'cell type': 'monocyte derived macrophage', 'individual': '1', 'organism': 'Homo sapiens'}",primary_cells,"['CL:0000738', 'CL:0000235', 'CL:0000988', 'CL:0000766']"
873,"{'source_name': 'brain', 'tumor type': 'glioblastoma (Grade IV)'}",tissue,"['EFO:0000272', 'EFO:0000616', 'DOID:3068', 'EFO:0000311', 'UBERON:0000955', 'EFO:0000408', 'EFO:0005543', 'DOID:14566', 'EFO:0000519']"
874,"{'BioSampleModel': 'Human', 'age': '20', 'biomaterial_provider': 'Carmen Marsit', 'isolate': 'Term placenta', 'sex': 'female', 'tissue': 'Term placenta'}",tissue,"['UBERON:0001987', 'UBERON:0003100']"
875,"{'agent': 'Actinomycin D', 'cell type': 'NPC', 'knockdown': 'TAF15', 'source_name': 'TAF15 KD 1hr', 'time': '1hr'}",in_vitro_differentiated_cells,[]
876,"{'BioSampleModel': 'Human', 'age': '0', 'biomaterial_provider': 'WiCell', 'isolate': 'ES04 embryonic stem cell-derived mesenchymal stem cells EXP2', 'sex': 'male', 'tissue': 'embryo'}",in_vitro_differentiated_cells,"['CL:0002322', 'UBERON:0003101', 'CL:0000034', 'CL:0000134', 'UBERON:0000922']"
877,"{'disease status': 'control', 'source_name': 'control_brain', 'tissue': 'brain', 'tissue subtype': 'dorsolateral prefrontal cortex'}",tissue,"['UBERON:0000955', 'EFO:0003534', 'UBERON:0009834']"
878,"{'differentiation day': 'day 12', 'source_name': 'embryonic stem cells'}",in_vitro_differentiated_cells,"['CL:0002322', 'CL:0000034']"
879,"{'cell type': 'Lymphocytes', 'genotype': 'L254F OGT', 'relationship': 'Affected nephew', 'source_name': 'Lymphoblastoids'}",cell_line,"['EFO:0005292', 'CL:0000738', 'CL:0000988', 'CL:0000542']"
880,"{'BioSampleModel': 'Human', 'age': 'not collected', 'biomaterial_provider': 'Xinxiang Medica University Lab, Laboratory of Molecular Oncology', 'cell_line': 'EC9706', 'cell_type': 'esophageal cancer', 'isolate': 'The transcriptomes were performed with PLCE1 inactivated human esophageal cancer cells by means of CRISPR/Cas11 technology', 'sex': 'not collected', 'tissue': 'cell line'}",cell_line,"['EFO:0000616', 'EFO:0000311', 'EFO:0000408', 'DOID:162', 'DOID:5041', 'CVCL:E307', 'DOID:14566', 'EFO:0000322', 'CL:0000010']"
881,"{'analyte type': 'RNA', 'biospecimen repository': 'NHGRI_NeuroendocrineProstateCancer', 'biospecimen repository sample id': 'WCMC119_1_C_RNA_Tumor', 'body site': 'Lymph node', 'gap_accession': 'phs000909', 'gap_consent_code': '1', 'gap_consent_short_name': 'GRU', 'gap_sample_id': '1722805', 'gap_subject_id': '1314188', 'histological type': 'Tissue', 'is tumor': 'Yes', 'molecular data type': 'RNA Seq (NGS)', 'sex': 'male', 'study design': 'Prospective Longitudinal Cohort', 'study disease': 'Adenocarcinoma', 'study name': 'Neuroendocrine Prostate Cancer (Trento/Cornell/Broad 2015)', 'subject is affected': 'Yes', 'submitted sample id': 'WCMC119_1_C_RNA_Tumor', 'submitted subject id': 'WCMC119', 'submitter handle': 'NHGRI_NeuroendocrineProstateCancer'}",tissue,"['UBERON:0000029', 'EFO:0000616', 'DOID:14566', 'UBERON:0003101', 'EFO:0000408']"
882,"{'batch': 'B', 'condition': 'Trisomic', 'source_name': 'Monocyte'}",primary_cells,"['CL:0000842', 'CL:0000738', 'CL:0000988', 'CL:0000766', 'CL:0000576']"
